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0.2 Abstract
Spt4/5 and its bacterial homologue NusG are the only known universally conserved RNAP-
associated transcription elongation factors. In the hyperthermophilic archaeon Methanocaldo-
coccus jannaschii, Spt5 comprises an N-terminal NGN domain and a C-terminal KOW domain,
and is bound at its NGN domain by Spt4. NusG and Spt5 increase the processivity of RNAP by
binding to the RNAP clamp via the NGN domain. This maintains the RNAP clamp in a closed
conformation, thereby enabling RNAP to remain bound to the template DNA. The NusG KOW
domain interacts with ribosomes, thereby coupling transcription to translation.
The functions of Spt4/5 in archaea are less well characterised. The work contained within this
thesis demonstrates that in the context of M. jannaschii cell extract, Spt4/5 is found in the same
fractions as ribosomes and RNAP, and therefore has the potential to couple transcription and
translation. Furthermore, data obtained by microscale thermophoresis suggests that the KOW
domain of Spt5 interacts with purified ribosomes.
Electron paramagnetic resonance was performed on Spt4/5, demonstrating that Spt5 is confor-
mationally flexible, and that the presence of Spt4 restricts its mobility. Limited proteolysis and
thermofluor assays support the notion that Spt4 stabilises the Spt5 NGN domain.
In E. coli, NusA binds to RNAP as a component of the antitermination complex, along with
NusG, NusB, and NusE. This enables RNAP to enter a pause and termination-resistant state.
M. jannaschii NusA consists of two KH domains. Mutational analysis identified the contribu-
tion of the two KH domains to RNA binding and identified additional residues involved in the
interaction. Archaeal NusA does not coelute with RNAP, raising the possibility that archaeal
NusA does not have antitermination functions.
In summary this thesis argues that Spt4/5 likely couples transcription and translation in archaea
and indicates that archaeal NusA binds to RNA via a novel binding site.
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16 1.1. Archaea
1.1 Archaea
Archaea were first identified as a class of organism distinct from both bacteria and eukaryotes
in 1977, based on the sequencing of 16S ribosomal RNA (Woese and Fox, 1977), leading to
their classification as a separate domain of life (Woese et al., 1990). Archaea are single-celled
organisms that can range from 0.1 to over 15 µm in length. Archaea exhibit a diverse range of
morphologies and some archaeal species form aggregates that can be 200 µm in length. Archaea
are often associated with living in extreme conditions (Chaban et al., 2006). They have been
observed to grow at temperatures as high as 121◦C (Kashefi and Lovley, 2003), and have also
been isolated from cold environments such as Antarctica (Cavicchioli, 2006). The archaeal genus
Picrophilus has been observed to grow at a pH very close to 0 (Schleper et al., 1995). However
archaea also inhabit fresh water and have been isolated from humans within the large intestine
(Miller and Wolin, 1982). One distinguishing feature of archaea is their cell membranes, which
comprise mainly glycerol-ether lipids (Gambacorta et al., 1995). This is in contrast to bacteria
and eukaryotes whose membranes are glycerol-ester based. In terms of metabolic pathways, ar-
chaea are more closely related to bacteria than to eukaryotes. The organisation of their genomes
is also closer to bacteria than to eukaryotes, being small and circular with genes often arranged
in operons. However, archaea are more reminiscent to eukaryotes with respect to information
processing. Archaeal DNA replication, transcription, and translation all closely resemble their
eukaryotic counterparts.
The precise origins of archaea is still under dispute, with two main arguments proposed (Grib-
aldo et al., 2010). The “three domains” hypothesis argues that bacteria, archaea, and eukaryotes
are three distinct lineages, each of which has its own common ancestor. Within the three domain
hypothesis, archaea and eukaryotes are “sister lineages” which share an ancestor prior to their
split (Figure 1.1A). In contrast, the “two domains”, or eocyte, hypothesis argues that there are
only two distinct lineages: bacteria and archaea (Figure 1.1B). According to the eocyte hypoth-
esis, eukaryotes arose as the result of a symbiotic relationship between bacteria and crenarchaea.
Thus within the two domains hypothesis eukaryotes are not a distinct lineage. (Williams et al.,
2013).
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Figure 1.1: Two hypotheses of the tree of life. A) In the traditional three-domain model there
are three distinct branches: bacteria, archaea and eukaryotes. Archaea and eukaryotes split
after the separation from bacteria. All archaea and eukaryotes can be traced back to a common
archaeal/eukaryotic ancestor. B) In the eocyte hypothesis there are only two distinct branches:
bacteria and archaea. Eukaryotes arose through a symbiotic relationship between crenarchaea
and bacteria. Thus archaea and eukaryotes do not all share a common archaeal/eukaryotic
ancestor.
The archaeal domain can be subdivided into distinct phyla. The two main archaeal phyla
are the crenarchaea and the euryarchaea. The crenarchaea are more closely related to eu-
karyotes than the euryarchaea, and include the well-studied species Sulfolobus solfataricus and
Sulfolobus acidocaldarius. The euryarchaea are less closely related to the eukaryotes and include
the methanogens and haloarchaea. Among the well-studied euryarchaea are Methanocaldococ-
cus jannaschii and Pyrococcus furiosus. Recently, several additional phyla of archaea have been
proposed. These include the korarchaea which have properties in common with both the cre-
narchaea and the euryarchaea (Elkins et al., 2008), the thaumarchaea which are closely related
to the crenarchaea but which are typically mesophilic (Brochier-Armanet et al., 2008), and the
nanoarchaea, of which there is currently only one characterised member, Nanoarchaeum equi-
tans. N. equitans has a genome of only 480 kb, making it the smallest cellular genome to be
sequenced (Brochier et al., 2005).
The work in this thesis seeks to enhance knowledge of transcription in the archaeon M. jannaschii.
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M. jannaschii is a euryarchaea that grows in hydrothermal vents at approximately 80◦C, under
high pressure and anaerobic conditions (Figure 1.2)1. M. jannaschii is a methanogen, which
generates energy through the reduction of CO2 to methane (Zhu et al., 2004). It was the first
archaeal species to have its complete genome sequenced (Bult et al., 1996). This identified that
is has one large chromosome of 1.66 mega basepairs, a large circular extra chromosome of 58
kilo basepairs, and a small circular extra chromosome of 16.5 kilo basepairs (Bult et al., 1996).
Interestingly the M. jannaschii genome is AT rich with only 30% GC content. However the
proteins have evolved to life at high temperatures. Compared to homologues from mesophilic
members of the Methanococcus phylum, M. jannaschii proteins contain more residues, with a
greater proportion being hydrophobic or charged (Haney et al., 1999).
Figure 1.2: A) M. jannaschii cells viewed under an electron microscope. M. jannaschii has
an uneven spherical shape and has flagella to enable motility. B) M. jannaschii grows at high
temperature and pressure in hydrothermal vents.
1.2 Transcription Overview
Transcription is the synthesis of an RNA polymer from monomeric nucleoside triphosphates
(NTPs), using a DNA template. The enzyme that carries out this process is called RNA poly-
merase (RNAP). This essential enzyme is found in all forms of life (Werner and Grohmann,
2011). Transcription can be divided into three key phases: initiation, elongation and termina-
1Figure 1.2 photos from https://microbewiki.kenyon.edu/index.php/Methanococcus jannaschii
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tion. During initiation the RNAP binds to the promoter and the DNA is melted, exposing the
template DNA bases. During elongation the RNAP moves along the DNA template catalysing
the addition of nucleotides to the 3′ end of the nascent RNA chain. Finally the RNAP must
dissociate from the template DNA and release the transcript during termination. After termi-
nation RNAP is free to initiate another round of transcription. Thus transcription is a cyclic
process.
1.3 RNA Polymerase Structure and Function
RNAPs from all three domains of life show a high degree of structural similarity with a char-
acteristic crab claw appearance (Campbell et al., 2001; Cramer et al., 2001; Hirata et al., 2008;
Werner and Grohmann, 2011) (Figure 1.3A). The catalytic subunits across the three domains
all contain a double-psi-β-barrel motif, suggesting that they originate from a common ancestor
(Werner and Grohmann, 2011). Bacterial RNAP is the simplest, containing five subunits: α1,
α2, β, β
′, and ω (Figure 1.3B). The β and β′ subunits make up the catalytic core and comprise
approximately 70% of the RNAP mass. The two α subunits are required for assembly of the
multi-subunit complex (Werner and Weinzierl, 2002). The ω subunit has a stabilising effect
on RNAP (Mukherjee and Chatterji, 1997). This core structure is conserved in archaeal and
eukaryotic RNAPs, which have homologues of all bacterial RNAP subunits plus a number of
additional subunits.
In archaea the two catalytic subunits (Rpo1 and Rpo2) are closely related to the bacterial β′
and β subunits. In many archaea the genes encoding the catalytic subunits have undergone
a gene splitting process. In P. furiosus the β′ homologue is encoded by Rpo1 and Rpo1′. In
M. jannaschii the β homologue has also split into two polypeptides, Rpo2 and Rpo2′ (Werner,
2007). The catalytic subunits contain the trigger loop and bridge helix (for substrate selection
and RNAP translocation respectively), two Mg2+ ions (one permanently bound, the other enters
with NTPs and leaves with PPi) and the clamp which encloses the DNA during transcription
(Werner and Grohmann, 2011). Archaeal RNAP contains four subunits that make up the assem-
bly platform (Rpo3, Rpo11, Rpo10 and Rpo12) in an analogous manner to the two α subunits
of bacterial RNAP. They form a stable heterotetrameric complex in vitro (Werner et al., 2000)
and all four are required for assembly of the polymerase (Werner and Weinzierl, 2002). Archaeal
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RNAP also contains a number of auxiliary subunits with additional functions (Rpo4, Rpo5,
Rpo6, and Rpo7) (Figure 1.3C). Rpo4 and Rpo7 form a stable sub-complex together and are
non-reversibly incorporated into the RNAP (Grohmann et al., 2009). Subunit Rpo6 is required
for the incorporation of Rpo4/7. When it is deleted from RNAP, the RNAP is unable to form a
stable complex with free Rpo4/7. Rpo5 contacts Rpo1 forming the lower jaw and is important
for open complex formation (Gru¨nberg et al., 2010).
Not all archaeal RNAPs have an identical subunit arrangement. Hyperthermophilic crenarchaea
and korarchaea also contain a subunit called Rpo8 which is not present in euryarchaea (Gru¨nberg
et al., 2010; Koonin et al., 2007). Rpo8 is homologous to the eukaryotic RNAPII subunit RPB8.
Crenarchaeal RNAP also contains a subunit called Rpo13 which has no known euryarchaeal nor
eukaryotic homologue. Structural data suggests that Rpo13 stabilises the downstream DNA-
RNAP interaction (Wojtas et al., 2012).
The most striking difference between bacterial and archaeal/eukaryotic RNAP is the presence of
the stalk domain that is composed of subunits Rpo4/7 in archaea and RPB4/7 in eukaryotes. In
M. jannaschii, the Rpo4/7 subcomplex has multiple functions. During transcription initiation it
promotes formation of the open complex and is necessary for the initiation factor TFE to stimu-
late transcription (Ouhammouch et al., 2004). During elongation it enhances the processivity of
RNAP (Hirtreiter et al., 2010b) and it also stimulates termination (Hirtreiter et al., 2010b). The
Rpo4/7 stalk guides the emerging transcript away from the RNAP (Hirtreiter et al., 2010b). In
eukaryotes, when RPB4/7 binds to RNAP, the RNA-interacting tip undergoes a loop-to-helix
conformational change (Armache et al., 2005). However, solution studies in M. jannaschii have
indicated that Rpo4/7 binding does not result in any large scale conformational change within
Rpo4/7 (Grohmann et al., 2010).
Bacteria and archaea have one RNAP which is responsible for the expression of all RNAs,
whereas eukaryotes have three to five distinct RNAPs (I, II, III, IV, and V) which share a con-
served core. RNAPII synthesises mRNAs that will be transcribed into proteins (Woychik and
Hampsey, 2002). Of the eukaryotic RNAPs, RNAPII is most similar to that found in archaea
(Figure 1.3D). The other eukaryotic RNAPs are more complex and have gained additional sub-
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Figure 1.3: Subunit and structural conservation of RNAPs across the three domains of life.
A) Bacteria, archaea and eukaryotes have a common core subunit composition. Archaeal and
eukaryotic RNAPs are more complex, with a number of additional subunits. B, C, and D) All
RNAPs have a common core ‘crabclaw’ structure with the two catalytic subunits forming the
‘pincers’ (grey and sand). The most obvious difference between bacterial and archaeal/eukaryotic
RNAP is the addition of the Rpo4/7 stalk. Bacterial RNAP: Thermus aquaticus (PDB 1HQM),
archaeal RNAP: Sulfolobus shibate (PDB 2Y0S), eukaryotic RNAPII: Saccharomyces cerevisiae
(PDB 1Y1V).
units to perform specific functions within the cell. RNAPI synthesises the precursors to the 18S,
28S, and 5.8S ribosomal RNAs (rRNA) (Grummt, 1998) within the nucleolus (Grummt, 2003),
comprising over 50% of cellular transcriptional output (Russell and Zomerdijk, 2006). RNAPIII
is mainly involved in the synthesis of tRNAs and the 5S rRNA (Schramm and Hernandez, 2002;
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Willis, 2005). RNAPIV and RNAPV are found only in plants (Herr et al., 2005) and are involved
in gene silencing through the synthesis of siRNAS and DNA methylation (Kanno et al., 2005;
Onodera et al., 2005).
1.4 Initiation and the Role of Basal Transcription Factors
1.4.1 Initiation in Bacteria
The first stage of transcription is called initiation, during which RNAP binds to the promoter and
opens the double-stranded DNA, forming the transcription bubble. Unlike DNA polymerase,
RNAP does not require a DNA or RNA primer to initiate transcription. RNAPs from all
three domains of life require additional factors to initiate transcription in a promoter-dependent
and start-site-specific fashion. However, these vary between bacterial and archaeal/eukaryotic
RNAPs. Bacterial RNAP requires only a sigma factor to initiate transcription in a sequence-
specific manner. σ factors recognise specific gene promoters (Paget et al., 2003) through associ-
ation with the -10 and -35 regions (Campbell et al., 2008) and promote open complex formation
(Browning and Busby, 2004). In bacteria, different σ factors enable gene-specific regulation of
transcription. In E. coli, the main class of σ factor, σ70, regulates expression of “housekeeping”
genes, which are required for normal growth. σH is σ70-like and promotes expression of genes
in response to heat shock (Browning and Busby, 2004). σ54 regulates the expression of genes
in response to nitrogen starvation. σ54 is the major class of alternative σ factor and recognises
regions -12 and -24. σ54 requires ATP hydrolysis from a hexameric AAA+ activator to melt the
DNA, in contrast to σ70 (Buck et al., 2000).
1.4.2 Initiation in Eukaryotes
Eukaryotic RNAPII initiation requires a host of basal initiation factors, namely TFIIA, TFIIB,
TFIID, TFIIE, TFIIF, and TFIIH. The basal initiation factors regulate the expression of all
genes, unlike the σ factors which enable gene-specific regulation. Initiation begins with the
binding of TATA-binding protein (TBP), a component of the TFIID complex that contains an
additional 13 proteins, to the TATA box. The TATA box is a region of DNA that is about 25 nu-
1.4. Initiation and the Role of Basal Transcription Factors 23
cleotides upstream from the transcription start site. TBP is a saddle-shaped protein that binds
in the minor groove of DNA (Kim et al., 1993a,b). The binding of TBP to the TATA box at the
promoter causes the DNA to bend 90◦ (Kim et al., 1993a,b). This enables TFIIB to bind. TFIIB
is composed of two domains; an N-terminal Zn-ribbon domain and a C-terminal core domain
which are connected by a flexible linker (Figure 1.4). The N-terminal domain recruits RNAP
to the initiation complex through interaction with the RNAP dock domain, and the C-terminal
domain binds to and stabilises the TBP-TATA complex (Bushnell et al., 2004). In addition,
the core domain of TFIIB makes sequence-specific contacts to a region of DNA called the B-
recognition element (BRE) (Lagrange et al., 1998). TFIIB stimulates abortive and full-length
transcription through insertion of a flexible region, called the B finger, deep into the catalytic
site of RNAP (Werner and Weinzierl, 2005). Furthermore, the TFIIB B reader facilitates the
separation of the DNA-RNA duplex, guiding the RNA towards the exit channel (Sainsbury et al.,
2013). After TFIIB has bound, a factor called TFIIA binds to the pre-initiation complex and
stabilises it by interacting with TBP of the TFIID complex (Buratowski et al., 1989). TFIIA
also acts as an anti-repressor, competing with repressors such as NC2 for binding to the pre-
initiation complex (Xie et al., 2000). Next, RNAP which is in complex with TFIIF binds to
the pre-initiation complex. TFIIF stabilises the pre-initiation complex. RNAP then recruits
TFIIE, which facilitates template DNA melting (Holstege et al., 1995). Finally a complex called
TFIIH binds. Separation of the duplex DNA to form the open complex requires energy from
ATP hydrolysis. This is achieved by a subunit of TFIIH called XPB (Gru¨nberg et al., 2012).
1.4.3 Initiation in Archaea
In archaea, initiation of transcription utilises just three basal factors: TBP, TFB, and TFE
(Werner and Weinzierl, 2005). Initiation in archaea therefore represents a streamlined version
of that found in eukaryotes. Initiation begins with the binding of TBP to the TATA box. In
archaea TBP binds to the TATA box by itself, rather than as part of a large complex. This
is followed by the binding of TFB. TBP and TFB are necessary and sufficient for initiation in
vitro. The third factor, TFE consists of a winged-helix domain and a zinc ribbon domain, and
is homologous to the N-terminus of eukaryotic TFIIEα (Bell et al., 2001). There is no complete
structure available for TFE, although the archaeal winged-helix domain alone has been solved by
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Figure 1.4: A) Crystal structure of TFIIB bound to RNAP (PDB 3K1F). TFIIB comprises an
N-terminal Zn ribbon domain which binds RNAP, and a C-terminal core domain which binds
to TBP. B) TFIIB binds to RNAP, inserting its B finger into the RNAP active centre.
X-ray crystallography (Meinhart et al., 2003) and the human zinc-ribbon domain from TFIIEα
has been solved by NMR (Okuda et al., 2004), enabling the generation of a homology model
(Grohmann et al., 2011). TFE binds to RNAP and stimulates the opening of the duplex DNA
through its interaction with the upstream end of the partially-formed transcription bubble (For-
get et al., 2004). In contrast to eukaryotes, no ATP hydrolysis is required for the formation of
the transcription bubble in archaea.
Figure 1.5: Comparison of the basal transcription machinery across the three domains of life.
A) Bacterial RNAP requires only a σ factor to initiate transcription in a promoter-specific man-
ner. Different σ factor classes provide gene-specificity. B) Archaea utilise three initiation factors
called TBP, TFB and TFE. C) Eukaryotes require many basal factors to initiate transcription
in a sequence-specific fashion. The same basal machinery is used for all genes.
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Bacteria Archaea Eukaryotes (RNAPII) Function
σ factors Sequence-specific recruitment of RNAP to
promoter, DNA strand separation, and pro-
moter escape
TBP TBP (component of TFIID complex) Recruits TF(II)B to promoter
TFB TFIIB Recruits RNAP to promoter, transcription
start site selection
TFE TFIIE Stimulates DNA melting, stabilises open com-
plex
TFIIA Stabilisation of pre-initiation complex and
cancelling out repressors e.g. NC2
TFIIF Stabilises pre-initiation complex
TFIIH DNA melting
Table 1.1: Summary of basal transcription factors across the three domains of life and their
function. Bacteria use just a sigma factor which binds the promoter, helps form the open
complex, and facilitates promoter escape. Archaea have three basal initiation factors to perform
these functions. Eukaryotes utilise many basal transcription factors.
After recruitment of the basal initiation factors, the open complex is formed in which about 14
basepairs of double-stranded DNA at the promoter are unwound. This exposes the nucleotide
bases of the template strand, enabling their base-pairing with incoming nucleotides. RNAP
then undergoes multiple rounds of abortive initiation during which small RNA products of 4-11
nucleotides in length are produced. In archaea and eukaryotes the short transcripts clash with
the B-reader of TF(II)B. Similarly in bacteria, the transcript clashes with σ region 3.2 (Mu-
rakami et al., 2002). Data obtained by FRET indicates that during initiation RNAP draws the
downstream template DNA into the active site, whilst the upstream DNA remains in a constant
position with respect to RNAP (Kapanidis et al., 2006). This has been explained by a scrunching
mechanism in which the unwinding of approximately one turn of DNA and the pulling of said
DNA into the active site results in a stressed intermediate. The stress is relieved either by disen-
gagement of RNAP with the downstream DNA (resulting in abortive initiation) or the escape of
RNAP from the promoter (Revyakin et al., 2006). During promoter escape in archaea and eu-
karyotes the 3′ end of the RNA transcript displaces the TF(II)B B-reader (Kostrewa et al., 2009).
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1.5 General Mechanism of Transcription Elongation
1.5.1 The Nucleotide Addition Cycle
RNAP catalyses the formation of a phosphodiester bond between the 3′ terminus of a nascent
RNA chain and an NTP using DNA as a template. The double-stranded DNA enters the RNAP
via the DNA-entry channel, which is located between the two RNAP ‘pincers’ of the catalytic
subunits. In order act as a template, double-stranded DNA must be progressively unwound to
expose the DNA bases of the template strand and to enable their base-pairing with the NTP
that is to be incorporated into the RNA chain. The incoming nucleotides enter the active site via
a pore called the secondary channel which has dimensions of 15 x 20 A˚. This is too small for the
passage of double-stranded DNA (Vassylyev et al., 2007b). During elongation RNAP undergoes
a repeated nucleotide addition cycle comprising of i) entry of the NTP into the RNAP active site
which subsequently base-pairs with the template DNA at position i+1, ii) the RNAP-catalysed
condensation reaction between the 3′ end of the nascent RNA chain which is in the i-site, and
the NTP which is in the i+1 site, iii) the release of PPi, and iv) translocation of RNAP one
nucleotide along the DNA such that the newly-incorporated nucleotide is now in the i-site. Ef-
ficient gene expression depends on this cycle being rapidly repeated up to thousands of times.
1.5.2 Role of the Bridge Helix and Trigger Loop
The RNAP translocation mechanism relies on a mobile element of the β′/Rpo1 subunit called
the bridge helix. The bridge helix has been observed in a straight conformation (Vassylyev et al.,
2007a) and in a kinked conformation (Vassylyev et al., 2002) (Figure 1.6). Molecular dynamics
studies suggest that there are two flexible hinges, called the N-terminal hinge and C-teminal
hinge, within the bridge helix that enable it to adopt the kinked conformation (Weinzierl, 2010).
The ability to undergo conformational changes is believed to be important in the nucleotide ad-
dition cycle. Mutations within the bridge helix that introduce a proline to destabilise the helix
and to induce kinking also increase the activity of RNAP in transcription assays (Tan et al.,
2008).
One hypothesised mechanism proposes that the bridge helix is in a straight conformation when
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Figure 1.6: The bridge helix has been observed in A) straight and B) bent conformations. The
interconversion between the straight and bent states is believed to be important for RNAP
translocation during elongation. The bridge helix spans residues β′ V1067 – H1103 in Thermus
thermophilus, from which A) and B) are both taken (PDB 2O51 and 1IW7 respectively).
the incoming nucleotide enters the i+1 site and during catalysis. The bridge helix then un-
dergoes a conformational change into the kinked state, translocating the nascent RNA such
that the newly incorporated 3′ end moves from the i+1 site into the i site. The bridge he-
lix then undergoes a conformational change back to the straight conformation, without further
translocation of RNA, preparing RNAP for incorporation of the next NTP (Gnatt et al., 2001).
RNAP translocates via a brownian-ratchet mechanism with only thermal fluctuations required
for RNAP translocation (Bar-Nahum et al., 2005). RNAP oscillates forwards and backwards in
a stochastic manner, fluctuating between the pre- and the post-translocated state. Upon NTP
binding the equilibrium is shifted such that RNAP tends towards the post-translocated state.
The RNAP oscillations have a distance of 3.4 A˚, consistent with the distance between two nu-
cleotides in B-form DNA (Abbondanzieri et al., 2005).
The Trigger Loop
Another important mobile element in the nucleotide addition cycle is the trigger loop, which is
also a component of the catalytic β′/Rpo1 subunit. The trigger loop is required for selection of
the correct nucleotide during elongation. In the absence of NTP it is disordered (Figure 1.7A).
However, in the presence of the correct NTP, it undergoes a structural transition and makes
contacts with the NTP ribose 3′ OH, the nucleotide base, and the β phosphate, resulting in the
enclosure of the nucleotide (Wang et al., 2006) (Figure 1.7B). If a mismatched NTP enters the
active site, the trigger loop will not enclose it, and catalysis will not occur. Mutations of the
trigger loop decrease the fidelity of RNAP (Fouqueau et al., 2013; Kaplan et al., 2008). Fur-
thermore, the trigger loop has a role in the hydrolysis of the 3′ nucleotide in backtracked RNAP
(Yuzenkova and Zenkin, 2010).
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Figure 1.7: The trigger loop is involved in substrate selection. A) If no nucleotide or a non-
cognate nucleotide is present in the active site, the trigger loop is disordered (PDB 2E2J).
GMPCPP is shown in the active site. B) Upon binding of the correct nucleotide into the active
site, the trigger loop undergoes a conformational change into its closed state where it encloses
the nucleotide, enabling catalysis to occur (PDB 2E2H). GTP is shown in the active site. Green:
trigger loop (S. cerevisiae RPB1 P1060 – L1101), black: DNA, orange: RNA, yellow spheres:
Mg-1 and Mg-2, blue: nucleotide.
1.5.3 The Clamp
The clamp is a mobile element of the Rpo1 subunit that exists in an open conformation in free
RNAP but which can rotate up to 30◦ about a switch region in yeast during transcription elon-
gation (Gnatt et al., 2001). The closing of the clamp enables the stable association of the DNA
and stabilises the elongation complex. In addition to the open and closed states, a collapsed
clamp state has also been observed in free RNAP in which the clamp is even more closed than
during elongation (Chakraborty et al., 2012). Within this state the DNA entry channel is too
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Figure 1.8: The nucleotide addition cycle begins after translocation with the 3′ terminus of the
nascent RNA chain in the i position (red). An NTP (purple) enters the i+1 site and basepairs
with the template DNA (blue). The trigger loop (green) then undergoes a conformational change,
enclosing the nucleotide and catalysis occurs. The NTP is incorporated into the RNA chain and
PPi is released. The bridge helix (black) undergoes a conformational change, resulting in the
translocation of the DNA-RNA hybrid within the active site so that the 3′ terminus is once again
in the i site, enabling the cycle to begin again. Figure inspired by (Cramer et al., 2008).
narrow to enable the loading of DNA, and it is not therefore apparent whether the collapsed
state has a biological function.
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1.5.4 Additional Mobile Elements
During elongation the transcription bubble is maintained. The downstream DNA must contin-
ually be separated, whilst at the 5′ end of the transcription bubble the DNA-RNA hybrid must
be melted and the template and non-template DNA strands must reanneal. A number of mobile
elements within RNAP facilitate these functions. Fork loops 1 and 2 separate the template and
non-template DNA strands at the downstream edge of the transcription bubble. The zipper
functions in the reannealing of the two DNA strands. A region called the wall limits the length
of the DNA-RNA hybrid to 8-9 basepairs and also causes the template strand to bend 90◦ in its
exit path from RNAP. The rudder contributes to the stability of the elongation complex (Cramer
et al., 2001; Gnatt et al., 2001; Kuznedelov et al., 2002).
1.5.5 Catalytic Mechanism of RNAP
Catalysis occurs by a conserved two-metal mechanism (Steitz, 1998) involving two Mg2+ ions
that are coordinated by three evolutionary conserved aspartates (Zaychikov et al., 1996) of the
absolutely conserved DXDGD motif. One of the Mg2+ ions, referred to as Mg-1, is permanently
bound within the RNAP active site by the aspartates. The other Mg2+ ion, referred to as Mg-2,
enters with every NTP, associated with the β and γ phosphates, and leaves with the liberated
PPi. Structural data suggests that the incoming NTP initially binds to a pre-insertion site, be-
fore being ‘flipped’ 180◦ into the insertion site, where it is appropriately aligned for incorporation
into the transcript (Westover et al., 2004). The 3′ OH group at the 3′ terminus of the nascent
RNA chain is coordinated by Mg-1, yielding an activated 3′ O−. The activated 3′ terminus then
nucleophilically attacks the α phosphate of the NTP in an SN2 reaction and an electron pair is
subsequently transferred to the β phosphate resulting in the release of PPi (Figure 1.9). RNAP
also has exonuclease activity, for example when non-complementary nucleotides enter the active
site (Sosunov et al., 2003).
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Figure 1.9: Catalytic mechanism of RNAP. The 3′ OH of the nucleotide in the i site is activated by
Mg-1 and nucleophilically attacks the α phosphate of the incoming nucleotide. An electron pair
is subsequently transferred to the β phosphate of the incoming nucleotide and PPi is liberated.
1.5.6 The Role of RNA-Processing Factors
RNAP frequently pauses and backtracks along the DNA template (Werner and Grohmann, 2011).
Pausing is believed to play a fundamental role in gene expression (Landick, 2009), for example by
enabling the recruitment of transcription factors and by enabling RNA folding and attenuation
mechanisms to occur. Pausing also means that elongation by RNAP is inherently inefficient
and discontinuous. In order to overcome this, elongation requires processivity and transcript
cleavage factors. RNAP backtracking results in the 3′ end of the transcript protruding into
the NTP-binding site, preventing the addition of further nucleotides (Komissarova and Kashlev,
1997). To overcome this the RNAP must cleave the 3′ end of the transcript resulting in a new
3′ terminus at the active site. While RNAP can carry out this exonucleic cleavage by itself, it
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is aided by the cleavage factors. These are called Gre factors in bacteria and TFS in archaea
(TFIIS in eukaryotes). The bacterial and archaeal/eukaryotic cleavage factors share no sequence
or structural identity. However they function in the same manner. GreB in bacteria comprises
an N-terminal and a C-terminal domain. The N-terminal domain of GreB is a coiled-coil that
binds to the RNAP secondary channel and extends 45 A˚ into the active site. Two absolutely
conserved acidic residues (one aspartate, one glutamate) play a critical role through interactions
with the two Mg2+ ions, stimulating transcript cleavage (Opalka et al., 2003). In eukaryotes
TFIIS contains three domains (domain I, domain II, and domain III) and an inter-domain linker
between domains II and III. Domain I is poorly conserved and not required for TFIIS activity
(Nakanishi et al., 1995). Domain II is α helical in structure. Along with the inter-domain linker,
it is required for binding to RNAP subunits RPB1 and RPB9. Domain III is folded into a zinc-
ribbon. Like GreB, it extends into the RNAP secondary channel where two acidic residues at
the end of a hairpin (one aspartate, one glutamate) are in close proximity to Mg-1 (Kettenberger
et al., 2003), resulting in promotion of RNAP nuclease activity (Figure 1.10). Whole-genome
sequencing revealed that TFIIS also functions on RNAP III-expressed genes (Ghavi-Helm et al.,
2008). The bacterial Gre factors are non-essential, since knocking them out is not lethal to cells
(Stepanova et al., 2007). In eukaryotes TFIIS is also non-essential. In yeast, TFIIS knockouts
are viable but display increased sensitivity to oxidising substances (Koyama et al., 2003). This
suggests that intrinsic transcript cleavage by RNAP is important for viability (Sigurdsson et al.,
2010).
1.6 Transcription Termination
1.6.1 Termination in Bacteria
Transcription termination can occur by two mechanisms in bacteria: intrinsic and factor-dependent.
Intrinsic termination is mediated by RNA secondary structure and is encoded by a GC-rich hair-
pin, followed by a polyU stretch. It is believed that the polyU:polyA RNA:DNA hybrid, which
has fewer hydrogen bonds than hybrids containing GC regions, facilitates the disengagement of
RNAP from the ternary complex. Factor-dependent termination requires a hexameric helicase
called rho.
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Figure 1.10: TFIIS bound to RNAP from S. cerevisiae (PDB 1Y1V). TFIIS binds to the sec-
ondary channel of RNAP, where it extends into the active site. Two conserved acidic residues
(black) coordinate Mg-1, stimulating transcript cleavage. A) Complete RNAP structure shown.
B) Close-up showing coordination of the magnesium ion by TFIIS. RNAP subunits RPB1, RPB2,
and RPB9 only are shown.
There is ongoing debate regarding the mechanism by which rho acts to stimulate efficient termi-
nation. Classical models postulate the rho hexamer translocating along the emerging transcript
in a 3′-5′ direction until it collides with the RNAP pushing it away from the RNA. Alterna-
tively ATP hydrolysis results in the RNA being pulled out of the active site. More recently an
allosteric mechanism has been suggested. In this model rho can bind to RNAP in the absence of
RNA. UV crosslinking demonstrated close proximity between rho and the large catalytic β and
β′ subunits. The ratio of rho-β and rho-β′ crosslinked adducts changes depending on whether
the RNAP is paused at a rho utilisation (rut) site. The crosslinking on the β′ subunit was then
mapped to the trigger loop. Since this is a highly mobile element, it was suggested that rho
binding might affect conformational changes in the trigger loop. Mutants of the trigger loop were
then shown to affect the efficiency of rho termination and antibiotics that stabilise the closed
trigger loop conformation prevented rho termination occurring (Epshtein et al., 2010). Other
studies, however, present conflicting evidence, suggesting that rho and RNAP form part of the
same complex only in elongation complexes where the nascent RNA is long and contains a rut
site (Kalyani et al., 2011).
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1.6.2 Termination in Eukaryotes
In eukaryotes transcription termination requires a 5′-3′ exoribonuclease called Rat1/Xrn2 which
is recruited to RNAPII via the poly(A) stretch at the 3′ end of the transcript and also to the
C-terminal tail of RNAPII (Kim et al., 2004; West et al., 2004). After transcribing the poly(A)
tail, RNAPII pauses and recruits proteins such as CPSF which process the 3′ end of the tran-
script. The 3′ processing enzymes are thought to create a free 5′ end for the Rat1/Xrn2 which
can degrade the RNA until it reaches the RNAPII, disengaging it from the DNA (Richard and
Manley, 2009).
1.6.3 Termination in Archaea
In archaea termination occurs at a polyU stretch within the transcript (poly dT in the template
DNA) and the Rpo4/7 stalk increases termination efficiency in vitro (Hirtreiter et al., 2010a).
Termination still occurs when the terminator sequences are not predicted to form hairpins, un-
like in bacteria (Santangelo et al., 2006). No factor-dependent termination has been observed in
archaea. However, the fact that bacteria and eukaryotes both have factor-dependent termination
makes it likely that archaea do too. One candidate which may function in termination is Mj0669.
Mj0669 is a putative DEAD box RNA helicase which contains motifs characteristic of helicases
such as the Walker A and Walker B sequences (Story et al., 2001). A crystal structure has been
solved but no functional analyses have been carried out.
1.7 The Universally Conserved Elongation Factors
Spt4/5 and NusG
Spt4/5 is the only universally conserved RNAP-associated transcription factor (Werner and
Grohmann, 2011) and as such is one of the most ancient proteins involved in transcription reg-
ulation (Harris et al., 2003). In bacteria NusG (the Spt5 homologue) consists of two domains: a
NusG N-terminal domain (NGN) and a C-terminal Kyrpides-Ouzounis-Woese domain (KOW)
(Kyrpides et al., 1996) (Figure 1.11A). In E. coli NusG is an essential protein. However, in
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Bacillus subtilis and Staphylococcus aureus there is no loss of viability when NusG is deleted
(Ingham et al., 1999; Xia et al., 1999). Archaea and eukaryotes retain the core structure found
in bacteria, with a number of additions. Archaeal and eukaryotic Spt5 is bound at the NGN do-
main by a smaller protein called Spt4 (Hirtreiter et al., 2010a; Ivanov et al., 2000; Wenzel et al.,
2010) (Figure 1.11B). Unlike Spt5, Spt4 is not essential for cell viability (Malone et al., 1993).
No Spt4 homologue has been discovered in bacteria (Guo et al., 2008). Eukaryotic Spt5 also
contains multiple KOW domains and C-terminal heptad repeats which can be phosphorylated
(Ivanov et al., 2000) (Figure 1.11C). In humans the heptad repeats function in an analogous
manner to the CTD of RNAPII, with phosphorylation of Thr-4 by P-TEFb being a requirement
for the activation of the elongation-enhancing properties of Spt5 (Yamada et al., 2006).
Figure 1.11: Schematic representation of NusG and Spt4/5 across the three domains of life.
A) Bacterial NusG contains an N-terminal NGN domain and a C-terminal KOW domain. B) In
archaea, the NGN domain of Spt5 is bound by Spt4 (purple). C) Eukaryotic Spt4/5 contains
multiple KOW domains and heptad repeats (orange) at its C terminus.
The NGN domain of Spt5 from M. jannaschii consists of a four-stranded antiparallel β sheet,
surrounded by three α helices. The KOW domain of Spt5 is comprised of five β strands which
fold to form a compact barrel. The two domains do not interact with each other (Burmann
et al., 2011; Mooney et al., 2009b) and are connected by a flexible linker (Figure 1.12). Spt4 is
composed of a four-stranded antiparallel β sheet and interacts with the NGN domain of Spt5 via
a hydrophobic interface forming a continuous eight-stranded β sheet. Four conserved cysteines
in Spt4 coordinate a zinc atom (Hirtreiter et al., 2010a). The NGN domain of Spt5 does not
undergo any structural reorganisations upon binding Spt4 (Zhou et al., 2009).
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Figure 1.12: Homology model of M. jannaschii Spt4/5. Spt5 is in green. Spt4 is stably associated
with the Spt5 NGN domain.
1.7.1 Spt4/5 and NusG are Versatile Multifunctional Transcription
Factors
The primary function of Spt4/5 is to increase the processivity of RNA polymerase, and it stim-
ulates transcription elongation in vitro (Hirtreiter et al., 2010a). The NGN domain of Spt5 is
necessary for elongation stimulation in archaea, but not sufficient. In addition it requires either
the KOW domain or Spt4 (Hirtreiter et al., 2010a). Site-directed mutagenesis studies demon-
strated that Spt4/5 binds to the coiled-coil of the RNAP clamp via a small hydrophobic patch
on the NGN domain (Hirtreiter et al., 2010a). The clamp is a regulatory ‘hotspot’ and is bound
by a number of factors that modulate transcription, including the initiation factor TF(II)E
(Grohmann et al., 2011), the σ2 domain in bacteria (Sevostyanova et al., 2008) and the TFIIB
linker region in eukaryotes (Kostrewa et al., 2009). NusG proteins also make contacts with the
β gate loop of RNAP which results in the enclosing of the DNA-binding channel (Sevostyanova
et al., 2011) and prevents nucleic acid escape from the elongating RNAP. Vice versa Spt4/5
binding to non-transcribing RNAP inhibits DNA loading and non-specific initiation (Grohmann
et al., 2011). This may not hold true for eukaryotic Spt4/5, where in vitro data suggests that
Spt4/5 can only efficiently bind elongation complexes that have already transcribed at least 30
nucleotides of RNA (Cheng and Price, 2008). However, ChIP analysis indicates that Spt4/5 is a
component of the elongation complex immediately after promoter escape suggesting that it can
bind to RNAP in the absence of a long transcript (Mayer et al., 2010).
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1.7.2 Structure of RNAP-Spt4/5 Complexes
A cryoEM structure showed that when Spt4/5 is bound to RNAP, it encloses the active site
(Klein et al., 2011). A high-resolution crystal structure of Spt4/5 NGN in complex with a
recombinant RNAP clamp domain has also been obtained. This was then fitted to RNAP
structures, confirming the conclusions drawn from the cryoEM data and providing much more
detailed information on the specific interactions between Spt4/5 and RNAP (Martinez-Rucobo
et al., 2011) (Figure 1.13).
Figure 1.13: Spt4/5-RNAP complex structures. A) Crystal structure of S. shibate RNAP (PDB
2Y0S). The clamp coiled-coil helices are indicated in red. B) Crystal structure of P. furiosus
Spt4/5 bound to recombinant RNAP clamp (PDB 3QQC). Spt5 NGN: green, Spt4: purple.
C) Fitting of the P. furiosus Spt4/5 recombinant clamp structure to the S. shibate RNAP
structure.
In addition to the structural model, an allosteric mechanism of NusG-like proteins has also been
proposed (Svetlov et al., 2007). The coiled-coil to which the NGN domain of Spt5 binds is part of
the RNAP clamp and is 75 A˚ from the active centre. At the base of the clamp is the bridge helix
and trigger loop, which are mobile elements that are important for translocation and substrate
selection respectively. Therefore Spt4/5 binding to the coiled-coil of the clamp may induce a
conformational change within the clamp, the effects of which could be amplified in the trigger
loop and active centre, thereby increasing the processivity of RNAP.
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1.7.3 Molecular Mechanisms of Spt4/5 During Promoter Escape
The transcription initiation factor TFE binds to the same region of RNAP as Spt4/5. Single
molecule FRET based NPS analysis showed that the winged helix domain of TFE, like the NGN
domain of Spt5, interacts with the tip of the RNAP coiled-coil, while the zinc ribbon domain of
TFE interacts with the clamp and Rpo4/7 stalk of RNAP. Mutagenesis of the RNAP confirmed
these binding sites. It was then shown that TFE and Spt4/5 compete for the binding of this
site. The addition of Spt4/5 to the pre-initiation complex inhibits promoter-directed transcrip-
tion initiation. However in order to displace TFE in the pre-initiation complex Spt4/5 had to be
at a 50 times higher concentration than TFE. This shows that in the initiation complex RNAP
has a higher affinity for TFE than for Spt4/5. However, once promoter escape has occurred
RNAP has a greater affinity for Spt4/5 over TFE and ‘swaps’ the transcription factors in favour
of Spt4/5 (Grohmann et al., 2011). In bacteria the initiation factor σ70 competes with the NusG
paralogue RfaH for binding to the RNAP clamp in an analogous manner (Sevostyanova et al.,
2008).
1.7.4 Molecular Mechanisms of NusG During the Coupling of
Transcription and Translation
In prokaryotic cells there is no compartmentalisation and the processes of transcription and
translation are not separated by a nuclear membrane, enabling them to be coupled in bacteria
and archaea (French et al., 2007). This allows the transcriptional output to be adjusted for the
translational requirements. This increases energy efficiency which is advantageous for single-
celled species that are growing under stress conditions and that are in constant competition
with each other for resources. As soon as the ribosome-binding site on the transcript emerges,
the ribosome can initiate translation while the RNA is still being transcribed. There have been
reports of transcription-translation co-regulation for over 30 years. In an operon, distal genes are
often less frequently transcribed. This is because during gene expression the distance between
RNAP and the ribosome increases, resulting in increased termination by rho (Richardson, 1991).
This phenomenon is called polarity.
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Attenuation
Attenuation is a mechanism in which the ribosome regulates transcription. The trp operon con-
tains the genes involved in the synthesis of tryptophan (Yanofsky, 1981). During transcription,
the trp leader RNA can fold in two conformations. The first is a termination hairpin that pre-
vents expression of the operon. The second is an antiterminator structure that allows the RNAP
to express the genes within the operon. The levels of tryptophan present in the cell regulate its
further expression. The operon leader sequence, trpL, is about 130 nucleotides long and contains
four sequences that are complementary to each other. The first of these sequences contains
two adjacent codons for tryptophan. When tryptophan is abundant in the cell there is enough
charged tRNATrp for the ribosome to read through the two Trp codons rapidly. The ribosome
occludes sequences 1 and 2. This results in the termination hairpin being formed between se-
quences 3 and 4 and the RNAP will not transcribe the operon (Figure 1.14A). If the levels of
tryptophan in the cell are low then the ribosome will stall at the two tryptophan codons as there
will not be enough charged tRNATrp. When the ribosome stalls here it occludes sequence 1
only, enabling the antitermination hairpin to form between sequences 2 and 3 and thereby pre-
venting formation of the termination hairpin. Therefore RNAP is able to transcribe the genes
of the operon (Figure 1.14B). Thus the rate of translation of the leader sequence determines the
secondary structure of the RNA and controls transcription of the operon. This mechanism is
not exclusive to the trp operon. The his operon, which contains the genes required for histidine
biosynthesis, contains seven adjacent His codons. In a similar fashion to the trp operon, when
histidine is abundant, the ribosome reads through the histidine codons and a terminator struc-
ture forms preventing expression of the operon. When histidine is scarce the ribosome pauses at
one of the seven histidine codons, occluding the terminator from forming and enabling expression
of the operon (Chan and Landick, 1993, 1989).
More recently, it has become apparent that not only are transcription and translation co-
regulated but that they are also directly coupled through their respective machinaries, RNAP
and the ribosome. An NMR study by Burmann et al. analysed the interaction between the ri-
bosomal protein S10 and NusG (Burmann et al., 2010b). HSQC experiments demonstrated that
the KOW domain of NusG binds to S10 mainly through hydrophobic interactions (Figure 1.15).
Titration experiments indicate a Kd of 50 µM for this interaction. S10 is a component of the
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Figure 1.14: Mechanism of attenuation on the tryptophan operon. A) When tryptophan is
abundant, the ribosome is able to readily translate through the two adjacent tryptophan codons
(yellow stars) of sequence 1, and it occludes sequences 1 and 2. Therefore a terminator hairpin
forms between sequences 3 and 4, preventing further transcription of the operon by RNAP.
B) When tryptophan is low, the ribosome stalls at the two adjacent tryptophan codons of
sequence 1, and it occludes sequence 1 only. Therefore a hairpin forms between sequences 2 and
3, and no terminator is formed. This enables expression of the operon.
small ribosomal subunit and has also been identified as an antitermination factor (Friedman
et al., 1981).
The ribosome binding face of S10 is still accessible when it is in complex with NusG and the
authors propose a model whereby NusG acts to bridge the translating ribosome to the elongat-
ing RNAP. Taking an alternative approach, a study by Proshkin et al. uses an in vivo system
to monitor the rates of translation elongation and transcription elongation (Proshkin et al.,
2010). Using antibiotics to specifically modulate ribosome translocation they demonstrated that
a decrease in the rate of translation is accompanied by a decrease in the rate of transcription.
Additionally mutants with slow ribosomes also showed a decreased rate of transcription. The
use of antibiotics to partially rescue this mutant resulted in a recovery of transcription rates. In
summary, they showed that the rates of transcription and translation are matched so that for
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Figure 1.15: NMR structure of the NusE-NusG complex. NusE (S10) is in blue, NusG KOW
domain is in green. PDB 2KVQ.
every amino acid incorporated into the nascent chain, three nucleotides are added to the tran-
script (Proshkin et al., 2010). Since each codon consists of three nucleotides this provides very
strong evidence that transcription and translation are coupled in E. coli. An in vitro system to
study the coupling of transcription and translation has been developed for E. coli which utilises
purified ribosomes and recombinant transcription/translation factors. This has the potential to
explore the phenomenon of transcription-translation coupling in molecular detail. However, the
role of NusG has not yet been analysed in this system (Castro-Roa and Zenkin, 2012).
The ribosome also helps prevent RNAP backtracking and facilitates the read-through of road-
blocks (Proshkin et al., 2010). RNAP can get stuck in an unproductive backtracked state where
the 3′ end of the transcript is no longer in the active site (Komissarova and Kashlev, 1997; Reeder
and Hawley, 1996). This prevents the addition of further nucleotides. The ribosome ‘pushes’
RNAP forward and out of the backtracked state (Proshkin et al., 2010). This complements
earlier data which showed that if RNAP is stuck in a backtracked state, a second transcribing
RNAP behind it can push it out of this state with no cleavage of RNA required (Epshtein and
Nudler, 2003; Epshtein et al., 2003).
S10 Interactions Within the Ribosome
Within the ribosome S10 makes multiple protein-protein, and protein-RNA contacts (Figure 1.16).
It contacts the ribosomal proteins S3 and S14, and it contacts RNA helices H31, H34, H38, H39,
H41, and H43 of the 16S rRNA. A long β hairpin protrudes deep into the ribosome (Wim-
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berly et al., 2000). The structure of S10 within the ribosome (Figure 1.16D) initially appears
dramatically different and much more elongated compared to that of free S10 (Figure 1.16E).
However, the apparent differences are because the elongated ribosome-binding loop was deleted
in the structure of free S10 (Luo et al., 2008). In both structures, the core globular domain
of S10 contains two α helices. In ribosome-incorporated S10, the rest of the core appears not
to adopt a canonical secondary structure. In free S10, this region comprises four β strands
which form a continuous antiparallel sheet. However, the overall conformation of the S10 core
is similar in both structures, suggesting that it does not undergo global refolding to convert it
from a ribosomal protein into an antitermination factor (Luo et al., 2008). In both free S10 and
ribosome-incorporated S10, the residues that interact with the NusG KOW domain are accessi-
ble (Figure 1.17).
1.7.5 NusG as a Suppressor of Foreign DNA
The NusG KOW domain interacts with the termination factor rho (Burmann et al., 2010b; Li
et al., 1993) and stimulates transcription termination (Sullivan and Gottesman, 1992). One
study, looking at the effects of rho on a whole-genome level, found that when rho is inhib-
ited by the antibiotic bicyclomycin there is an increase in expression of non-coding regions and
horizontally transferred genes from bacteriophage and other species. When these horizontally
transferred genes are deleted to make a synthetic strain, MDS42, E. coli becomes much more
resistant to bicyclomycin treatment. One of the deleted genes in this strain is the lambdoid bac-
teriophage gene rac, which inhibits cell division. If rac alone is deleted, bicyclomycin resistance
also occurs, suggesting that rho acts to prevent expression of this lethal gene. In cells where kil
is deleted, nusG and nusA can also be deleted, even though they are essential to the wild-type
cell. This suggests that NusG and NusA act with rho to terminate transcription of the kil gene
(Cardinale et al., 2008).
1.7.6 RfaH - A Bacterial NusG Paralogue
RfaH is a paralogue of NusG. Like NusG it increases the processivity of RNAP and reduces
RNAP pausing at regions where backtracking occurs. However, while NusG is involved in the
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Figure 1.16: S10 in the context of the ribosome. A) The 30S subunit of the T. Thermophilus
ribosome. The S10 protein is in blue and the remaining protein and 16S rRNA is in grey. B) S10
makes protein-protein interactions with S3 (pink) and S14 (cyan) within the ribosome. C) S10
interacts with the 16S rRNA (orange). D) Ribosome-incorporated S10 structure. E) Free S10
without the ribosome-binding loop. A-D) PDB 1FJG (Carter et al., 2000), E) PDB 3D3B (Luo
et al., 2008).
expression of most genes, RfaH acts only on a small set which contain a 12 nucleotide ops se-
quence. RfaH contains two domains that are connected by a flexible linker. The N-terminal
domain is structurally similar to that in NusG. The C-terminal domain adopts an α helical
structure, unlike NusG. The two domains of RfaH are associated via a hydrophobic interaction
resulting in a closed inactive conformation. When RfaH binds the non-template strand at the
ops site the two domains separate (Belogurov et al., 2007). The RNAP-binding surface of RfaH
is exposed only after ops-dependent isomerisation has occurred. At the ops site RNAP pauses
and RfaH is recruited and loaded, even in the presence of excess NusG (Belogurov et al., 2008).
RfaH functions as an antiterminator, suppressing the action of rho. The antipausing effects at
rho-termination sites are mediated solely through the N-terminal domain (Belogurov et al., 2008).
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Figure 1.17: Availability of the NusG-binding face of S10. A) Structure of E. coli S10 (PDB
2KVQ). The residues identified as interacting with the NusG KOW domain are highlighted in
yellow. B) Structure of S10 within the small ribosomal subunit from T. thermophilus. The corre-
sponding residues that interact with NusG are highlighted in yellow (PDB 1FJG). C) Structure
of S10 within the 30S ribosomal subunit. Ribosomal proteins S3 (pale pink) and S14 (cyan),
which interact with S10, are shown as a space-filling model. The residues that are predicted to
interact with NusG are accessible, suggesting that NusG can bind to ribosome-incorporated S10.
A recent NMR study has shed further light on the auto-regulation of RfaH. The solution structure
of full length RfaH is in good agreement with the crystal structure showing that the N-terminal
domain adopts a similar fold the NusG NGN domain, and that the C-terminal domain associates
with the N-terminal domain and adopts an α helical structure (Figure 1.18A). However, when
the C-terminal domain of RfaH is analysed in isolation it adopts a completely different secondary
structure, comprising five β strands (Burmann et al., 2012). This is fitting with a previous bioin-
formatics analysis which suggested that the C-terminal domain was capable of folding into a β
structure (Belogurov et al., 2008) (Figure 1.18B). The refolded RfaH C-terminal domain can
interact with ribosomal subunit S10 and thereby couple transcription and translation (Burmann
et al., 2012).
RfaH is the best characterised additional NusG-like protein but it is not unique in being a
NusG paralogue. Multiple NusG paralogues which act in a sequence-specific manner have been
identified. The bacterium Bacteroides fragilis has eight NusG paralogues, each responsible for
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Figure 1.18: The RfaH C-terminal domain can adopt two folds. A) In free full-length RfaH
(PDB 2OUG), the C-terminal domain of RfaH adopts an α helical structure. B) When the two
RfaH domains separate, its C-terminal domain undergoes a complete refolding and adopts a β
barrel structure (PDB 2LCL). This enables it to bind to the ribosome.
preventing premature termination during expression of different enzymes in a polysaccharide
synthesis pathway (Chatzidaki-Livanis et al., 2009).
1.7.7 Functions of Spt4/5 in Eukaryotes
In eukaryotes Spt4/5 variants lacking one of the KOW domains are not able to bind RNAP
as tightly, and the KOW domain alone exhibits low affinity binding to RNAP (Viktorovskaya
et al., 2011). Crosslinking data suggests that in S. cerevisiae, the Spt5 KOW domains 4 and 5
interact with the RPB4/7 stalk (Li et al., 2014). This is in contrast to prokaryotes and archaea
where the KOW domain has no RNAP-binding activity. The C-terminal repeats (CTR) that are
present in eukaryotic Spt4/5 are also involved in the regulation of transcription. For example,
when the CTR2 is removed there is an increase in basal transcription but also an increase in
DRB-mediated inhibition (Ivanov et al., 2000). Eukaryotic Spt4/5 also binds to RNAPI where
it can mediate positive and negative effects on transcription (Viktorovskaya et al., 2011).
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Promoter-proximal Stalling
In metazoans (animals) Spt4/5 is involved in transcription regulation by promotor-proximal
stalling (Figure 1.19). During this process, the initiation of transcription occurs before gene
activation and RNAPII is poised near the promoter in a phosphorylation state associated with
initiation rather than elongation. Promoter-proximal stalling was initially described through the
use of DNA-protein cross-linking experiments (Rougvie et al., 1988). It was shown that RNAP
is bound about 40 nucleotides from the promoter region of heat-shock genes such as hsp70 even
in the absence of heat-induction. Furthermore, by carrying out nuclear run-on assays it was
determined that, not only were these RNAPs bound, they were transcriptionally active. It was
subsequently shown that promoter-proximal stalling may occur, not only on inducible genes, but
also on those which are constitutively expressed (Rougvie and Lis, 1990). The development of
ultra-high-throughput sequencing enabled a genome-wide study of stalled genes, suggesting that
around 30% of human genes undergo promoter-proximal stalling (Core et al., 2008).
The human homologue of Spt4/5 is called DSIF, an abbreviation of DRB sensitivity inducing
factor. DRB is a kinase inhibitor that prevents phosphorylation of transcription factors, re-
lease of stalled complexes and thus transcription. DSIF, in conjunction with negative elongation
factor (NELF), is part of the stalled RNAPII complex. Association of NELF to the complex
requires DISF (Missra and Gilmour, 2010). In order to become elongation competent NELF,
DSIF and RNAP are phosphorylated by a protein called P-TEFb. Although it is not known why
the stalling occurs around 40 nucleotides downstream of the promoter, one hypothesis suggests
that it is connected to the fact that the RPB4/7 complex interacts with around 40 nucleotides
of transcribed RNA (U´jva´ri and Luse, 2005).
It is widely thought that promoter-proximal stalling is important for enabling a rapid induction
of gene expression in response to external stimuli, such as TNF-α expression in response to an
antigen (Adelman et al., 2009). However it may have other roles in promoting gene expression.
For example, when NELF levels are dramatically reduced by RNAi, a nucleosome appears over
the promoter preventing RNAP access in TepII (Gilchrist et al., 2008).
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Figure 1.19: Mechanism of promoter-proximal stalling. After initiation RNAP transcribes ap-
proximately 40 nucleotides of RNA. Association with DSIF and NELF (red) results in the stalling
of RNAP slightly downstream of the promoter. The complex remains stalled until RNAP, NELF
and DSIF are phosphorylated by P-TEFb (blue). After phosphorylation RNAP continues tran-
scribing the gene.
Nucleosome Remodelling and RNA Processing
The KOW domains of eukaryotic Spt5 enable the recruitment of multiple transcription factors
with a range of functions. Spt5 copurifies in complexes containing Spt6 (Lindstrom et al., 2003),
a protein that has multiple roles including the restoration of nucleosomes on highly transcribed
genes (Ivanovska et al., 2011). Human Spt4/5 interacts with the protein Paf1, which is itself
important for generating histone modifications associated with transcription such as H2B K123
monoubiquitination and H3 K4, K36 and K79 trimethylation (Chen et al., 2009). Spt4/5 is also
genetically linked with CET1 and CEG1 (Lindstrom et al., 2003), which between them form
the 5′ RNA capping complex that is required to add a 5′ guanine-N7 cap in eukaryotes. Fur-
thermore, Spt4/5 has also been observed to copurify with the RNA capping enzyme, suggesting
a function for Spt4/5 in pre-mRNA processing.
48 1.8. Transcription and Translation are Coupled in Archaea
Function Bacteria Archaea Eukaryotes
Increase RNAP processivity 4 4 4
Coupling of transcription and translation 4 ?
Factor-dependent termination 4 ?
Antitermination 4 ?
Silencing of foreign DNA 4 ?
Promoter-proximal stalling ? 4
RNA processing ? 4
Chromatin remodelling ? 4
Table 1.2: Summary of known NusG and Spt4/5 functions across the three domains of life.
1.8 Transcription and Translation are Coupled in
Archaea
There is strong evidence that transcription and translation are coupled in the euryarchaeota
Thermococcus kodakaraensis (Santangelo et al., 2008). T. kodakaraensis is naturally competent.
Mutations can be introduced via homologous recombination. A gene expression reporter sys-
tem was developed in T. kodakaraensis to enable the analysis of transcription and translation
in vivo. Transcription was monitored by microarray hybridisation and translation was moni-
tored by β-glycosidase activity. A nonsense codon was introduced towards the 5′ end of the
reporter operon to stop translation. This also resulted in greatly reduced transcription of the
operon. This demonstrates that there is polarity in archaeal operons and that transcription and
translation are coupled. When the ribosome was stopped, transcription of the operon decreased
(Santangelo et al., 2008). The mechanisms behind the coupling remain unknown. However,
given the conservation of NusG proteins, there is a sound rationale for studying the possible role
of Spt4/5 in the coupling of transcription and translation in archaea.
1.9 Structure and Function of NusA
In E. coli, nusA is an essential gene, and homologues have been identified in all sequenced
bacterial genomes. Bacterial NusA comprises an RNAP-binding N-terminal domain, an S1 do-
main and two RNA-binding KH domains. Evidence suggests that NusA probably functions as
a monomer (Gopal et al., 2001). Its N-terminal domain binds to the β flap of RNAP (Mah
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et al., 1999) and, when acting in isolation, NusA promotes RNAP pausing at RNA hairpins and
stimulates termination (Schmidt and Chamberlin, 1987; Toulokhonov et al., 2001). In E. coli
and M. tuberculosis, NusA is associated with RNAP throughout the entire genome, including
promoter-proximal peaks (Mooney et al., 2009a; Uplekar et al., 2013). This suggests that NusA
is bound to both actively transcribing and stalled RNAP complexes.
Figure 1.20: M. tuberculosis NusA KH domains bound to RNA (PDB 2ASB). The RNA binds
across both KH domains in a continuous, elongated conformation.
1.9.1 Regulation of Gene Expression by Antitermination of
Transcription
Whilst NusA acts to promote pausing on its own, it is also a component of the antitermina-
tion complex. Antitermination complexes enable RNAP to enter a pause-resistant state and to
transcribe through termination sequences. Antitermination was first described in bacteriophage
lambda genes. A phage-encoded protein called N enables RNAP to read through intrinsic ter-
mination sequences of the early-stage phage genes and transcribe the middle-stage genes. While
the N protein can bind RNAP by itself, the complex is unstable. The addition of host Nus
(N-utilisation substance) factors NusA, NusG, NusE (S10), and NusB results in the formation
a stable antitermination complex with stronger antitermination properties (Dodd et al., 2005;
Gusarov et al., 2001; Mason and Greenblatt, 1991) (Figure 1.21). The Nus factors were first
identified by searching for E. coli mutants that were unable to support N-mediated antitermina-
tion (Friedman et al., 1981, 1976). The proteins were subsequently isolated. The NusA protein
was first purified by using λN to pull down proteins from E. coli cell extract and searching for a
protein that had the correct predicted mass (Greenblatt and Li, 1981). It was later shown that
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the addition of NusA, B, E, and G enable RNAP to read through terminator sequences in vitro
(DeVito and Das, 1994).
The formation of an antitermination complex also requires a conserved region of RNA called
the N-utilisation site (Nut). The Nut site is found towards the 5′ end of a transcript and is
composed of a sequence called BoxA and an RNA hairpin called BoxB, which are separated by
a spacer region. BoxB is bound by the N-terminal domain of N (Legault et al., 1998; Scha¨rpf
et al., 2000). NusA then binds directly to N with its C-terminal domain (Mah et al., 1999) and
to the RNA spacer between BoxA and BoxB with its KH domains. BoxA is bound by a dimer of
S10 and NusB (Lu¨ttgen et al., 2002). Mutations within BoxA prevent this association and result
in impaired antitermination (Heinrich et al., 1995). NusB forms a stable complex with NusE
(S10) (Mason et al., 1992) and the two proteins coelute in affinity purifications. Upon forming a
dimer with S10, NusB binds RNA with 10-fold higher affinity than NusB alone (Burmann et al.,
2010a). The antitermination function of S10 is mutually exclusive from its ribosomal function.
When S10 is within the 30S subcomplex its NusB binding face is occluded (Luo et al., 2008).
This is supported by the fact that when the ribosome binding loop of S10 is substituted with a
serine, it is still able to mediate antitermination (Luo et al., 2008).
Figure 1.21: Schematic of an antitermination complex. A Phage protein called N (mauve) binds
to an RNA hairpin called BoxB towards the 5′ end of the transcript. N is bound by NusA
(beige), which is itself bound to RNAP (grey). In addition NusB (red) loads NusE/S10 (blue)
on to the BoxA RNA. The KOW domain of NusG (green) is also bound to S10.
Phage λ Antitermination Factor Q
Bacteriophage λ have another antitermination factor called Q, which functions to enable the late
phage genes to be expressed. After initiation at the late promotor (PR), RNAP pauses about
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16 nucleotides downstream from the transcription start site. This pausing is necessary to enable
DNA-bound Q to also bind to RNAP (Ring and Roberts, 1994). Q initially interacts with the
σ factor (Nickels et al., 2002), and subsequently displaces it to bind to the β flap of RNAP
(Deighan et al., 2008), becoming stably incorporated into the elongation complex. The precise
mechanism of Q action remains unclear but it is known that NusA stimulates its activity (Yarnell
and Roberts, 1992). It is likely that Q and NusA bind to the RNA transcript, preventing the
formation of hairpin terminators and the action of rho (Santangelo and Artsimovitch, 2011).
1.9.2 Antitermination on Ribosomal Operons
The ribosomal operons account for up to 60% of cellular transcription (Bremer et al., 1996) dur-
ing exponential growth. Robust expression of the rRNA genes is therefore extremely important.
There are 7 ribosomal operons in E. coli. Each operon contains the 16S rRNA gene, a tRNA
gene, the 23S rRNA gene and the 5S rRNA gene. The rRNA genes are not translated, thereby
potentially exposing RNAP to the termination factor rho. However, antitermination also occurs
on ribosomal RNA operons to prevent this. Antitermination complex formation on ribosomal
operons also requires the proteins NusA, NusB, NusE and NusG. Ribosomal operons contain a
BoxA-like region at their leader that can be bound by a complex of NusB and S10 (Nodwell and
Greenblatt, 1993). NusA also binds close to this region in the rrn operon (Vogel and Jensen,
1997). In addition several other ribosomal proteins have been implicated (Condon et al., 1995),
for example S4 binds to RNAP and has been shown to have antitermination properties similar to
NusA (Torres et al., 2001). NusA mutant strains show increased polarity on the rRNA operons
with two-fold fewer RNAPs transcribing the downstream 23S rRNA compared to wild-type E.
coli cells (Quan et al., 2005). This demonstrates the importance of NusA in antitermination of
the ribosomal operons. Unlike λN antitermination which allows read through of rho-dependent
and rho-independent terminators, rrn antitermination functions only on rho-dependent termi-
nation sites (Albrechtsen et al., 1990). No N-like protein has been implicated in antitermination
of ribosomal operons and its precise mechanism and regulation is poorly understood.
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1.9.3 NusA in rRNA Processing
In E. coli, NusA is also required for processing of the pre-16S rRNA. The rRNA folds and is
processed as it is being transcribed. The leader and downstream regions of the 16S gene are 1700
nucleotides apart and are complementary in sequence. They can therefore hybridise to form a
dsRNA region with the 16S rRNA forming a loop at the end. A mismatch within the comple-
mentary double-stranded region is a target for cleavage by RNaseIII (Young and Steitz, 1978).
RNaseIII processing is normally very rapid and occurs as soon as the two complementary regions
of RNA have annealed. Mutations in NusA result in impaired biogenesis of the 30S subunit due
to a buildup of 21S RNA, a precursor that is normally rapidly processed into the full 30S. This
occurs because the rRNA is cleaved by RNaseIII in a misfolded conformation and suggests that
NusA is required for the correct folding of the 16S RNA. When RNaseIII is also deleted, normal
ribosome biogenesis resumes (Bubunenko et al., 2013). In the absence of RNaseIII, processing
occurs by other RNases at a much slower rate, giving more time for the RNA to fold correctly.
The role of NusA can be rationalised on a structural level. NusA tethers the rRNA 5′ end of
the RNA by binding to the leader BoxA sequence, and being bound to RNAP itself. The 3′
end of the transcript is also constrained as it is bound within the active site. Thus the RNA
is constrained at both ends whilst it is being transcribed, which facilitates loop formation and
correct folding of the transcript (Figure 1.22).
1.9.4 Archaeal NusA
Little is known about the role of NusA in archaea. Sequence analysis indicates that NusA is
much smaller in archaea than in bacteria. M. jannaschii NusA contains 183 residues compared
to M. tuberculosis NusA which contains 347 residues. The crystal structure of A. pernix (ar-
chaeal) NusA demonstrated that it contains two KH domains (Shibata et al., 2007). While
structurally similar to the KH domains from bacterial NusA there is little sequence identity,
although BLAST analysis indicates genuine homology. Archaeal NusA does not retain the N-
terminal RNAP-binding domain or the S1 domain. It is therefore not known whether archaeal
NusA is able to promote RNAP pausing, act as a component of an antitermination complex, or
even bind to RNAP. Of a small selection of RNA targets it was found to bind the 23S rRNA
terminator sequence with very high affinity (Kd = 5.6 ×10−8 M) and to have a preference for
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Figure 1.22: The role of NusA in ribosome biogenesis. NusA binds to the RNA transcript near
the 5′ end, and to RNAP. The 3′ end of the transcript is within the active site. The nascent
RNA is therefore constrained at both ends and forms a loop as it is transcribed, which facilitates
RNA folding and therefore ribosome biogenesis.
pyrimidine-rich sequences. However, this does not provide any information about the in vivo
target of archaeal NusA (Shibata et al., 2007).
1.9.5 Antitermination in Archaea?
There is very little data concerning antitermination in archaea. There is no nuclear membrane,
so transcription and translation of a gene can occur at the same time (French et al., 2007).
Archaeal genes are often organised and expressed in operons, similar to bacteria. Furthermore
it has been shown in vivo that when translation of an operon is paused by introduction of a
non-sense codon, transcription of downstream genes decreases (Santangelo et al., 2008). The
fact that polarity exists in archaea raises the possibility that they have evolved mechanisms to
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overcome it and to allow expression of distal genes in operons.
M. jannaschii has homologues of three of the Nus antitermination factors. These are NusA,
NusE (S10), and Spt5 (NusG). M. jannaschii does not have a NusB homologue. However, NusB
is not essential in E. coli (Taura et al., 1992). Therefore there is a sound rationale for studying
NusA, Spt5, and S10 in archaea, with the aim of determining whether they are able to form a
functional complex.
1.10 Summary
Transcription is a highly complex process in which a large array of proteins and nucleic acid motifs
interact to carry out the genetic programme with astounding accuracy. RNAP is a multisubunit
enzyme with a conserved structure and function across the three domains of life, with archaeal
RNAP being similar to eukaryotic RNAPII. During elongation RNAP is prone to pausing, which
on one hand can lead to transcription termination and on the other hand can be overcome in
a regulated fashion through a plethora of transcription factors. Some of these factors are not
conserved despite having similar roles. GreB in bacteria and TF(II)S in archaea/eukaryotes are
a good example of this. Other factors are conserved, such as Spt4/5, which is the only known
universally conserved RNAP-associated transcription factor. Its primary function is to increase
the processivity of RNAP, which is supported by biochemical and structural data. This function
is mediated by the NGN domain. However, NusG and Spt4/5 have additional functions, which
are mediated by the KOW domain(s). In bacteria NusG couples transcription to translation
by interacting with ribosomal protein S10 (NusE). It also supports factor-dependent transcrip-
tion termination through its interaction with rho helicase and thereby reduces the expression of
horizontally acquired genes. In eukaryotes Spt5 also binds to the RNAP clamp via its NGN do-
main. In addition eukaryotic Spt4/5 binds RNA-processing and nucleosome remodelling factors
via its multiple KOW domains, and mediates promoter-proximal stalling. Thus the function of
the NGN domain is conserved across the three domains of life whilst the KOW domain(s) have
evolved separate functions. The KOW-mediated functions in archaea have not been studied in
depth, and are poorly understood.
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Bacteria Archaea Eukaryotes (RNAPII) Function
NusG Spt5 SPT5 All: Increases RNAP processivity
Bacteria: Couples transcription and translation
Eukaryotes: Promoter-proximal stalling
Spt4 SPT4 Archaea: Stabilisation of Spt5
Eukaryotes: Unknown
NusA NusA Bacteria: Promotes termination by itself. Reduces
termination efficiency as component of antitermina-
tion complex
Archaea: Unknown
NusE (S10) S10 S10 All: Ribosomal protein
Bacteria: Binds NusG and component of antiter-
mination complex
NusB Bacteria: Forms dimer with S10. Component of
antitermination complex
Gre factors TFS TFIIS All: Stimulates transcript cleavage of stalled poly-
merases
NB: Gre factors and TF(II)S are not homologous
Rho Transcription termination
Table 1.3: Summary of transcription elongation factors across the three domains of life and their
function.
NusA is an essential protein in E. coli which also has multiple functions. It contains an RNA-
binding N-terminal domain, an S1 domain and two RNA-binding KH domains. In E. coli, NusA
can bind to RNAP and stimulate transcription termination. However, it is also a component of
the antitermination complex where it promotes antitermination. In phage λ-mediated antitermi-
nation, NusA forms an antitermination complex with the proteins NusG, NusB, NusE, and the
phage protein N. Antitermination also occurs on ribosomal operons, where additional proteins
such as S4 have been implicated. NusA has an important role in the processing of pre-ribosomal
RNA and ribosome biogenesis. Archaeal NusA is smaller, containing two KH domains only. It
is not known whether archaeal NusA acts as an antitermination factor or whether it binds to
RNA with any degree of sequence specificity.
There is evidence that transcription and translation are coupled in archaea. Due to the evolu-
tionary conservation of NusG proteins, there is a sound basis for studying the potential role of
Spt4/5 in this process. In addition archaea have homologues of three of the four Nus factors.
Antitermination complex formation in bacteria requires the presence of specific RNA sequences
(BoxA and BoxB). There is therefore a sound rationale for analysing the RNA-binding of archaeal
NusA to determine whether it functions as a component of an archaeal antitermination complex.
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1.11 Aims of this Thesis
This thesis is concerned with the transcription factors Spt4/5 and NusA in M. jannaschii. The
key aims and objectives are:
• To establish whether M. jannaschii Spt4/5 and NusA are found in complexes containing
RNAP and ribosomes.
• To quantify and dissect the interaction between ribosomes and Spt4/5 in vitro.
• To determine whether M. jannaschii Spt5 exists in multiple conformations using EPR.
• To analyse and quantify the role of Spt4 in stabilising Spt5.
• To identify the regions of NusA that bind to RNA and assess their relative contributions
to the interaction.
Chapter 2
Materials and Methods
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2.1 Reagents
2.1.1 Buffers
• FSB: 10 mM CH3COOK, 45 mM MnCl2 (BDH ), 10 mM CaCl2 (BDH ), 3 mM Co(NH3)6Cl3,
10% [v/v] glycerol (Fischer Bioreagents), pH 6.4
• Rich liquid media: 2% [w/v] tryptone (BD), 1.5% [w/v] yeast extract (BD), 0.8% [w/v]
NaCl (VWR International), 0.2% [w/v] Na2HPO4 (Applichem), 0.1% [w/v] KH2PO4
(VWR International) and 0.8% [v/v] glycerol
• LB media: 1% [w/v] tryptone (BD), 0.5% [w/v] yeast extract (BD), 1% [w/v] NaCl (VWR
International)
• TAE buffer: 2 M Tris base, 6% acetic acid [v/v], 50 mM EDTA
• 4× P0: 20 mM Tris-acetate pH 7.9, 14 mM 2-mercaptoethanol (Sigma Aldrich), 10 mM
Mg-acetate (Acros Organics), 100 µM ZnSO4 (VWR International). 4× P0 buffer was
used as a base for many buffers. P buffers denote the addition of potassium acetate.
N buffers denote the addition of sodium chloride. For example, P300 is 1× P0 buffer
containing 300 mM potassium acetate. N500 is 1× P0 containing 500 mM NaCl.
• SDS PAGE 2× loading buffer: 4% [w/v] SDS, 125 mM Tris HCl pH 6.8, 20% [v/v] glycerol,
0.2% [w/v] bromophenol blue (Fischer Biotech) and 4% [v/v] 2-mercaptoethanol
• SDS PAGE running buffer: 25 mM Tris, 190 mM glycine, 0.1% [w/v] SDS, pH 8.3
• Coomassie stain: 60% [v/v] methanol (VWR International) and 0.2% [w/v] Brilliant Blue
250 R (Fischer Scientific)
• SDS PAGE Destain: 25% [v/v] ethanol (Sigma Aldrich), 8% [v/v] acetic acid (Fischer
Bioreagents)
• 6× DNA loading dye: 10 mM Tris-HCl pH 7.6, 0.03% [w/v] bromophenol blue, 0.03%
[w/v] xylene, 60% [v/v] glycerol, 60 mM EDTA
• 10× M9 salts: 0.4 M Na2HPO4, 0.2 M KH2PO4, 0.1 M NaCl, 0.2 M NH4Cl
• 100× glucose/ampicillin stock: 20% [w/v] glucose, 10 mg/ml ampicillin sodium salt
2.1. Reagents 59
• PBS: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4
• 2000× Trace Elements: Per L contained 9 g Na2B4O7.10H2O, 0.44 g ZnSO4.7H2O, 0.1 g
CuCl2.2H2O, 0.06 g NaMoO4.2H2O, 0.06 g VOSO4.2H2O, 0.02 g CoSO4.7H2O, and 3.6 g
MnCl2.4H2O
• HMNE buffer: 40 mM HEPES pH 7.3, 250 mM NaCl, 2.5 mM MgCl2, 0.1 mM EDTA, 5%
[v/v] glycerol and 10 mM dithiothreitol
2.1.2 Competent Cells
α-select Bronze Efficiency (Bioline) and DH5α Subcloning Efficiency (Invitrogen) were used for
cloning and DNA preparation. One Shot BL21 Star (DE3) (Invitrogen) and Rosetta 2 were used
for protein expression.
The cloning competent cells have been engineered to produce large amounts of high quality
plasmid DNA. The α-select and DH5α cells contain a mutation in endA1, which encodes an
intracellular endonuclease that can degrade plasmids. This results in higher yields of plasmid
preparations. The α-select and DH5α cells also contain a mutation in recA to prevent homol-
ogous recombination occurring, which may otherwise lead to the disruption of the plasmid of
interest.
The expression strains have been engineered to promote high levels of protein expression. BL21
DE3 cells lack lon and ompT, which encode proteases. This results in higher final yields of
purified recombinant protein. DE3 cells also have a chromosomal copy of the T7 RNAP gene,
under the control of the lacUV5 promoter. The operator region of this promoter is bound by
the lac repressor which prevents expression of the polymerase. Upon the addition of IPTG, the
repressor dissociates from the operator and the T7 polymerase is expressed. This enables the
specific induction of recombinant protein expression from pET vectors where the gene of interest
is positioned downstream of a T7 promoter. Rosetta 2 cells are derivatives of BL21 DE3 cells
which also encode tRNAs for 7 rare codons. This facilitates the expression of proteins from
species that have a different codon bias to E. coli.
60 2.1. Reagents
2.1.3 Vectors
Expression Three plasmids were used for the expression of protein. Untagged proteins were
expressed in pET-21a(+). His-tagged proteins were expressed in pET151D or pET-21a(+).
GST-tagged proteins were expressed in a pGEX-2TK vector.
Subcloning and in vitro transcription pGEM-T vectors were used for subcloning and as a
vector for in vitro transcription of riboprobes.
pET vectors contain a T7 promoter, transcription start site, and terminator. This enables
expression of genes by T7 RNA polymerase. pET-21a(+) and pET151D vectors also confer re-
sistance to ampicillin, enabling selection of transformants. pET-21a(+) also provides the option
of a C-terminal hexa-histidine tag whilst pET151D vectors result in proteins with an N-terminal
hexa-histidine tag. In pET vectors, a lac operator is located 5′ to the cloned gene. This is
bound by the lac repressor, blocking transcription. When IPTG is added, it binds to the lac
repressor, which then dissociates from the operator enabling transcription of the gene. In BL21
DE3 cells, expression of T7 RNAP is also regulated by the lac repressor, conferring a double
lock on expression of the cloned gene, until expression is induced.
pGEX-2TK vectors are used to express proteins with an N-terminal GST tag. The GST fusion
gene is under the control of a tac promoter, and is regulated by the lac repressor. Addition of
IPTG enables expression of the gene. The tac promoter is transcribed by the E. coli RNAP,
which is constitutively expressed. There is therefore only one lock on leaky expression, com-
pared to pET vectors where there are two. The pGEX-2TK vector also confers resistance to
ampicillin allowing for selection of transformants. A thrombin-cleavage site between the GST
and recombinant protein of interest enables them to be easily separated.
pGEM-T vectors are commonly used for cloning PCR products. It is a linearised vector which
contains 3′ T overhangs at both ends. This allows easy ligation from PCR products that have
been synthesised by Taq DNA polymerase, which leaves A overhangs on the 3′ end of amplified
DNAs. pGEM-T vectors confer resistance to ampicillin. They contain T7 and SP6 promoters
and are suitable for in vitro transcription to produce riboprobes.
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2.3 Experimental Methods
2.3.1 Polymerase Chain Reaction
For each 50 µl PCR reaction the following reagents were incubated together on ice in a PCR
tube:
• Phusion High-fidelity DNA polymerase (NEB): 1 µl
• 5× Phusion HF buffer (NEB): 10 µl
• 25 mM dNTP mix (Sigma Aldrich): 4 µl
• Forward primer, 10 µM: 2 µl
• Reverse primer, 10 µM: 2 µl
• DNA template, 100 ng/µl: 1 µl
• H2O: 30 µl
The reaction was conducted in a Bio-Rad C1000-Thermo Cycler. The lid was heated at 95◦C
to prevent condensation of the reaction mixture. The reaction was initially heated to 95◦C for
60 seconds. Then a three-step cycle was performed. Within this cycle, the reaction was first
heated to 95◦C for 30 seconds to melt the DNA strands. Then it was lowered to 5◦C below
the primer melting temperature for 30 seconds to allow the annealing of the primers to their
complementary region on the template DNA. The temperature was raised to 72◦C to allow
polymerase extension. Generally 30 seconds per kb was given for the extension. This cycle
was carried out 35 times in total. The sample was then heated to 72◦C for 300 seconds before
being held at 12◦C. PCR products were purified using a QIAprep PCR purification kit (Qiagen)
according to the manufacturer’s instructions.
2.3.2 Restriction Digests of DNA
Restriction digests were performed using either Fermentas FastDigest, or NEB enzymes. Ap-
proximately 500 ng DNA was digested. 4 µl of 10× FD buffer (Fermentas) or 10× CutSmart
buffer (NEB) was incubated with 1 µl of each restriction endonuclease used in the digestion.
The volume was made up to 40 µl with dH2O. The reaction was incubated at 37
◦C for 1 hour.
5 µl of the reaction was analysed on an agarose gel. The remaining reaction was purified using
a QIAprep reaction cleanup kit (Qiagen) according to the manufacturer’s instructions.
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2.3.3 DNA Ligation into pET Vector
100 ng pET-21a(+) was digested for 1 hour with EcoRI (Fermentas) and NdeI (Fermentas) in a
40 µl reaction and treated with 1 µl alkaline phosphatase (Promega). The insert was also digested
with EcoRI and NdeI, but not treated with alkaline phosphatase. The restriction enzymes were
inactivated by heating the reaction to 65◦C for 15 minutes. The digested insert and vector were
incubated together in a molar ratio of 6:1 in a total volume of 10 µl, also containing 1 unit
DNA ligase (NEB) and 1 µl 10× ligase buffer (NEB). The reaction was incubated at room
temperature for 1 hour and 2.5 µl was transformed into α-select cells. A reaction containing no
insert was carried out in parallel as a control.
2.3.4 DNA Agarose Gel Electrophoresis
1% or 0.5% agarose (Sigma) gels were made with TAE buffer. The agarose-TAE was melted in
a microwave and ethidium bromide (final 0.01% v/v) was added. The agarose was poured into
a gel caster, a comb was added, and the gel left at room temperature to set. DNA samples were
mixed with 6× DNA loading buffer and loaded into the wells. The gel was run in TAE buffer at
100 V for approximately 30 minutes. A standard (Hyperladder by Bioline or Low Range Gene
Ruler by Thermo Scientific) was included to enable sizing of bands.
2.3.5 Preparation of Competent Cells
An overnight culture of E. coli cells was grown in LB, from a single colony. 1 ml of culture
was then diluted with 100 ml medium and grown in an incubator at 37◦C, shaking at 200 rpm
until an OD600 of 0.5-0.6 was reached. The cells were then kept on ice for 10 minutes. The
cells were centrifuged at 3500 × g for 10 minutes, and the supernatant removed. The pellet
was then resuspended in 20 ml FSB buffer, and incubated on ice for 10 minutes. The cells were
centrifuged at 3500 × g for 10 minutes and resuspended in 8 ml ice-cold FSB buffer. 280 µl
DMSO (Sigma Aldrich) was added and the cells incubated for 15 minutes on ice. A further
280 µl DMSO was added and the cells aliquoted into 50 µl fractions in microcentrifuge tubes
which had been pre-chilled at -20◦C. The cells were snap frozen in liquid nitrogen and stored at
-80◦C.
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2.3.6 Transformation of Competent Cells
Aliquots of competent cells were thawed on ice. 100 ng of plasmid DNA was added and the cells
kept on ice for 20 minutes. They were then heat-shocked at 42◦C for 45 seconds and put on
ice for a further 2 minutes. The cells were then plated onto an LB plate containing ampicillin
(Sigma Aldrich) at 50 µg/ml and grown overnight at 37◦C to enable selection of transformed
cells.
2.3.7 Colony PCR
Colony PCR was performed after transformation of ligation reactions to test for the presence
of the desired plasmid containing the correct insert. 10 µl of 2× RedTaq ready mix (Sigma
Aldrich) was incubated with 8 µl H2O, 1 µl T7 forward primer (final 0.5 µM), and 1 µl reverse
primer (final 0.5 µM). A sterile pipette tip was used to pick up a single colony and the tip was
placed into the reaction mixture and then plated on an LB-agar plate. The PCR settings were
the same as for other PCR reactions with the exception that the initial melting at 95◦C lasted
for a duration of 10 minutes to enable sufficient disruption of the bacterial cells and liberation
of the plasmid template DNA.
2.3.8 Plasmid Purification
A single colony from a transformation of the desired plasmid was added to 5 ml LB media con-
taining 50 µg/ml ampicillin. The culture was grown overnight at 37◦C. The plasmid DNA was
purified using a QIAprep spin mini-prep kit (Qiagen) according to the manufacturer’s instruc-
tions.
2.3.9 DNA Sequencing
10 µl 100 ng/µl purified plasmid DNA was sent to Source BioScience for sequencing, using a T7
forward primer.
2.3.10 Overnight Cultures
A single colony was added to 50 ml liquid media in an Erlenmeyer flask. 500 µl glucose (Fischer
Scientific) was added at a final concentration of 0.2% [w/v] and ampicillin at a final concentration
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of 50 µg/ml. The cells were grown overnight at 37◦C, shaking at 200 rpm.
2.3.11 Expression of Recombinant Protein
1 L of rich liquid medium was added to an Erlenmeyer flask. Glucose was added at a final
concentration of 0.2% and ampicillin at a final concentration of 50 µg/ml. 15 ml of starter
culture, grown the night before, was used to inoculate the media. The culture was grown at
37◦C, shaking at 200 rpm until an OD600 of 0.6-0.8 was reached. Recombinant protein expression
was induced by addition of IPTG (Glycon Biotechnology) at a final concentration 1 mM and the
cells incubated for a further 5 hours. The cells were centrifuged for 15 minutes at 6000 × g and
frozen at -20◦C.
2.3.12 Extraction of Protein
Cell pellets were resuspended in N500 buffer. Approximately 15 ml of buffer was used per litre
of culture grown. 10 µl of 1000 units/ml DNaseI (Sigma Aldrich) and 10µl of 20 mg/ml RNaseI
(Fermentas) were added. The resuspended pellets were sonicated with 20 seconds on/20 seconds
off pulses for 10 minutes, whilst sitting on ice. Cell extracts were then centrifuged at 16,000 × g
for 30 minutes at 4◦C to separate soluble and insoluble protein.
2.3.13 Heat Inactivation of Supernatants
Supernatants were separated into 1.5 ml aliquots and heated at 65◦C for 30 minutes. Samples
were then centrifuged at 20,000 × g for 10 minutes, and the insoluble material was discarded.
2.3.14 Ammonium Sulphate Precipitation
Proteins that were to be purified by size exclusion chromatography were first heat-inactivated.
The supernatants were placed on ice, and ammonium sulphate was gradually added until it
reached saturation. The solution was allowed to sit for 10 minutes and the precipitated protein
was removed, with care taken not to remove any undissolved ammonium sulphate. The pre-
cipitated protein solution was centrifuged at 16,000 × g for 30 minutes, and the supernatant
carefully removed and discarded. The pellet was resuspended in 5 ml buffer, and passed through
a 0.22 µm filter.
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2.3.15 Protein Purification
N.B. “Wash buffer” refers to the buffer that the protein was extracted or stored in before loading
on to the column. “Elution buffer” refers to the buffer that was passed through the column to
specifically elute the bound protein of interest.
Non-tagged Proteins
The heat-stable supernatant was ammonium sulphate precipitated, and resuspended in 5 ml
buffer. The protein was purified on a HiPrep 16/60 Sephacryl S-100 column (GE Healthcare)
using a Bio-Rad BioLogic DuoFlow FPLC. 5 ml fractions were collected and analysed by SDS
PAGE.
His-tagged Proteins
A 1 ml HisTrap FF crude column (GE Healthcare) was equilibrated in elution buffer, containing
250 mM imidazole, to remove any previously bound protein. It was then equilibrated in wash
buffer containing 20 mM imidazole for five column volumes. The sample was loaded on to the
column at a flow rate of 1 ml/min and the flow was collected for analysis by SDS PAGE. After the
sample was fully loaded, ten column volumes of wash buffer was passed through the column. The
protein was purified in an imidazole gradient, which went from 20 mM to 250 mM imidazole in
10 ml. Then 10 ml 100% elution buffer was passed through the column. The eluent was collected
in 1 ml fractions. Wash buffer was passed through the column again for five column volumes to
equilibrate it for the next run. After use the columns were washed with water then 20% ethanol
and stored at 4◦C.
Heparin Affinity purification
Heparin is a highly negatively charged glycosaminoglycan which is able to mimic the structure
of DNA and RNA. This makes it a useful molecule for the purification of nucleic acid-binding
proteins. A 1 ml HiTrap Heparin HP column (GE Healthcare) was equilibrated in elution buffer
containing 1000 mM NaCl or NH4Cl to remove any previously bound protein. It was then
equilibrated in wash buffer containing 50 mM NaCl or NH4Cl for five column volumes. The
sample was loaded on to the column at a flow rate of 1 ml/min and the flow was collected for
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analysis by SDS PAGE. After the sample was fully loaded, ten column volumes of wash buffer
was passed through the column. The protein was eluted in a salt gradient, which went from
50 mM to 1000 mM salt in 10 ml. Then 10 ml 100% elution buffer was passed through the
column. 1 ml fractions were collected. Wash buffer was passed through the column again for
five column volumes to equilibrate it for the next run. After use the columns were washed with
water then 20% ethanol and stored at 4◦C.
GST-tagged Proteins
A 1 ml Bioscale mini pro affinity GST cartridge (Bio-Rad) was equilibrated in elution buffer,
containing 20 mM reduced glutathione, to remove any previously bound protein. It was then
equilibrated in wash buffer for five column volumes. The sample was loaded on to the column
at a flow rate of 1 ml/min and the flow was collected for analysis by SDS PAGE. After the
sample was fully loaded, ten column volumes of wash buffer was passed through the column.
Then elution buffer was passed through the column for ten column volumes and the eluent was
collected in 1 ml fractions. Wash buffer was passed through the column again for five column
volumes to equilibrate it for the next run. After use the columns were washed with water then
20% ethanol and stored at 4◦C.
2.3.16 Removal of the GST Tag
Purified GST-tagged proteins were treated overnight with thrombin at 4◦C to separate the de-
sired archaeal protein from the GST tag. Samples were then heat treated at 65◦C for 30 minutes,
resulting in the precipitation of the GST. The heat-stable archaeal protein remained in solution.
Samples were centrifuged at 20,000 × g for 10 minutes to separate the insoluble and soluble
protein. The supernatant was carefully removed, aliquoted and stored at -20◦C.
2.3.17 Concentration of Protein
Purified recombinant proteins were concentrated, if required, in centrifugal filter units (Milli-
pore). Samples were placed inside the units and centrifuged at 6000 × g until the desired volume
was obtained.
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2.3.18 Determination of Protein Concentration
Protein concentrations were determined using a Qubit 2.0 fluorometer (Invitrogen) according
to the manufacturer’s instructions. Briefly, working solution was prepared by preparing a 199:1
ratio of Qubit protein buffer to Qubit protein dye. A standard curve was generated by incubating
10 µl samples of known concentration with 190 µl working solution. 1–10 µl of protein whose
concentration was being determined was incubated with working solution at a final volume of
200 µl. The protein concentration was determined by comparison to the standard curve.
2.3.19 SDS PAGE
Polyacrylamide gels were made from a 40% polyacrylamide solution1 (Sigma Aldrich). The
recipe for a 16% gel is shown (Table 2.2). The polyacrylamide, Tris, and H2O were first mixed
together. Next, APS (Acros Organics) and TEMED (Sigma Aldrich) were added to the resolving
gel solution which was quickly poured into 0.75 mm thick Mini-PROTEAN glass plates (Bio-
Rad), leaving about 1 ml at the top. Isopropanol was carefully poured on top to create an even
layer and the resolving gel was left to polymerise. The isopropanol was then washed away. APS
and TEMED were added to the stacking gel solution, which was quickly poured on top of the
resolving gel. A 10 or 15 well comb was inserted and the gel was left to polymerise. Protein
samples were mixed with 2× loading buffer in a 1:1 ratio, heated to 95◦C for 3 minutes, and
loaded into the wells. Gels were run at 200 V for 45 minutes in Tris/Glycine SDS PAGE running
buffer. 5 µl of broad range standard (Bio-Rad) was run to allow sizing of the bands. Gels were
stained with coomassie stain and then destained in SDS PAGE destain buffer to visualise protein
bands.
Stacking Resolving
40% polyacrylamide solution 4 ml 1 ml
1.5 M Tris HCl, pH 8.8 containing 0.4% SDS 2.5 ml 0 ml
0.5 M Tris HCl, pH 6.8 containing 0.4% SDS 0 ml 2.5 ml
10% [w/v] APS 100 µl 100 µl
TEMED 10 µl 10 µl
H2O 3.5 ml 6.5 ml
Table 2.2: Recipe to make polyacrylamide gels.
140% polyacrylamide solutions contained a 37.5:1 ratio of acrylamide:bisacrylamide.
2.3. Experimental Methods 69
2.3.20 Silver Staining
Gels were fixed for 1 hour in fixing buffer (50% [v/v] methanol, 12% [v/v] acetic acid). 100 µL
of 37% formaldehyde (Fischer Bioreagents) was also added. The gels were then washed three
times for 1 minute in 50% [v/v] ethanol and then once in 0.0125% [w/v] di-sodium-thiosulfate
(Sigma Aldrich) for 1 minute. The gels were washed three times for 20 seconds in dH2O. They
were stained in 0.1% [w/v] silver nitrate (Sigma Aldrich) solution, also containing 100 µl of
37% formaldehyde for 20 minutes. The gels were subsequently washed in dH2O three times
in 30 seconds and developed in 6% [w/v] sodium carbonate (BDH ). When the desired level of
development was reached the reaction was stopped with 5% [v/v] nitric acid.
2.3.21 Preparation of Double Spin-labelled Spt5
Double cysteine mutants of Spt5 were expressed with a C-terminal His-tag in a pET-21a(+)
vector. The protein was extracted and bound to a NiNTA column. Reducing agent was removed
by washing and buffer containing 1 mM iodoacetamide-PROXYL (Sigma Aldrich) was passed
through the column for 1 hour. The sample was eluted using an imidazole gradient, and further
iodoacetamide-PROXYL was added to protein-containing fractions to a final concentration of
3 mM, an approximate 30:1 ratio compared to the protein. The sample was then incubated at
4◦C overnight. The sample was diluted 10 times to reduce the imidazole concentration, and was
reapplied to a NiNTA column. Unbound spin label was removed by washing. The protein was
then eluted in an imidazole gradient.
2.3.22 Ellman’s Test
In order to effectively couple spin labels to cysteines it was necessary to ensure there was no
reducing agent present. After on-column labelling and purification of double cysteine Spt5
mutants the protein sample was analysed for free thiol groups. 1 µl of 5 mg/ml DTNB reagent
(Sigma Aldrich) dissolved in methanol was added to 39 µl of the protein preparation. DTNB,
which absorbs at 324 nm reacts with thiol groups to produce TNB, which is bright yellow and
absorbs at 412 nm. The concentration of accessible thiols was determined using the Beer-Lambert
law:
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A = lc (2.1)
where  is the extinction coefficient of the protein, l is the path length of light in cm, and c is
the molar concentration of the protein.
2.3.23 Dimerisation Between Spt4 and Labelled Spt5
Spt5 and Spt4 were added together in a molar ratio of roughly 1:1.5 and incubated at 65◦C for
10 minutes. The sample was then centrifuged for 20 minutes at 20,000 × g. The sample was
diluted approximately 10 times in N500 to reduce the imidazole concentration to about 20 mM
and purified by Ni-NTA affinity chromatography. Fractions containing Spt4/5 were pooled and
concentrated to a final volume of about 200 µl. The sample was diluted two-fold in 50% D8
glycerol (Sigma Aldrich) in D2O and snap frozen in liquid nitrogen.
2.3.24 DEER
All DEER measurements were carried out at 50 K on a Bruker ELEXSYS E580 spectrometer
at 9 GHz, with an ER-4118-x-MS-3W resonator. Predicted distance distributions were made
using rotamer libraries in MMM (version 2013) and the obtained DEER data was analysed using
DeerAnalysis (2013 version).
Electronic paramagnetic resonance (EPR) is a spectroscopic technique for analysing paramag-
netic centres. Most proteins do not contain a paramagnetic centre, so they must be incorporated
through coupling to a spin label. Nitroxide spin labels can be incorporated in a site-specific man-
ner at cysteine residues. Unpaired electrons can exist in two spin states, -1/2 and +1/2, which
have different energies when placed within an external magnetic field. An electron in the lower
-1/2 spin state can be excited into the higher energy +1/2 spin state if it absorbs microwaves
whose energy precisely matches the energy difference between the two spin states. The energy
at which an electron is excited can be further influenced by another unpaired electron which is
in close proximity due to a phenomenon called dipolar coupling. The strength of the dipolar
coupling is proportional to 1/r3. Therefore, by determining the strength of the dipolar coupling
it is possible to determine the distance between two spin labels on a protein. The experiment
that is used to determine the distance distribution between two spin labels is called double elec-
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tron electron resonance (DEER). DEER is able to measure distances in the region of 2–8 nm.
For a more detailed discussion of EPR techniques, see Chapter 4.
2.3.25 Production of Polyclonal Antibodies
200 µl pure recombinant protein at 1 mg/ml was sent to Davids Biotechnologie for immunisation
in rabbits. A test serum was taken 35 days after immunisation and tested by ELISA. 40–90 ml
final serum was taken after 63 days.
2.3.26 Antibody Purification
200 µl protein G Sepharose resin (GE Healthcare) was added to a filter drip column. The protein
G resin was equilibrated with 2 ml PBS. 4 ml polyclonal antibody serum (Davids Biotechnologie)
was added to the column and allowed to clear by gravity flow. The resin was washed in 2 ml
PBS and the antibody was eluted by addition of 800 µl 0.1 M glycine, pH 2.8. Then, 80 µl 1 M
Tris-HCl, pH 8.5 was added to the purified antibody to neutralise the buffer.
2.3.27 Western Blotting
Recombinant proteins were diluted 100× in PBS, separated by SDS PAGE and transferred to
nitrocellulose membranes (GE Healthcare) at 100 V for 1 hour on ice in transfer buffer (192 mM
glycine, 25 mM Tris base, 20% [v/v] methanol). The membranes were blocked overnight in
PBS containing 2% [w/v] BSA (Sigma Aldrich) at 4◦C. The membranes were then washed
three times in PBS containing 0.1% [v/v] Tween 20 (Sigma Aldrich). The membranes were
subsequently incubated with polyclonal antibody from rabbit serum at a 1:1000 dilution at room
temperature for 1 hour. The membranes were then washed again three times for 20 minutes in
PBS/0.1% Tween. The membranes were then incubated with anti-rabbit secondary antibody,
which was conjugated to DyLight680 (Thermo Scientific) for 1 hour at a 1:10,000 dilution. The
membranes were washed in PBS/0.1% Tween three times for 20 minutes. They were visualised
using a Typhoon FLA 9500 by exciting at 700 nm.
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2.3.28 Thermal Denaturation Assay Using Differential Scanning
Fluorimetry
20 µl of purified recombinant protein was incubated with 5 µl of SYPRO orange in a 96-well
plate. This was placed in a RT PCR machine (Bio-Rad). The temperature was increased in
0.5◦C increments and the change in fluorescence emission was monitored. The dye was excited
at 492 nm and emission was detected at 610 nm.
2.3.29 Limited Proteolysis
25 µg trypsin (Thermo Scientific) was resuspended in 250 µl 1 mM HCl, giving a stock concentra-
tion of 100 µg/ml. All digests contained a total volume of 15 µl. For single digests recombinant
protein (final concentration 40 µM) was incubated with trypsin at the following concentrations
in µg/ml: 50, 25, 10, 5, 2.5, 1.125, 0.56, 0.28, 0.14. Digests were left at 37◦C for 1 hour. 15 µl
2× SDS loading buffer was added to stop the reaction and 10 µl was analysed by SDS PAGE.
2.3.30 Analytical Size Exclusion Chromatography
Superose 6 and Superose 12 size exclusion chromatography were carried out to analyse interac-
tions between purified recombinant proteins. The column (Superose 6 10/300 GL or Superose
12 10/300 GL) was first washed in two column volumes of filtered dH2O, followed by two col-
umn volumes of filtered buffer. 100 µl of size standard (Bio-Rad) was run at 0.5 ml/min to
allow sizing of protein complexes (Figure 2.1). Proteins were run individually on the column
and sized by comparison to the standard. Proteins were then incubated together at 65◦C for
30 minutes, centrifuged at 20,000 × g for two minutes and separated on the Superose column.
Proteins/complexes were sized and their identity confirmed by SDS PAGE.
Superose columns are packed with crosslinked agarose-based sugars, which form a mesh contain-
ing pores of different sizes. Larger proteins are unable to enter the pores and travel a direct path
through the column, and elute first. Smaller proteins are able to enter the pores and travel a
longer path through the column, therefore eluting later.
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Figure 2.1: Example of a Superose 6 standard run. 100 µl standard was loaded into the the
column, and separated at 0.5 ml/min. The larger proteins eluted first as they took a shorter
path through the column. The sizes of the standard proteins are 670, 158, 44, 17, and 1.4 kDa.
Aggregates result in a small peak at 8.5 ml, which represents the void volume of the column.
2.3.31 Sizing of Putative Antitermination Factors
1.5 g mid-log phase M. jannaschii cell mass2 was ground using a mortar and pestle on ice for
5 minutes with 3 g Al2O3 powder (Sigma Aldrich). 3 ml lysis buffer (20 mM Tris pH 7.5,
50 mM NH4Cl, 10 mM MgCl2) was added and the cells were ground for a further 10 minutes
on ice. The cell extracts were evenly aliquoted into microcentrifuge tubes. Extracts were then
treated with either 10 µl DNaseI, 10 µl RNaseI, 10 µl DNaseI and 10 µl RNaseI, or untreated.
The extracts were heated at 37◦C for 2 hours. The extracts were then centrifuged twice at
20,000 × g for 20 minutes at 4◦C. 100 µl of the resulting supernatants were separated by
Superose 6 size exclusion chromatography and 500 µl fractions were collected. 400 µl of each
fraction was added to 100 µl of 6× SDS PAGE loading buffer. 20 µl samples were separated
by SDS PAGE, and Western blot analysis was conducted against the putative antitermination
factors. A size standard was also run to enable rough determination of the molecular weight of
protein complexes.
2M. jannaschii cell mass was provided by Prof. Michael Thomm.
74 2.3. Experimental Methods
2.3.32 Ribosome Preparation from M. jannaschii Cell Mass
M. jannaschii Cell Extraction
Mid-log phase M. jannaschii cell mass was stored at -80◦C. M. jannaschii cells and Al2O3
powder (Sigma Aldrich) were ground using a mortar and pestle on ice for 5 minutes in a mass
ratio of 1:2. 10 µl 1000 units/ml DNaseI was added and the cells were ground for a further
5 minutes. Two volumes of lysis buffer (20 mM Tris pH 7.5, 50 mM NH4Cl, 10 mM MgCl2) was
added and the cells were ground for a further 10 minutes on ice.
S30 Fraction
The suspension from the cell grinding was centrifuged at 30,000 × g in a Beckman optima L-
100 XP Ultracentrifuge in a Type 70 Ti rotor for 30 minutes. The supernatant was carefully
removed and was centrifuged again under the same conditions. This removed the cell wall and
other insoluble materials.
S100 Fraction
The S30 fraction was processed further to give an S100 fraction. 7 ml S30 supernatant was
centrifuged at 100,000 × g for 4 hours through a 9 ml 18% sucrose cushion in a Type 70 Ti rotor,
using a Beckman optima L-100 XP Ultracentrifuge. The supernatant was carefully removed and
the ribosome-containing pellet was resuspended in 2 ml wash buffer (20 mM Tris pH 7.5, 50 mM
NH4Cl, 10 mM MgCl2, 7 mM 2-mercaptoethanol).
Analysis of Ribosome Preparation
Ribosomes were analysed on a sucrose gradient. An 11.5 ml sucrose (Sigma Aldrich) gradient
was prepared from 10 to 30% sucrose. 3.5 ml 30% sucrose was pipetted into the bottom of
the centrifuge tube. 3.5 ml 20% sucrose was pipetted on top with care taken not to disrupt
the 30% layer underneath. 3.5 ml 10% sucrose was pipetted on top with care taken again not
to disrupt the layers below. The centrifuge tube was left vertically at room temperature for
18 hours to allow a linear gradient to form. 200 µl crude ribosomes was loaded onto the gradient
and centrifuged at 62,000 × g for 17 hours in a SW41 Ti rotor. The gradient was then carefully
separated in 250 µl fractions by pipetting and 9 µl was analysed on a 1% agarose gel.
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2.3.33 Bioanalyzer to Analyse RNA
Ribosomal RNA was extracted from purified ribosomes using an RNeasy kit (Qiagen) according
to the manufacturer’s instructions and eluted in 30 µl RNase-free water. An Agilent RNA 6000
Nano Kit was used to analyse 1 µl samples of RNA on a RNA Nano Chip according to the
manufacturer’s instructions. The RNA Nano Chips were run on an Agilent 2100 Bioanalyzer
instrument.
2.3.34 Labelling of Ribosomes with Maleimide-Coupled NT650 Dye
The ribosome preparation was labelled with NT650 using an L006 Monolith kit (NanoTemper)
according to the manufacturer’s instructions. Unbound dye was separated from the labelled
ribosomes on a gel filtration column, and the labelled ribosomes were eluted in fractions of
100 µl.
2.3.35 Protein Preparation for MST
Spt4/5 variants were expressed as GST-fusions in Rosetta 2 cells. The protein was extracted
in MST protein buffer (20 mM Tris pH 7.5, 10 mM MgCl2, 1 mM ZnCl2, 300 mM NH4Cl,
3.5 mM 2-mercaptoethanol). The Spt4/5 variants were first purified on a GST affinity column
and eluted in MST protein buffer containing 20 mM reduced glutathione. The purified GST
fusion was treated with thrombin overnight and heated at 65◦C for 30 minutes to precipitate the
GST. The sample was then centrifuged at 20,000 × g for 5 minutes, the supernatant carefully
removed, and diluted 6× in MST protein buffer containing no NH4Cl. The diluted protein was
purified on a heparin affinity column. The protein was loaded on to the column in MST protein
buffer containing 50 mM NH4Cl and eluted in a gradient with MST protein buffer containing
1 M NH4Cl. Fractions containing Spt4/5 variants were buffer-exchanged to MST protein buffer
containing 300 mM NH4Cl and concentrated in Millipore centrifugal units at 6,000 × g.
2.3.36 Generation of NusA KH Domain GXXG–to–GDDG Mutants
The GXXG motif of KH domains, where X is any amino acid, is necessary for RNA binding and
its mutation to GDDG abolishes RNA binding without affecting protein integrity (Hollingworth
et al., 2012). In order to mutate the NusA KH1 and KH2 domain GXXG loops, a PCR-based
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protocol called splice by overlap extension (SOE) was utilised (Heckman and Pease, 2007). For
each mutation three separate PCR reactions were performed. pET-21a(+) containing a wild-
type M. jannaschii NusA insert was used as template DNA. pET-21a(+) vectors contain a T7
promoter and a T7 terminator. The first step in the SOE process required two PCR reactions.
The first reaction utilised a T7 forward primer and a reverse primer within the gene that con-
tained the desired mutation. The second PCR reaction used a forward primer containing the
desired mutation and a T7 terminator reverse primer. The two reactions yielded overlapping
fragments of the final desired PCR product, with the 3′ end of the first PCR reaction and the
5′ end of the second PCR reaction being complementary to each other. The overlapping regions
also contained the desired mutation as the mismatched primers were incorporated into the PCR
product. The two PCR products were then separated on an agarose gel and purified using a
gel extraction kit (Qiagen) according to the manufacturer’s instructions. The two purified PCR
products were then incubated together as template DNA in the third and final PCR reaction,
utilising a T7 forward primer and a T7 terminator reverse primer. The template DNAs annealed
at the region of mutation and were extended by the DNA polymerase to form one product, con-
taining the desired mutation (Figure 2.2).
An empty pET-21a(+) vector was then digested with the restriction endonucleases EcoRI and
NdeI and treated with alkaline phosphatase to prevent self-annealing. The product of the third
PCR reaction was also digested with EcoRI and NdeI. The digested insert and vector, with
complementary sticky ends, were then incubated together in a ligation reaction in a 6:1 ratio,
resulting in the insertion of the mutated NusA gene into the pET-21a(+) vector (Figure 2.3).
2.3.37 EMSAs with Fluorescent A2 RNA
A2 RNA with a 5′ Cy3 label at a final concentration of 50 nM was incubated with different
concentrations of protein (1, 2.5, 5, 7.5, 10, 15, and 20 µM) in HMNE buffer for 5 minutes at
65◦C in a volume of 20 µl. 10 µl 15% ficoll was added and 10 µl of each sample was immediately
loaded onto a 12% native polyacrylamide gel, which was run at 100 V for approximately 2 hours.
The gel was visualised in a Typhoon FLA 9500 by exciting with a laser at 550 nm.
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Figure 2.2: Splice by overlap extension for introducing mutations into the M. jannaschii NusA
gene. Initially, two PCR reactions are carried out, resulting in the production of two overlapping
products, each containing the desired mutation and being fragments of the final desired product.
The products of the first two PCR reactions are purified and incubated together as template
DNA in the final PCR reaction which results in one PCR product.
2.3.38 In vitro Transcription of Riboprobes
A pGEM-T vector containing the riboprobe insert was linearised by PstI digestion. In vitro
transcription of riboprobes from the linearised pGEM-T vector was performed using a T7 MAX-
Iscript kit (Ambion). The following reagents were incubated together at 37◦C: 2 µl 10× T7
buffer, 6 µl H2O, approximately 2 µg template DNA, 1 µl 10 mM ATP (final 500 µM), 1 µl
10 mM GTP (final 500 µM), 1 µl 10 mM CTP (final 500 µM), 2.5 µl 32Pα-UTP (25 µCi), and
2 µl T7 RNAP mix. The reaction solution was incubated for 30 minutes at 37◦C and then cold
UTP was added to a final concentration of 100 µM. The reaction solution was then incubated
for 2 hours at 37◦C. 2 µl 1000 units/ml DNaseI was added to digest the template DNA for
15 minutes. 20 µl RNase-free water was subsequently added and the reaction solution heated to
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Figure 2.3: Splice by overlap extension for introducing mutations into the M. jannaschii NusA
gene (continued). The SOE PCR product and an empty pET-21a(+) vector are both digested
with EcoRI and NdeI, yielding two products with complementary sticky ends. The insert and
vector are ligated together to yield the final desired construct.
75◦C for 2 minutes to heat inactivate the T7 RNAP. The RNA was then purified using a G25
column (GE Healthcare) according to the manufacturer’s guidelines.
2.3.39 EMSAs with Riboprobes
1:50 dilutions of riboprobes in HMNE were prepared. 10 µl of the diluted riboprobe was in-
cubated with 10 µl protein at varying final concentrations (25 nM, 125 nM, 250 nM, 500 nM,
1µM, 2µM, and 10µM) at 65◦C for 5 minutes. The samples were then placed on ice and 10 µl
15% ficoll was added. 10 µl was loaded onto an 8% continuous native gel made from 0.5 M
Tris-HCl, pH 6.5. The gel was run at 100 V for approximately 1 hour. The gel was transferred
to Whatman paper and dried. It was exposed to an imaging plate for approximately 12 hours
and was visualised using a Typhoon FLA 9500 phosphoimager.
2.3.40 Preparation of 15N Minimal Media
860 ml H2O was autoclaved in an Erlenmeyer flask. To this the following was added: 100 ml
sterile 10× M9 salts (minus NH4Cl), 20 ml of 20% [w/v] sterile glucose, 5 ml of 20% [w/v]
15NH4Cl, 100 µl of sterile 1 M CaCl2 (BDH ), 1 ml of sterile 1 M MgSO4 (Fischer Scientific)
and 10 ml of 100× MEM salts (Sigma Aldrich).
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2.3.41 15N Labelling of Protein
For each litre of expression culture a 25 ml overnight starter culture was grown in rich media. The
starter culture was centrifuged at 6000 × g for 15 minutes. The supernatant was removed and
the pellet resuspended in 10 ml of sterile 1× M9 salts. The resuspended cells were centrifuged
again at 6000 × g for 15 minutes, the supernatant was removed and the cells resuspended in
2 ml of sterile 1× M9 salts and added to 1 L of 15N minimal media. Cells were grown at 37◦C
shaking at 200 rpm until an OD600 0.6 was reached. IPTG was added at a final concentration of
1 mM. Cells were grown for a further 5 hours at 37◦C. The cells were centrifuged for 15 minutes
at 6000 × g and the pellets were stored at -20◦C.
2.3.42 Preparation of 15N, 13C, 2H Minimal Media
For 1 L media the following was added:
• 15NH4Cl: 3 g
• 13C glucose (Cambridge Isotopes): 5 g
• Na2HPO4: 7 g
• KH2PO4: 6.6 g
• MgSO4: 0.5 g
• Na2SO4: 0.7 g
• Sodium succinate: 5.4 g
• 10× MEM vitamins: 10 ml
• 2000× trace metals: 500 µl
• Ampicillin: 0.1 g
• 1 M CaCl2: 300 µl
• D2O (Sigma): Up to 1 L
The media was subsequently filter sterilised and stored at 4◦C until required.
2.3.43 15N, 13C, 2H Labelling of Protein
The morning before the labelled protein was prepared, a single transformed colony was isolated
in 100 ml LB media and grown at 37◦C for approximately 10 hours. The culture was centrifuged
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at 6000 × g and resuspended in 20 ml of 15N, 13C, 2H minimal media per litre to be expressed.
The resuspended cells were grown at 37◦C overnight. 20 ml overnight culture was then added to
each litre of media, giving an OD600 of approximately 0.1. The cells were grown at 37
◦C to an
OD600 of 0.6 and protein expression was induced by the addition of IPTG at a final concentration
of 1 mM. After 5 hours of protein expression the cells were centrifuged at 6000 × g for 15 minutes,
and the pellets were stored at -20◦C.
2.3.44 Scaffold-Independent Analysis (SIA) - Sample Preparation
NusA samples for SIA analysis were expressed in 15N minimal media and extracted in N50
buffer. The soluble fraction was heat inactivated at 75◦C for 30 minutes and centrifuged at
20,000 × g for 3 minutes. The heat stable NusA in the supernatant was purified by heparin
affinity chromatography. The sample was loaded in wash buffer consisting of 50 mM NaCl and
10 mM Na2HPO4, pH 6.5. It was eluted in a gradient consisting of wash buffer and elution buffer
(1 M NaCl and 10 mM Na2HPO4, pH 6.5). The eluted protein was concentrated and the buffer
exchanged to 50 mM NaCl, 10 mM Na2HPO4, pH 6.5 (wash buffer) in a Vivacon concentrator.
SIA is used to determine the sequence specificity of RNA-binding KH domains (Beuth et al.,
2007). KH domains bind regions of RNA which are 5 nucleotides in length, of which the last four
are bound in a sequence-specific manner (Lewis et al., 2000). SIA works on the principle that
the sequence identity of each nucleotide position can be identified independently of the other
nucleotides within the binding motif. This is achieved by preparing 15N-labelled protein, which
is subsequently analysed by HSQC spectroscopy in the presence of pools of RNA pentamers.
The identity of each position in the pentamer is random (any of A, C, G, or U) except for the
position that is being analysed whose identity is known and constant within a given RNA pool.
For example, to analyse the sequence preference at position 1, four spectra would be recorded.
In the first spectrum, position 1 would always be A. In the second spectrum, position 1 would
always be C. In the third spectrum, position 1 would always be G. In the fourth spectrum,
position 1 would always be a U. Since the other positions of the RNA pentamers are completely
random, this enables the relative preference of the KH domains at each position to be determined
independently of the other positions. The nucleotide preference is obtained by determining which
nucleotide results in the greatest change in chemical shifts of selected peaks upon the addition
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of RNA pentamers compared to the spectrum of free protein. For a more detailed description
of SIA, see Chapter 5.
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Chapter 3
Characterising Complexes
Containing Spt4/5, S10, and
NusA
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3.1 Introduction
3.1.1 Transcription-Translation Coupling in E. coli
Transcription is the most important stage in gene expression and its three main products are all
required for translation. The ribosome is composed of rRNA and ribosomal proteins. tRNAs
bring amino acids to the 3′ end of the nascent chain through codon-anticodon base-pairing. The
mRNA product of transcription is the template for translation (Figure 3.1).
Figure 3.1: The three main products of transcription, tRNA, mRNA and rRNA are all required
for translation.
Translation is the process whereby individual amino acids are sequentially incorporated into
a polypeptide chain from the N to C terminus by the ribosome. Ribosomes are large macro-
molecular machines that contain an RNA core, which carries out the catalysis, and ribosomal
proteins that stabilise and enhance the catalytic properties of the RNA. In archaea, ribosomes
are composed of a 50S and a 30S subunit which associate to form a functional 70S complex. The
small subunit contains a 16S RNA and the large subunit contains a 5S RNA and a 23S RNA.
Whilst high-resolution structures are available for complete bacterial (Schuwirth et al., 2005)
and eukaryotic (Ben-Shem et al., 2011) ribosomes, no such structure currently exists for the
archaeal ribosome. However, models are available based on cryoEM data (Armache et al., 2013).
It has been known for many years that transcription and translation are co-regulated in bacteria
through mechanisms such as attenuation (see Chapter 1). More recently it has become apparent
that transcription and translation are directly coupled. NusG is able to bind to RNAP via its
NGN domain (Hirtreiter et al., 2010a) and to the ribosome via its KOW domain (Burmann
et al., 2010b). In vivo data indicates that the transcription and translation rates are correlated,
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and that the ratio of amino acids incorporated into the nascent chain to nucleotides added to
the RNA is always 3:1. This provides further evidence that transcription and translation are
directly coupled (Proshkin et al., 2010).
The ribosome binding face of S10 is still accessible when in complex with NusG. NusG may
therefore act as a bridge between transcription and translation complexes (Figure 3.2), bound to
the RNAP coiled-coil clamp helices via the NGN domain and to S10 via the KOW domain. RfaH
is a NusG paralogue (Bailey et al., 1997) with an N-terminal NGN domain that is structurally
similar to that in NusG (Belogurov et al., 2007). Like NusG, it also increases the processivity
of RNAP (Artsimovitch and Landick, 2002) by enclosing the DNA within the RNAP active site
(Sevostyanova et al., 2011). RfaH has recently been shown to undergo a complete refolding of
its C-terminal domain upon binding its target DNA sequence, enabling it to also couple tran-
scription and translation by linking RNAP and the ribosome (Burmann et al., 2012).
Figure 3.2: NusG is hypothesised to act as a direct protein link between transcription and
translation. In addition to being connected by RNA (orange), RNAP and the ribosome are
bridged by NusG. NusG binds to RNAP via the NGN domain and to the S10 protein of the
small ribosome subunit via the KOW domain.
3.1.2 Chapter Aims
The aim of this chapter is to determine whether the putative antitermination factors Spt4/5 and
NusA associate with RNAP and the ribosome in cell extract. In order to test this, preparations
of M. jannaschii cell lysate were made and separated by size exclusion chromatography. If the
factors elute in the same fraction peaks, this will suggest association. Western blot analysis
was carried out against the fractions using polyclonal antibodies generated against recombinant
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factors. Comparison of elution volumes with a size standard enabled sizing of protein complexes.
Whilst the interaction between archaeal Spt4/5 and RNAP is well documented (Hirtreiter et al.,
2010a) the interaction with ribosomes has yet to be characterised. This work in this chapter
therefore aims to observe this interaction. This was achieved by performing microscale ther-
mophoresis on ribosomes prepared from M. jannaschii cell extract and recombinant Spt4/5.
The final aim of this chapter is to ascertain whether stable interactions can be observed between
Spt4/5 and recombinant ribosomal protein S10. This was examined by Superose 12 size exclu-
sion chromatography.
3.2 Characterisation of Complexes Containing Spt4/5,
NusA, and S10 in Cell Extract
Whilst the interaction between recombinant archaeal Spt4/5 and RNAP is well documented in
vitro (Hirtreiter et al., 2010a) the interaction has yet to be observed in the context of endoge-
nous proteins from the M. jannaschii cell. Furthermore whilst interactions between NusG and
recombinant S10 have been detected, interactions between Spt4/5 and translation complexes
containing complete ribosomes have not. To determine whether these interactions occur in vivo,
preparations of mid-log M. jannaschii cell extract were made and separated by size exclusion
chromatography. Western blot analysis was then carried out against the fractions using poly-
clonal antibodies generated against recombinant factors.
First, a size standard was run on a Superose 6 column to enable sizing of any complexes (Fig-
ure 3.3). Plotting the log of the molecular weight against the elution volume enabled the gener-
ation of a standard curve (Figure 3.3B) with the equation:
y = −3.26x+ 24.4 (3.1)
where y is the elution volume and x is log MW. This can be rearranged to:
x = (24.4− y)/3.26 (3.2)
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so that for any given elution volume, the molecular weight can be calculated.
There is a small peak at 8.7 ml (Figure 3.3A). This represents the exclusion limit of the column.
The accuracy of size-determination decreases as the elution volume approaches the limit of the
column.
Figure 3.3: Superose 6 size standards. A) Chromatogram of the standard run. B) Elution
volumes of the five proteins in the size standard. C) Plotting the elution volume of the proteins
in the size standard against log MW enables the generation of a standard curve. Using the
standard curve the molecular weight of any complex can be determined, given its elution volume.
Due to the nucleic acid binding properties of the putative antitermination complexes, M. jan-
naschii cell extract was also treated with DNaseI or RNaseI for 1 hour at 37◦C. The nuclease-
treated cell extracts were analysed on a 1% agarose gel (Figure 3.4A). After DNase treatment,
the largest nucleic acids have been destroyed and there is a very strong band at 600 bp. RNase
treatment results in the disappearance of the intense band at 600 bp. Treating the extract
with DNase and RNase removes nearly all of the high molecular weight nucleic acids and the
intensity on the gel is significantly less than for the DNase-only and RNase-only treated extracts
(Figure 3.4A). The nuclease-treated extracts were also separated by Superose 6 size exclusion
chromatography. Western blots were carried out against eluted fractions to determine whether
the complexes are nuclease-sensitive. After DNase treatment there is a slight difference in the
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Superose 6 chromatogram (Figure 3.4B&C). The peak at 21.5 ml has a greater intensity for both
protein (280 nm) and nucleic acid (260 nm). After RNase treatment (Figure 3.4D), the 260 nm
and 280 nm absorbance at 17 ml is greatly reduced compared to untreated extract.
Figure 3.4: Chromatograms of Superose 6 separation of M. jannaschii cell extract. A) 10 µl
nuclease-treated M. jannaschii cell extract was resolved on a 1% agarose gel. B) Untreated
extract. C) DNase-treated extract. D) RNase-treated extract. RNase treatment results in the
disappearance of the 260 and 280 nm peaks at 17 ml. Light blue: 214 nm, purple: 260 nm,
green: 280 nm, orange: 405 nm.
3.2.1 Analysis of Rpo4/7 Elution Profile from M. jannaschii Extract
After fractionation of cell extract, Western blot analysis was performed using antibodies against
the RNAP subunits Rpo4/7 which form the stalk (Figure 3.5A). The stalk was chosen because,
in addition to being a stably incorporated sub-complex of the RNAP (Grohmann et al., 2009),
it binds to the emerging RNA transcript (Hirtreiter et al., 2010b; Meka et al., 2005). RNAP
elutes in three peaks when the cells are untreated. A high molecular weight complex at 10 ml
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represents a mass in the MDa range. This likely corresponds to transcription complexes that
are coupled to translation complexes. A peak at 13-14 ml corresponds to RNAP that is not
bound to ribosomes with a molecular weight of approximately 470 kDa. M. jannaschii RNAP
has a molecular mass of approximately 370 kDa. However, given that it is bound to DNA and
is likely to be associated with additional transcription factors it is not unexpected to find it in
complexes of higher molecular weight. The third peak at 18-20 ml corresponds to a molecular
weight of just under 20 kDa, which is less than the actual Rpo4/7 molecular weight of 33.5 kDa.
The Rpo4/7 that elutes here represents free subunits that have either not been incorporated
into RNAP or have dissociated from the RNAP during extraction of the protein from the cell.
Since previous data suggests that Rpo4/7 is stably incorporated into RNAP, it is more likely to
be excess Rpo4/7 that has yet to be incorporated into an RNAP.
Upon treatment of the cell extract with DNaseI the peak corresponding to ribosome-associated
RNAP in the MDa range disappears (Figure 3.5B). This could be because RNAP was bound
to large regions of genomic DNA. Alternatively, DNase treatment may have broken up large
RNAP-protein complexes that are dependent on DNA for their integrity. The other two Rpo4/7
elution peaks remain; there is still a peak at 13-15 ml which represents transcription complexes
and a peak at 18-20 ml representing the free subunits.
Treatment of the cell extract with RNaseI abolishes the highest molecular weight complexes
of RNAP at 10 ml, although some ribosome-bound RNAP is still present at 11-12 ml (Fig-
ure 3.5C). RNase treatment does not affect the RNAP fraction, with Rpo4/7 still eluting at
13-15 ml. However, the peak that represents free Rpo4/7 has upshifted in its profile, eluting
at 16-19 ml, compared to 17-20 ml for non-treated extract. This could be because large RNAs
are degraded into shorter RNAs that can now be bound by Rpo4/7, resulting in an increase in
RNAP mass. Each nucleotide in an RNA molecule is approximately 330 Da on average, so every
three nucleotides would add 1 kDa to the mass of a complex.
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Figure 3.5: Western blot analysis of Superose 6 separated Rpo4/7 from cell extract. Comparison
with a size standard (red) enabled sizing of complexes. A) In untreated extract Rpo4/7 elutes
in three peaks corresponding to ribosome-bound, transcription complexes and free subunits.
B) Upon DNase treatment of the cell extract Rpo4/7 is no longer found associated to ribosomes.
C) After RNase treatment, Rpo4/7 does not elute in the highest molecular weight fractions. The
elution volume for free Rpo4/7 is upshifted by 1 ml.
3.2.2 Analysis of S10 Elution Profile from M. jannaschii Extract
Western blots were also carried out on the same separated M. jannaschii cell extract using
antibodies against the ribosomal protein S10 (Figure 3.6A). There is a peak from 10-13 ml
representing a complex in the MDa range. This is the ribosomal fraction. There is no peak
at 13–14 ml, which corresponds to the mass of RNAP. Therefore S10 does not associate with
RNAP. There is also no peak at 19-20 ml corresponding to the mass of free S10, 12.24 kDa.
Therefore there is no free S10, and S10 is present only in ribosome-bound form. E. coli S10
has been reported to have low solubility by itself in vitro when not ribosome-bound (Luo et al.,
2008). It is therefore possible that any free M. jannaschii S10 precipitates out of solution during
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the cell extract preparation. Consequently no free S10 would be loaded on to the Superose 6
column, and therefore no free S10 would be detected.
Figure 3.6: Western blot analysis of Superose 6 separated S10 from cell extract. Comparison
with a size standard (red) enabled sizing of complexes. A) In untreated extract S10 elutes in
one peak only, corresponding to it being incorporated into the ribosome. B) DNase treatment
of the cell extract has no effect on the elution profile of S10. C) RNase treatment of the cell
extract has very little effect on the elution profile of S10. No free S10 is observed.
Treatment with DNaseI does not disrupt the complex (Figure 3.6B). This is not unexpected
since ribosomes are composed mainly of RNA. In addition there is no reported evidence of S10
binding to DNA. However, RNase treatment does not greatly alter the elution profile either
(Figure 3.6C), which demonstrates that the ribosomes are still completely intact and are there-
fore highly stable and resistant to RNase treatment. This may be due to the ribosomal proteins
protecting the rRNA from degradation. After both DNase treatment and RNase treatment, the
S10 at 10 ml becomes more prominent and it also becomes detectable at 9 ml.
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3.2.3 Analysis of Spt4/5 Elution Profile from M. jannaschii Extract
Spt4/5 elutes from the size exclusion column in three peaks (Figure 3.7A). Only Spt5 is visible on
the Western blots suggesting that very few of the antibodies in the polyclonal sample bind Spt4,
and that Spt4 is not very immunogenic. At 10-11 ml there is a peak corresponding to a very high
molecular weight complex of about 5.5 MDa, based on the size standard. This overlaps with the
elution of S10. This fraction is therefore likely to be ribosome-associated Spt4/5. Ribosomes
have a mass of 2.5 MDa in bacteria and 4.6 MDa in eukaryotes. Archaeal ribosomes are not
larger than their eukaryotic counterparts. However 10 ml is approaching the void volume of the
column (8.7 ml)(Figure 3.3A) explaining the poor accuracy of size prediction. The peak from
14-15 ml corresponds to a molecular weight of approximately 470 kDa. This fraction is most
likely transcription complexes as it overlaps with the elution of RNAP. The third Spt4/5 peak
is at 18-20 ml. Using the size standard, an elution volume of 19 ml corresponds to a molecular
weight of 20 kDa. Spt4/5 has a mass of 24 kDa. Therefore this low molecular weight peak is free
Spt4/5 that is not in complex with any other proteins. This data suggests that in the context
of M. jannaschii cell extract, Spt4/5 is found bound to ribosomes, bound to RNAP, and in its
free state. When also considering that RNAP is found in the ribosome fractions, this raises the
possibility that Spt4/5 couples transcription and translation in archaea.
Two species of Spt5 are detected on the Western blot of untreated extract which have slightly
different electrophoretic mobilities. The RNAP-associated Spt5 at 14-15 ml has a slightly higher
mass than ribosome-bound and free Spt5 (Figure 3.7A). This suggests that transcription complex
associated Spt4/5 may be post-translationally modified. In eukaryotes Spt4/5 is phosphorylated.
Post-translational modifications are not as common in archaea as in eukaryotes. However, they
have been reported in M. jannaschii (Giometti et al., 2002), including acetylation and methy-
lation (Forbes et al., 2004). Isolating Spt4/5 from cell extract by immunoprecipitation and
analysing it mass spectroscopy would enable identification of any post-translationally modified
Spt5.
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Figure 3.7: Western blot analysis of Superose 6 separated Spt4/5 from cell extract. Comparison
with a size standard (red) enabled sizing of complexes. A) In untreated extract Spt4/5 elutes
in three peaks corresponding to ribosome-bound, RNAP-bound and free protein. B) Upon
DNase treatment of the cell extract Spt4/5 is no longer found in its ribosome or RNAP-bound
state. C) RNase treatment destroys the interaction of Spt4/5 with ribosomes and results in a
broadening of the elution profile.
3.2.4 Spt4/5-Bound Transcription Complexes are Sensitive to
Treatment by Nucleases
After DNase treatment Spt4/5 no longer elutes in fractions containing ribosomes or RNAP (Fig-
ure 3.7B). Spt4/5 elutes only in fractions corresponding to free monomeric protein at 20-21 ml.
This suggests that the complexes of Spt4/5 with RNAP and ribosomes are DNA dependent.
This is consistent with its function as a transcription elongation factor that binds to transcrib-
ing RNAP with high affinity.
RNase treatment of the cell extract also abolishes the complex between Spt4/5 and the ribo-
some (Figure 3.7C) as there is no elution of Spt4/5 in fractions corresponding to a mass in the
MDa range. Spt4/5 is still associated with RNAP after RNase treatment, eluting at 14-15 ml.
Interestingly the peak corresponding to free Spt4/5 is broader and upshifted, overlapping with
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the RNAP-bound Spt4/5. It encompasses fractions from 16-20 ml with its apex at 18-19 ml.
This broad elution peak corresponds with a molecular weight ranging from 10-165 kDa.
3.2.5 Analysis of NusA Elution Profile from M. jannaschii Extract
NusA elutes in two peaks from the Superose 6 column in untreated cell extract (Figure 3.8A).
The first peak is at 11-12 ml, corresponding to a molecular weight in the MDa region. This
is approaching the exclusion limit of the column, and it is therefore not possible to accurately
determine the mass of the complex. However, the elution profile of NusA overlaps with the
elution profile of S10. This therefore raises the possibility that NusA is bound to the ribosome.
This is not an unexpected observation because NusA binds to the pre-16S rRNA, promoting its
folding and facilitating ribosome biogenesis (Bubunenko et al., 2013). The second elution peak
is broad, ranging from 18-21 ml with its apex between 19 and 20 ml. This is free NusA and
corresponds to a molecular weight of 14 kDa, which is below the actual NusA mass of 21 kDa.
Very little NusA is observed at 13-15 ml, where RNAP elutes.
DNase treatment of the cell extract has little effect on the elution profile of NusA (Figure 3.8B).
Given that archaeal NusA consists of two RNA-binding KH domains only and that no RNAP-
associated NusA was observed in the untreated cell extract, this is not an unexpected observation.
RNase treatment of the cell extract has a larger effect on the elution profile of NusA but it is
still found in fractions containing ribosomes. (Figure 3.8C). As with Spt4/5 and Rpo4/7, the
free NusA peak is broader and NusA is present in higher molecular weight complexes compared
to extract that has not been treated with RNase. NusA now elutes in one continuous peak from
9-18 ml. This may be due to more free RNA of different sizes being present and bound by NusA,
resulting in a broader range of NusA complexes.
Summary
The fractionation of M. jannaschii cell extract has demonstrated that Spt4/5 is present in
fractions that contain ribosomes and transcription complexes. These complexes are nuclease-
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Figure 3.8: Western blot analysis of Superose 6 separated NusA from cell extract. Comparison
with a size standard (red) enabled sizing of complexes. A) In untreated extract NusA elutes
in two peaks corresponding to ribosome-bound, and free protein. B) DNase treatment of the
cell extract has no effect upon the elution profile of NusA. C) RNase treatment results in a
broadening of the NusA elution profile.
sensitive, which can be explained by the fact that Spt4/5 is a transcription factor. The presence
of RNAP in the ribosomal fractions of untreated extract hints that transcription complexes may
be coupled to translation complexes. NusA elutes in fractions containing ribosomes, possibly
suggesting a role in translation. The size fractionation provides no evidence of NusA associating
with transcription complexes.
3.3 Recombinant Spt4/5 Interacts with Ribosomes
3.3.1 Microscale Thermophoresis
Microscale thermophoresis (MST) is a technique that can be used to quantify interactions be-
tween biomolecules. It exploits the fact that a biomolecule has different physical properties when
unbound compared to when it is within a complex. These differences are size, hydration shell and
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charge. By exploiting multiple differences in molecular behaviour, MST is able to obtain binding
data even when small unlabelled molecules bind large labelled molecules. This is particularly
useful when dealing with very large molecules that cannot be prepared to high concentrations,
such as ribosomes. This is an advantage over techniques such as fluorescence anisotropy which
rely on a significant increase in the molecular weight of the labelled complex. In MST one of the
interacting proteins is labelled with a fluorescent dye and always kept at constant concentration
whilst the other protein is diluted out by serial dilution. MST reactions occur in glass capillaries
and require very small volumes. Initially the molecules are evenly distributed throughout the
capillary. An infrared laser is then switched on which causes a localised temperature increase, in
the µm scale, of about 5◦C. The biomolecules within the capillary then migrate along a temper-
ature gradient, away from the source of heat induced by the laser in a phenomenon known as the
Soret effect (Duhr and Braun, 2006). The movement along the temperature gradient varies with
the aforementioned properties, such that the migrational behaviour of the labelled biomolecule
changes as complex formation occurs. At the same time, the fluorescently-labelled molecule is
excited by a laser and the fluorescence is monitored. Thus motion of the fluorescently-labelled
molecule along the temperature gradient is observable.
There are three parameters that enable binding affinities to be accurately determined. The first
is the temperature jump that is induced by the infrared laser. This occurs on a timescale of about
3 seconds. Fluorescence intensity changes with temperature. This can be due to a change in the
absorption of the dye, its quantum yield or the lifetime of its fluorescence emission. However,
the local environment of the dye also affects these properties. A bound protein can restrict local
mobility and can also alter the local chemical environment surrounding the dye. Thus the fluo-
rescence intensity is dependent on both the temperature shift but also on whether a biomolecule
is binding the protein near the fluorescent dye (within 2 nm) (Vaiana et al., 2003). The second
parameter that enables binding affinities to be determined is thermophoresis in the temperature
gradient. This occurs on a slower timescale to the temperature jump, taking about 30 seconds.
The final parameter is back diffusion. The thermophoresis results in an inhomogeneous distribu-
tion of the fluorescent molecule along the temperature gradient. When the temperature gradient
is eliminated the biomolecules will diffuse back to a homogeneous distribution (Figure 3.9). Since
there is no longer a temperature gradient present the rate of back diffusion depends only on the
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size of the complex. Therefore this phase yields no data when analysing a small unlabelled
molecule binding a much larger labelled one (Jerabek-Willemsen et al., 2011).
Figure 3.9: The migration of molecules in an MST experiment. At first the fluorescent molecules
are homogeneously distributed throughout the capillary, resulting in a steady fluorescence read-
ing. At approximately 5 seconds the infrared laser is switched on and focussed on the specific
region of the capillary that is observed. This creates a temperature gradient. The fluorescently-
labelled molecules move down the temperature gradient, resulting in a decrease in fluorescence
at the observed point. After approximately 35 seconds the infrared laser is switched off and the
temperature gradient dissipates. The fluorescently-labelled molecules diffuse back, resulting in
a restoration of the observed fluorescence. Figure from (Jerabek-Willemsen et al., 2011).
3.3.2 Expression of Recombinant Spt4/5
M. jannaschii Spt4/5 was expressed as a GST-fusion protein from a pGEX-2TK vector in Rosetta
2 E. coli cells and purified on a glutathione affinity column. The resulting protein was very pure
and contained few contaminants (Figure 3.10).
3.3.3 Removal of the GST Tag
The Spt4/5-GST fusion protein was treated with thrombin to separate Spt4/5 from GST. The
sample was then incubated at 65◦C for 30 minutes, resulting in the precipitation of the GST,
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Figure 3.10: SDS PAGE of Spt4/5 purification by GST-affinity chromatography. The GST-
tagged protein bound to the column and was eluted by addition of glutathione, yielding a pure
GST-tagged protein.
whilst the thermostable Spt4/5 remained folded in solution. The sample was then centrifuged
and the resulting supernatant contained the purified Spt4/5 (Figure 3.11).
Figure 3.11: SDS PAGE of GST removal and heat-inactivation. The GST tag was removed by
overnight treatment with thrombin to give Spt4/5 and GST. The GST was separated from the
Spt4/5 by heat inactivation. The sample was heated to 65◦C to precipitate the GST out of
solution. The sample was centrifuged, pelleting the GST whilst the heat-stable Spt4/5 remained
in solution in the supernatant.
3.3.4 Preparation of M. jannaschii Ribosomes
Ribosomes were prepared from M. jannaschii cell extract (see Chapter 2). The purified ribo-
somes were analysed on a 10–30% sucrose gradient. The OD260 was monitored and fractions
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analysed by Western blot against S10 (Figure 3.12A). The RNA from the peak fraction was ex-
tracted and was analysed on a bioanalyzer, which revealed the presence of two prominent RNAs,
corresponding to the 16S and the 23S rRNAs (Figure 3.12B). The RNA was also analysed on a
1% agarose/TBE gel (Figure 3.12C). 1
Figure 3.12: Purification of ribosomes from M. jannaschii cell extract. A) After washing through
a salt cushion to remove bound transcription and translation factors, the ribosomes were analysed
on a 10–30% sucrose gradient. The presence of ribosomes was confirmed by analysing the OD260,
and by Western blot analysis using antibodies against the ribosomal protein S10. B) The peak
fraction (starred) was characterised on a bioanalyzer, revealing the presence of two major RNA
bands, corresponding the 23S and 16S rRNAs. C) 1% agarose TBE gel of extracted rRNA.
These experiments were conducted by Dr Tina Daviter.
3.3.5 Labelling of Ribosomes with Maleimide-Coupled NT650 Dye
The ribosome preparation was labelled at cysteine residues with NT650. Unbound dye was
separated from the labelled ribosomes on a gel filtration drip column, and the labelled ribosomes
were eluted in fractions of 100 µl. Fractions containing labelled ribosomes were determined by
measuring absorbance at 260 and 650 nm on a Nanodrop UV/Vis spectrometer (Figure 3.13).
3.3.6 Interaction Between Ribosomes and Spt4/5
MST was performed to analyse interactions between recombinant Spt4/5 and ribosomes puri-
fied from M. jannaschii cell lysate. All experiments were recorded using a Monolith NT.115
1Ribosome preparations, bioanalyzer run, and agarose gel electrophoresis were performed by Dr Tina Daviter.
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Figure 3.13: Elution profiles of labelled ribosomes. Labelled ribosomes were separated from free
label on a gel filtration column. A) OD260 corresponding to ribosomes. B) OD650 corresponding
to labelled ribosomes.
instrument. A serial dilution of Spt4/5 from 3 nM to 100 µM was set up. Ribosomes at a
final concentration of 15 nM, labelled with a maleimide-coupled dye NT650 were incubated with
Spt4/5 at room temperature for 30 minutes. The samples were then excited at 650 nm, and the
infrared laser turned on 5 seconds later. Thermophoresis was analysed for 30 seconds, then the
infrared laser was turned off and back diffusion was analysed for 5 seconds thereafter. Plotting
the temperature jump against the concentration of Spt4/5 yields a binding curve, suggesting
that Spt4/5 is interacting with the purified ribosomes (Figure 3.14A). From this binding curve
a Kd of 2 µM was obtained for the interaction. This is the first time that an interaction between
Spt4/5 and whole ribosomes has been observed. A negative control whereby TATA-binding
protein (TBP) was titrated into the labelled ribosomes did not result in binding (Figure 3.14B),
thereby demonstrating that the decrease in fluorescence upon addition of Spt4/5 is due to spe-
cific binding.
3.3.7 The KOW Domain of M. jannaschii Spt4/5 Interacts with the
Ribosome
Previous studies in E. coli have demonstrated that only the KOW domain of NusG interacts with
the ribosomal protein S10. To determine whether it is the KOW domain that binds ribosomes in
archaea too and whether the NGN domain is involved in the interaction in the context of com-
plete ribosomes, further MST analysis was performed on two domain-deletion variants of Spt4/5.
The first was Spt4/5 NGN which consists of the NGN domain of Spt5 in complex with Spt4 but
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Figure 3.14: MST analysis indicates an interaction between recombinant Spt4/5 and ribosomes
prepared from M. jannaschii cell extract. A) Titration of Spt4/5 into labelled ribosomes.
B) Titration of TBP into labelled ribosomes. Data obtained at NanoTemper MST demon-
stration with Dr James Wilkinson.
which lacks the KOW domain. The second was the KOW domain only, lacking both the NGN
domain of Spt5 and Spt4. The experiments were carried out in the same way as for full length
Spt4/5. When MST was conducted using labelled ribosomes and the KOW domain, binding
was observed and analysis of the data yields a Kd of 4 µM (Figure 3.15A). This is in good agree-
ment with full length Spt4/5. When MST was carried out using labelled ribosomes and Spt4/5
NGN, no binding was observed (Figure 3.15B) indicating that the NGN domain is not involved
and that Spt4/5 interacts with ribosomes solely through the KOW domain as it does in bacteria.
Figure 3.15: MST analysis using labelled ribosomes prepared from M. jannaschii cell extract and
recombinant domain deletion variants of Spt4/5. A) The KOW domain interacts with ribosomes.
B) Spt4/5 NGN does not interact with ribosomes.
The interaction between the KOW domain and ribosomes was further characterised by pre-
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incubating the labelled ribosomes with either anti-S10 or anti-TBP antibodies that had been
purified from rabbit serum (Figure 3.16). When the ribosomes were incubated with anti-S10 no
binding was observed upon addition of the KOW domain (Figure 3.17A). This indicates that the
anti-S10 antibodies were blocking the binding site and that the KOW domain must therefore
bind to the S10 protein. When the labelled ribosomes were incubated with anti-TBP there was
no change in the MST analysis, and the KOW domain was shown to bind the ribosomes with a
Kd of 3 µM, indicating that the effect of the anti-S10 is not due to non-specific binding of the
antibodies (Figure 3.17B).
Figure 3.16: SDS PAGE of purified polyclonal antibodies. The heavy and light chains are
indicated.
Figure 3.17: MST analysis was performed on labelled ribosomes and the KOW domain in the
presence of polyclonal antibodies. A) When incubated with anti-S10 no binding is observed
indicating that anti-S10 abolishes the interaction. B) When incubated with anti-TBP the binding
face on the S10 subunit is still available for binding to the KOW domain.
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3.4 Interactions Between Spt4/5 and Recombinant S10
Having observed interactions between M. jannaschii Spt4/5 and ribosomes, experiments were
performed to attempt to observe interactions between purified recombinant factors. To this end
Superose 12 size exclusion chromatography on Spt4/5 and S10 was carried out. First Spt4/5
and S10 were separated on the column individually and their elution volume determined by SDS
PAGE and silver staining. Spt4/5 and S10 were subsequently incubated together at 65◦C for
30 minutes and the pre-incubated sample was separated on the Superose 12 column. Further
SDS PAGE and silver staining was conducted on the pre-incubated sample.
3.4.1 Purification of Recombinant S10
The ribosomal protein S10 was expressed in Rosetta 2 cells from a pET-21a(+) vector with no
affinity tag. After cell extraction, the soluble portion of the cell extract was heated-inactivated
to precipitate most of the endogenous E. coli proteins. The heat-inactivated sample was then
centrifuged to separate the soluble and insoluble portions. The protein in the soluble portion was
precipitated by adding ammonium sulphate. The precipitate was pelleted, resuspended in 5 ml
N500 buffer and purified by size exclusion chromatography on an S100 column (Figure 3.18).
The fractions containing pure protein were then concentrated.
Figure 3.18: SDS PAGE of S10 purification on a S100 column.
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3.4.2 Superose 12 Size Exclusion Chromatography on Spt4/5 and S10
First, a size standard was run on the Superose 12 column to enable sizing of any proteins or
complexes (Figure 3.19). Plotting the log of the molecular weight against the elution volume
enabled the generation of a standard curve (Figure 3.19C) with the equation:
y = −4.04x+ 33.4 (3.3)
where y is the elution volume and x is log MW. This can be rearranged to:
x = (33.4− y)/4.04 (3.4)
so that for any given elution volume, the molecular weight can be calculated.
Figure 3.19: A) Elution volumes of the five proteins in the size standard. B) Plotting the elution
volume of the proteins in the size standard against log MW enables the generation of a standard
curve. Using the standard curve the molecular weight of any complex can be determined, given
its elution volume.
When separated on the column on its own Spt4/5 elutes in a broad peak with the apex at 16 ml
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(Figure 3.20A). Comparison of this volume with a size standard indicates a molecular weight in
the region of 20.3 kDa which is consistent with Spt4/5 existing as a monomer in solution. When
pre-incubated with S10, the elution profile of Spt4/5 is the same, showing a broad distribution
with the apex of the peak at 16 ml (Figure 3.20C). Again this is consistent with a monomeric
Spt4/5 and indicates that under the conditions present in the Superose column, there is no stable
interaction occurring between Spt4/5 and S10.
The elution profile of S10 supports this conclusion. When separated on the column by itself S10
elutes at 16-17 ml (Figure 3.20B). By comparison with the size standard, 17 ml corresponds to
a molecular weight of 11.5 kDa. This is consistent with a monomeric S10 which has an actual
MW of 12.2 kDa. When preincubated with Spt4/5, S10 still elutes at 16-17 ml (Figure 3.20C).
The absence of a decrease in elution volume upon preincubation of the proteins indicates that
no stable complex has been formed between Spt4/5 and S10.
3.5 NusA is Stably Associated with the Ribosome
The size fractionation of cell extract showed that NusA elutes in the same fractions as ribo-
somes. The presence of NusA in ribosomes was confirmed by preparing ribosomes that had been
washed in 500 mM NH4Cl to remove any loosely-associated translation factors. The ribosomes
were then separated on a Superose 12 column and the fractions analysed by Western blot using
polyclonal antibodies against S10 and NusA. The ribosomes elute from the Superose 12 column
as one peak with a slight shoulder at the higher molecular weight end. This indicates that the
ribosomes exist largely as one species, and have not separated into their constituent large and
small subunits. The peak maximum is between 8-9 ml (Figure 3.21A). S10 elutes in one peak at
8-9 ml, in good agreement with the elution OD260 profile, and acting as a positive control for the
presence of ribosomes (Figure 3.21B). NusA is present in the same fractions as S10, indicating
that it is stably associated with the ribosome (Figure 3.21C).
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Figure 3.20: Silver stain analysis of Superose 12 size exclusion chromatography of Spt4/5 and
S10. Elution volumes in ml are indicated above the lanes. A) Spt4/5 separated by size exclusion
chromatography followed by SDS PAGE and silver staining. B) S10 separated by size exclusion
chromatography followed by SDS PAGE and silver staining. C) Spt4/5 preincubated with S10
and separated by size exclusion chromatography followed by SDS PAGE and silver staining.
Incubating Spt4/5 and S10 together does not result in a shift in either of their elution profiles,
suggesting that no stable interaction is formed.
3.6 Discussion
In this chapter, size exclusion chromatography of M. jannaschii cell extract followed by Western
blot analysis has shown that Spt4/5 is in fractions that contain i) RNAP and ii) ribosomes. The
nature of these complexes has been verified by using antibodies against the recombinant RNAP
subunits Rpo4/7 and the ribosomal protein S10. This suggests that Spt4/5 is present in both
transcription and translation complexes. This chapter has also shown that the complex between
Spt4/5 and RNAP is dependent upon DNA, since DNase treatment of the cell extract abolishes
the coelution of RNAP and Spt4/5. This is consistent with previous reports that Spt4/5 binds
to transcription elongation complexes (Grohmann et al., 2011). The presence of RNAP sub-
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Figure 3.21: Association of NusA with the ribosome. A) Purified ribosomes were separated on
a Superose 12 size exclusion column and the absorbance at 260 nm was monitored. Western
blots were carried out on the separated ribosome fractions to test for the presence of B) S10,
and C) NusA. S10 and NusA both elute at 8–9 ml, indicating that NusA is stably associated
with the ribosome.
units Rpo4/7 in ribosomal fractions raises the possibility that Spt4/5 binds to the ribosome and
RNAP simultaneously. This could be further examined in vivo by knocking out wild-type Rpo1′
and replacing it with the well-characterised coiled-coil deletion mutant in which the coiled-coil
residues (255–264) are replaced with a tetra-glycine linker (Hirtreiter et al., 2010a). This mu-
tant is unable to interact with Spt4/5. If RNAP were no longer found in the ribosomal fraction
after introduction of this mutation, it would provide strong evidence that Spt4/5 is coupling
RNAP and the ribosome. This experiment could not be performed in M. jannaschii as it is not
genetically tractable but could be conducted in other archaeal species such as S. acidocaldarius.
NusA was found to elute in two peaks corresponding to ribosome-associated and free protein.
The association of NusA in the ribosomes was confirmed by performing Western blots on puri-
fied ribosomes that had been separated on a size exclusion column. The lack of any NusA in
fractions corresponding to RNAP suggests that NusA does not bind to RNAP.
RNase treatment of the cell extract results in a broadening of the elution profile on the lower
molecular weight regions for Spt4/5, Rpo4/7 and NusA. For Rpo4/7 and NusA which are known
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to bind to RNA it is possible that RNase treatment results in the cleavage of large unavailable
RNAs in to smaller fragments of differing sizes. These liberated RNAs are then free to interact
with NusA and Rpo4/7, resulting in them eluting earlier from the column due to increased molec-
ular weight. Although archaeal Spt4/5 is not reported to bind nucleic acids in the literature, it
has become apparent through development of purification strategies that it copurifies with large
amounts of nucleic acids which can be removed by heparin affinity purification. Therefore this
hypothesis can also explain why the Spt4/5 peak broadens upon RNase treatment.
MST was conducted to quantitatively assess the interaction between Spt4/5 and the ribosome.
It was shown that Spt4/5 interacts specifically with the ribosome via the KOW domain. It was
demonstrated that Spt4/5 interacts with the S10 subunit of the ribosome since preincubation
with polyclonal antibodies against S10 abolishes the interaction. MST gave a Kd for the inter-
action in the region of 2-4 µM. This affinity is consistent with gene expression being a dynamic
process. The interaction must be strong enough to enable the robust coupling of transcription
and translation. Yet the interaction must also not be too tight. After the RNAP has terminated
transcription it needs to be able to reinitiate transcription. Similarly the ribosome needs to
reinitiate translation. This would not be possible if they were permanently coupled through
Spt4/5 with low nM affinity.
Size exclusion chromatography was then carried out between Spt4/5 and recombinant S10. How-
ever, specific interactions were not detected. This suggests that within the complexity of the
ribosome there is an increased affinity for Spt4/5 and that when the ribosomal subunit S10 is
isolated its affinity for Spt4/5 is decreased.
Another method that could be used to confirm the interactions observed by MST is co-pelleting.
In co-pelleting assays ribosomes are washed with salt to remove any loosely bound factors and
then incubated with the protein of interest. The incubation is centrifuged at high speed to pellet
the ribosomes which are then analysed by Western blot for the protein of interest. If the protein
interacts with the ribosome, it will be present in the pellet and give a positive signal in the
blot. This assay has the advantage of not requiring labelling of the ribosome, which may inter-
fere with binding events. The interactions between Spt4/5 and the ribosome could be further
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characterised by conducting site-directed mutagenesis of the Spt5 residues predicted to interact
with S10. In E. coli, for example, F165 of NusG is very important for the interaction with S10
(Burmann et al., 2010b).
The biological significance of the interaction could then be determined in vivo. For example,
what would be the effect on gene expression of abolishing the Spt4/5-ribosome interaction?
Would there be decreased transcription due to polarity? This could be examined by developing
an assay for determining in vivo transcription and translation rates, in a similar manner to that
which has been reported in bacterial systems (Proshkin et al., 2010; Vogel and Jensen, 1994).
Subsequent mutations could be introduced into the Spt5 KOW domain to prevent it binding the
ribosome. If this mutation disrupted the ratio between transcription and translation rates, it
would provide very strong evidence that Spt4/5 couples transcription and translation.
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4.1 Introduction
4.1.1 The Role of NusG Proteins in the Three Domains of Life
NusG and its homologue Spt5 are the only known universally conserved RNAP-associated tran-
scription factors, suggesting an ancient role in transcriptional regulation. NusG and Spt5 exhibit
strong sequence and structural homology across the three domains of life (Figure 4.1), which
demonstrates their key role in the regulation of gene expression and suggests that NusG-like
proteins were present in the last universal common ancestor. The NGN domain has been shown
to bind to RNAP in all three domains of life (Hirtreiter et al., 2010b; Mooney et al., 2009b;
Wenzel et al., 2010), enclosing the DNA binding channel and thereby increasing the processivity
of RNAP (Burova et al., 1995; Hirtreiter et al., 2010b; Wada et al., 1998).
Despite the conservation of structure and function, NusG proteins have also evolved additional
functions. The NGN domain of archaeal and eukaryotic Spt5 forms a stable complex with Spt4
but there is no Spt4 homologue in bacteria (Guo et al., 2008). One important question to be
addressed, therefore, is the function of Spt4 in archaea. Early studies indicated that Spt4 in-
creases the stability of the Spt5 NGN domain (Hirtreiter et al., 2010a), however this has yet to
be quantified. Furthermore, whilst the NGN domain of Spt5 is necessary to stimulate transcrip-
tion elongation in archaea, it is not sufficient and requires either Spt4 or the Spt5 KOW domain
(Hirtreiter et al., 2010a). This is in contrast to bacteria where the NusG NGN domain alone
is sufficient to stimulate RNAP elongation (Mooney et al., 2009b). The function of the KOW
domain also shows variation across the three domains of life. In bacteria and archaea the KOW
domain is not required for recruitment of NusG/Spt5 to RNAP. However, evidence from eukary-
otes suggests that the KOW domains show weak affinity for RNAP (Viktorovskaya et al., 2011)
and that the KOW domains bind to RNA, possibly as a requirement for recruitment to RNAP
(Cheng and Price, 2008). In addition, the KOW domain is believed to bind to the ribosome in
bacteria and archaea, thereby coupling transcription and translation (Burmann et al., 2010b).
In eukaryotes, however, the processes of transcription and translation occur in different cellular
compartments and cannot be directly coupled. Consequently the KOW domain has evolved al-
ternative functions in eukaryotes, acting as a recruitment platform for proteins involved in RNA
processing (Lindstrom et al., 2003) and promoter-proximal stalling (Missra and Gilmour, 2010).
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Figure 4.1: Structural alignment of the NusG/Spt5 domains from the three domains of life.
A) The NGN domain exhibits high structural conservation, which is indicative of its fundamental
role in the regulation of gene expression. Red: E.coli NusG NGN domain (PDB 2KO6). Green:
M. jannaschii Spt5 NGN domain (PDB 3LPE). Blue: S. cerevisiae Spt5 NGN domain (PDB
2EXU). B) The KOW domains also overlay, comprising a five-stranded β barrel. Red: E.coli
NusG KOW domain (PDB 2JVV). Green: P. furiosus Spt5 KOW domain (PDB 3P8B). Blue:
H. sapiens Spt5 NGN KOW 2 domain (PDB 2E6Z).
4.1.2 Chapter Aims
The aims of this chapter are to discover the contributions of each domain to the structure and
integrity of the Spt4/5 complex. To this end pulsed electron paramagnetic resonance (EPR)
techniques were performed on double spin-labelled Spt5 in the absence and presence of Spt4
to ascertain whether Spt4 influences the topology of the two Spt5 domains. Domain-deletion
mutants of Spt4/5 were also analysed by a thermal denaturation assay and by limited proteolysis.
The aims of these experiments were to determine which domains contribute to the stability of
114 4.2. Electron Paramagnetic Resonance
Spt4/5.
4.2 Electron Paramagnetic Resonance
The most common technique for determining protein structure is X-ray crystallography with
over 90% of structures in the protein data bank being determined by this method (Berman
et al., 2000). The biggest advantage of X-ray crystallography is the ability to resolve structures
to within a few A˚. However in order to achieve good scattering the protein must be arranged
in an orderly crystal and be immobile. Proteins however, are not static entities but dynamic
molecules which are often capable of undergoing large conformational changes. It is therefore
difficult to ascertain whether a structure obtained by crystallography represents a biologically
relevant state or that of an inactive conformation. Furthermore different crystal structures of the
same protein may present drastically different conformations. This issue can be circumvented
by using solution methods such as nuclear magnetic resonance (NMR). NMR is able to give
structures of proteins in solution. However protein concentrations in the region of 400 µM are
required, which is not always possible. The protein preparation is costly to produce, requiring
isotopic labelling with 15N, 13C, and 2H. Furthermore as molecules increase in mass, their slower
tumbling results in individual resonances broadening and overlapping, making assignment very
difficult. Consequently NMR is not routinely performed on proteins over 35 kDa.
An alternative technique to obtain structural information about a protein is electron paramag-
netic resonance (EPR), which analyses unpaired electrons. A protein molecule containing an
unpaired electron is said to be paramegnetic. Although most proteins do not contain paramag-
netic centres, it is possible to incorporate an unpaired electron into a protein by site-directed spin
labelling (SDSL) (Altenbach et al., 1989, 1990; Hubbell and Altenbach, 1994). This is achieved
by mutating residues of interest to cysteine and expressing the mutant, which will then contain a
cysteine in place of the wild-type residue at the selected position. The newly-introduced cysteine
can then be reacted with a nitroxide spin label that exhibits selectivity for sulfhydryl groups.
The two most commonly used cysteine-specific nitroxide spin labels are methanethiosilfonate
spin label (MTSSL) and 3-(2-Iodoacetamido)-PROXYL. Site-directed spin labelling may also
require replacing any native cysteines already present in the protein, usually with a serine or
an alanine (Klare and Steinhoff, 2009). The end result is a protein which is specifically labelled
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at the newly-introduced cysteine residue or residues, but nowhere else. It is also possible to in-
corporate spin labels in a site-specific manner into DNA (Edwards and Sigurdsson, 2007; Ward
et al., 2007) and RNA (Edwards et al., 2001), which is potentially very useful in the study of
transcription.
4.2.1 Continuous Wave EPR
An electron can exist in two spin states, -1/2 or +1/2. In the absence of an external magnetic
field the energies of the two states are degenerate. However, if an external magnetic field is
applied the energies of the two spin states separate, in a phenomenon known as the Zeeman
effect (Figure 4.2). The greater the strength of the external magnetic field, the greater the en-
ergy difference between the two spin states. Spins that are aligned parallel to the magnetic field
have a lower energy, and spins that are aligned antiparallel to the magnetic field have a higher
energy. An electron in the lower energy level can be excited into the higher energy level by the
absorbance of microwaves whose frequency is equal in energy to that between the two electron
spin states. The absorbance of energy, and excitation of an unpaired electron from a ground to
an excited state forms the basis for all EPR experiments. As the magnetic field strength that
the electron is placed within increases, the frequency of microwave energy required to achieve
resonance increases proportionally. In an X-band EPR experiment a microwave frequency of
approximately 9.5 GHz is used, corresponding to a magnetic field in the region of 3300 G.
In a continuous wave (CW) EPR experiment, the sample is placed within an external magnetic
field and irradiated with microwave energy of constant frequency. The magnetic field is then
swept and the first derivative of the absorbance spectrum recorded. The CW EPR spectrum
of a nitroxide spin label appears as three peaks (Figure 4.3). This is due to the phenomenon
of hyperfine coupling whereby atoms experience a small local magnetic field from neighbouring
atomic nuclei. The nitrogen atom that is bonded to the paramagnetic oxygen within a nitroxide
spin label has a spin number of 1, and can therefore exist in three spin states: -1, 0, or +1,
each with a different energy level. This results in the paramagnetic oxygen experiencing one of
three potential local magnetic fields, each local magnetic field corresponding to one of the three
possible spin states of the nitrogen. Consequently, for a given microwave frequency, there are
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Figure 4.2: Zeeman splitting of an electron in a magnetic field. An electron can exist in two
possible spin states. When placed in an external magnetic field (designated B) the two spin
states differ in energy. The difference in energy between the two spin states increases with the
magnetic field. This phenomenon is called Zeeman splitting.
three different magnetic field strengths that can enable the transition of a nitroxide spin label
to its excited state within a sample.
The shape of a CW EPR spectrum can yield much information about local structural elements
of a protein, such as secondary structure (Hubbell et al., 1998, 2000). Spin labels coupled to
cysteines in loops typically exhibit high motional freedom, resulting in a sharp spectrum. The
motion of spin labels coupled to cysteines on α helices and β sheets is more restricted, and
results in a broader spectrum. CW EPR can therefore be used to ascertain whether a spin label
has successfully been coupled to a protein, since the spectrum of a nitroxide spin label is much
broader when bound to a protein than when free in solution (Figure 4.4).
4.2.2 Pulsed EPR
When two unpaired electrons are in close proximity, the energy of the first may influence the
energy of the second, in a phenomenon known as dipolar coupling. This means that the spin of
one electron will influence the frequency at which its neighbour absorbs microwave radiation. If
spin A is aligned parallel to spin B, then spin B will be in a less energetically favourable position
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Figure 4.3: A CW EPR spectrum of a nitroxide spin label such as 3-(2-Iodoacetamido)-PROXYL
(bottom left) appears as three peaks due to a phenomenon called hyperfine coupling. The
paramagnetic oxygen of the label is bonded to a nitrogen which itself exists in one of three
possible spin states, each with a different energy. Therefore, for a given microwave frequency
there are three magnetic field strengths at which resonance can be achieved.
Figure 4.4: CW EPR spectrum showing different spin label mobilities. The more motion a spin
label can undergo, the narrower the spectral peaks.
and will have a higher ground-state energy. It will therefore require microwaves of lower energy
to be excited into its excited state. If spin A is aligned antiparallel to spin B, then spin B will
be in a more energetically favourable position and will have a lower ground-state energy. It will
therefore require microwaves of higher energy to flip into its excited state. The strength of the
dipolar interaction between the two electrons is proportional to 1/r3. Thus by monitoring the
strength of dipolar interaction between two paramagnetic centres, it is possible to determine
distance between them. The experiment used to determine the distance between two spin labels
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is called double electron-electron resonance (DEER) (Jeschke and Polyhach, 2007) and can nor-
mally measure distances up to 8 nm (Schiemann and Prisner, 2007).
In order to describe the DEER experiment it is necessary to define the spin label axis. The
x-axis runs parallel to the N-O bond of the nitroxide. The z-axis is perpendicular to the plane
of the ring of the label. The y-axis is perpendicular to both the x and z-axis. At equilibrium
the external magnetic field, B0, is aligned with the z-axis. The spins will be aligned along the
external magnetic field, in one of two spin states, which are either parallel or antiparallel to B0.
Since it is more energetically favourable to be aligned parallel, there is bulk magnetisation in
the +x-axis. The spins can be flipped and focussed into the x-y plane by providing a microwave
pulse of specific length. This is called a pi/2 pulse. The focussed spins in the x-y plane constitute
a divergence from equilibrium and relaxation occurs to restore it. Relaxation occurs in two ways.
Spin Relaxation
T1, or spin-lattice relaxation, describes the loss of energy from the system as it returns to equi-
librium. This is how quickly the spins realign with the external magnetic field along the z-axis.
T1 determines the repetition rate of the pulses. T2, or spin-spin relaxation describes how quickly
the aligned spins in the x-y plane ‘fan out’, or lose their coherence. T2 determines how long data
can be collected for an experiment, and therefore the length of distances that it is possible to
measure. It is possible to refocus the dispersing spins within the x-y plane by providing a 180◦,
or pi pulse at time t after the initial pi/2 pulse. This flips the dispersing spins 180◦, resulting in
them precessing in the opposite direction around the x-y plane and refocussing at time t after
the second pulse.
DEER works on the principle that it is possible to selectively excite different populations of
electrons within a system by using two different microwave frequencies (Figure 4.5). One set of
electrons called the observer electrons are excited with a pi/2 pulse to causing the magnetisation
precess around the x-y plane. These electrons become dispersed as the spins precess at slightly
different frequencies due to spin-spin relaxation. The same set of observer electrons are then
excited with a pi pulse to refocus the magnetisation, resulting in a Hahn echo. The magnetisa-
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Figure 4.5: Example of an EDFS revealing discrete populations of electrons. The observer and
pump electrons are excited separately in the DEER experiment and are separated by 65 MHz.
The effect of exciting the pump electrons is monitored by the ability of the observer electrons to
refocus.
tion is allowed disperse again and a second pi pulse is applied to the observer electrons and the
resulting echo recorded. However, between the first echo and second pi pulse on the observer
electrons, a second set of electrons, called the pump electrons, are excited with a pi pulse. Since
the pump electrons undergo dipolar interactions with the observer electrons, exciting the pump
electrons will alter the local energy of the observer electrons, thereby affecting their ability to
be refocussed, and resulting in a decrease of the recorded echo intensity. The series of pulses
is repeated, but the time at which the pump electron are excited is shifted (Figure 4.6). As
this time increases, the ability to refocus the magnetisation of the observer electrons decreases
further and thus the detected echo further decreases in intensity. This can be used to determine
the precise distance between the two dipolar-coupled electrons.
4.2.3 Determining T2 of the Sample
Prior to performing the DEER experiment, it is necessary to determine the spin-spin relaxation
time, or T2. T2, determines the length of time that signal can be recorded. The longer the T2,
the greater the possible distance that can be measured. T2 can be extended by maintaining the
sample in D2O-based buffer. By also deuterating the protein it is possible to measure distances
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Figure 4.6: Schematic of a DEER experiment. One subset of spins (the observer spins) is flipped
with a pi/2 pulse to focus them. After a time, τ1, the observer spins which have started to
dephase, are refocussed with a pi/2 pulse resulting in a Hahn echo. After a second time, τ2,
the observer electrons are refocussed again and the recording echo signal recorded. Between the
first echo and the second pi pulse on the observer electrons, a second subset of electrons (the
pump electrons) are excited. Due to dipolar coupling, this reduces the ability of the observer
electrons to refocus. The time at which the pump electrons are flipped shifts with each round
of the experiment, further limiting the extent to which the observer electrons can be refocussed,
and thereby decreasing the recorded signal.
of up to 10 nm (Ward et al., 2010). DEER experiments are typically performed at 50 K, which is
a trade-off between having a long T2 (and therefore the ability to measure longer distances) and
a shorter T1 (thereby increasing the repetition rate of the experiment). The experiment used to
determine T2 is called a 2-Pulse ESEEM. In this experiment the time between two pi/2 pulses
is increased. Due to dephasing, the intensity of the echo exponentially decays with increasing
time between the pulses since less magnetisation can be refocused (Figure 4.7). This enables
determination of the maximum time between the two pulses in the DEER experiment, which
will be the longest time between the pulses that still gives a signal.
4.2.4 Domain Topology of the Spt5 NGN and KOW Domains
Previous attempts to crystallise full-length M. jannaschii Spt4/5 have not been successful. How-
ever, the NGN domain of Spt5 has been crystallised in complex with Spt4 (Hirtreiter et al.,
2010a). From the Spt4/5 NGN structure, a homology model of the full-length protein was
generated, based on the structure of full length NusG from the thermophilic bacteria Aquifex
aeolicus (PDB 1M1G). Subsequently, a structure of the full length Pyrococcus furiosus Spt4/5
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Figure 4.7: Examples of a 2-Pulse ESEEM recorded in A) H2O-based buffer, and B) 50% D2O-
based buffer. The signal decays inverse exponentially. In H2O-based buffer there is signal until
8 µs. When there is 50% D2O in the buffer there is still some signal left at 10 µs.
was obtained (Klein et al., 2011). This crystallised as a dimer. Since Spt4/5 had never been
reported to exist in dimeric form in solution it is therefore possible that the domain topology
reported in the crystal structure does not represent a solution structure and is artefactual. Fur-
thermore it has become apparent that, like RfaH, NusG from the hyperthermophilic bacteria
Thermotoga maritima is capable of existing both an inactive, closed conformation and in an
open, active conformation (Dro¨gemu¨ller et al., 2013).
In order to determine whether M. jannaschii Spt4/5 also exhibits flexibility between the Spt5
NGN and KOW domains, site-directed spin labelling of the NGN and KOW domains followed
by DEER was performed. In addition, the distance distribution between the two domains was
compared in the presence and absence of Spt4 to determine whether Spt4 influences the domain
topology of Spt5.
4.2.5 Predicting the Distance Distributions of Spt5 NGN and KOW
Domains
Positions for mutagenesis to generate double-cysteine mutants for site-directed spin labelling
were selected to be surface accessible and to give distances that are in the optimal region for
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analysis by DEER. Surface accessibility and expected distance distributions were predicted in
MMM (version 2013), an open-source program that implements a rotamer library approach to
predict the possible conformations of a spin label attached to any position of a protein (Polyhach
et al., 2011). Based on these positions, the following double cysteine mutant pairs were selected
for analysis: G51/E137, E74/R111, and R111/E137 (Figure 4.8). The positions selected encom-
pass a range of secondary structures. Residues G51 and E74 are within an α helix, and residues
R111 and E137 are within a β sheet. These positions are predicted to be relatively rigid with
fewer rotamer positions than if they were located on a loop or a turn.
Figure 4.8: Rotamer libraries for M. jannaschii Spt4/5 homology model. Double cysteine
mutants labelled with iodoacetamide-PROXYL. A) G51/E137, B) E74/R111, C) R111/E137.
Green: Spt5. Purple: Spt4. Yellow: Iodoacetamide-PROXYL.
4.2.6 Comparison of the M. jannaschii Homology Model and P.
furiosus Crystal Structure
The M. jannaschii and P. furiosus Spt5 protein sequences were aligned (Figure 4.9A). The
P. furiosus Spt4/5 PDB file was loaded into MMM, and the residues corresponding to those
selected for DEER analysis in the M. jannaschii protein were labelled in silico (Figure 4.9B).
The expected distance distributions that would be obtained by performing DEER on P. furiosus
Spt4/5 according to the crystal structure constraints were predicted in MMM. The predicted
distributions from M. jannaschii and P. furiosus were then overlaid, enabling a comparison of
the M. jannaschii homology model and the P. furiosus crystal structure.
Although a crystal structure gives only a single distance between two given atoms, EPR gives
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Figure 4.9: A) Sequence alignment between M. jannaschii (top) and P. furiosus (bottom) Spt5.
Residues selected for mutation are indicated in a green box. Alignment performed using CLC
Main Workbench 5. B) Table showing the three M. jannaschii double cysteine mutants and
their corresponding mutants in P. furiosus Spt5.
a distance distribution. This is calculated based on all of the possible conformations of the
attached spin label, which is itself influenced by protein secondary structure and steric fac-
tors. Since MMM analysis attaches spin labels to PDB files in silico, both the crystal structure
and homology model result in predicted distance distributions, and not just a single distance.
The two models are in very good agreement, with the plots overlaying significantly. For the
G51/E137 mutant (Figure 4.10A) there is significant overlap between the two models with a
main population at around 4 nm. The homology model has a slight tendency towards lower
distributions, compared to the crystal structure. For the E74/R111 mutant (Figure 4.10B)
both the crystal structure and homology mode result in a broad distribution prediction, from
2 nm to 5.5 nm, with a major peak at 4 nm. For the R111/E137 mutant (Figure 4.10C) both
the crystal structure and the homology model give a predicted distribution from 1 nm to 3.5 nm.
4.2.7 Labelling of Spt5 Double Cysteine Mutants
Double cysteine mutants of Spt5 were expressed and labelled with iodoacetamide-PROXYL on a
NiNTA column. Spt5 was eluted in an imidazole gradient. Unbound spin label was removed and
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Figure 4.10: Comparison of the M. jannaschii Spt4/5 homology model and the P. furiosus
Spt4/5 crystal structure. The PDB coordinates were loaded into MMM, spin labels attached
to the appropriate sites in silico, and the distance distributions predicted. A) G51/E137,
B) E74/R111, C) R111/E137. Blue: M. jannaschii homology model. Green: P. furiosus crystal
structure. The predicted distance distributions of the two structures overlay well and are in
good agreement.
half of the protein was dimerised with Spt4 and repurified on a NiNTA column (Figure 4.11).
The protein was concentrated and subsequently diluted two-fold in 50% D8 glycerol in D2O. CW
EPR was conducted on the mutants to determine whether they had been successfully labelled.
All of the mutants gave spectra that showed broadening in the high field peak, indicating that
they were well-labelled (Figure 4.12).
Figure 4.11: SDS PAGE showing purification of His-tagged double cysteine Spt4/5 mutants.
A) Spt5 G51C/E137C, B) Spt4/5 G51C/E137C, C) Spt5 E74C/R111C, D) Spt4/5 E74C/R111C,
E) Spt5 R111C/E137C, F) Spt4/5 R111C/E137C.
4.2. Electron Paramagnetic Resonance 125
Figure 4.12: CW EPR measurements of double cysteine mutants.
4.2.8 DEER Reveals that Spt4 Reduces Spt5 Flexibility
DEER spectra of double labelled Spt5 and Spt4/5 samples were recorded at 50 K on a Bruker
ELEXSYS E580 spectrometer at 9 GHz, with an ER-4118-x-MS-3W resonator. The data was
analysed in DeerAnalysis (Jeschke et al., 2006) and plotted in MATLAB. For the G51/E137 mu-
tant, Spt4/5 gives one prominent and sharp distribution at 5.8 nm (Figure 4.13A). This is longer
than both the major predicted distance at 4 nm and the predicted sub-population at 5.5 nm,
based on the homology model. This supports the notion that Spt5 exists in conformations not
seen in the crystal structure. When the Spt5 G51/E137 mutant is analysed in the absence
of Spt4, two distinct populations are observed (Figure 4.13B). The long distance population at
5.8 nm is still present. In addition there is a significant population that gives a broad distribution
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between 3 nm and 5 nm. This second population is in broad agreement with the MMM-predicted
distribution, although slightly shorter. For the E74/R111 mutant, there are multiple distances
over a broad range for both Spt4/5 and Spt5, indicating that there is backbone flexibility within
Spt5 (Figure 4.13C&D). The range of distances observed is approximately 2 nm greater than
that predicted by MMM. The distinct populations are better defined in Spt4/5, suggesting that
Spt4 restricts mobility. For the R111/E137 mutant there is one major population at 2.6 nm for
both Spt4/5 and Spt5 (Figure 4.13E&F). When Spt4 is removed as very small population of
4 nm is present. This suggests that the presence of Spt4 may affect not only the conformation
of the NGN domain, but also the KOW domain. Together, the DEER data demonstrates that
there is flexibility between the NGN and KOW domains of Spt5. The presence of Spt4 restricts
this mobility by stabilising certain conformations.
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Figure 4.13: DEER analysis of Spt4/5 (left) and Spt5 (right). A&B) G51/E137 mutant. Spt4/5
shows one main distance distribution at 5.8 nm. Spt5 shows two prominent populations of
distance distributions, the first between 3 and 5 nm and the second at 5.8 nm. C&D) E74/R111
mutant. Spt4/5 and Spt5 both give a very broad distribution from 2–6 nm. Spt5 shows greater
flexibility than Spt4/5, with distinct populations less well defined. E&F) R111/E137 mutant.
Spt4/5 and Spt5 both result in a major population at 2.5 nm. When Spt4 is removed a small
subpopulation at 4 nm appears. Form factors shown in black. Red: Experimentally obtained
data. Blue: Predicted distributions from MMM analysis.
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4.3 Domain Dissection of Spt4/5
4.3.1 Spt4 Increases the Thermostability of the Spt5 NGN Domain
In archaea and eukaryotes, the NGN domain of Spt5 is bound by Spt4. Since bacteria have no
Spt4 homologue one of the key questions to be addressed is its function. This may also give
insights into the evolution of NusG-like proteins. In order to characterise the thermostability of
the different domains of Spt4/5, thermofluor assays were carried out. The thermofluor assay is
used to ascertain the best buffer conditions (e.g. pH, salt concentration) for stabilising a protein,
either for storage or as a precursor to crystallisation trials. However, it also has potential appli-
cations in the study of protein-ligand interactions, as a preliminary step in the drug discovery
process (Lo et al., 2004).
In the thermofluor assay, a protein is incubated with a fluorescent dye whose fluorescence emis-
sion is quenched when within an aqueous buffer but which exhibits high fluorescence when bound
to non-polar substances, such as the residues on the interior of a protein. The protein-fluorescent
dye mixtures are placed in clear PCR tubes inside a Real Time PCR machine (Niesen et al.,
2007). The temperature is increased in 0.5◦C increments and the fluorescence emission moni-
tored. Initially, within the aqueous solution where the fluorescence is quenched there is little
fluorescence observed. If the protein denatures its hydrophobic core is exposed. The fluorophore
binds to the exposed hydrophobic surface resulting in an increase in fluorescence emission (Erics-
son et al., 2006). This is seen as a sigmoidal melting curve as the fluorescence emission increases.
This may be followed by a decrease as the exposed hydrophobic residues aggregate together, to
the exclusion of the dye.
Expression and Purification of Spt4/5 Domain-Deletion Mutants
The Spt4/5, Spt5, Spt4/5 NGN, Spt5 NGN, and Spt5 KOW proteins were expressed as GST
fusion proteins and purified on a glutathione column (Figure 4.14). The GST was cleaved from
the Spt5 protein overnight and the GST was subsequently removed by heat-inactivation followed
by centrifugation (Figure 4.15).
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Figure 4.14: Purification of GST-tagged Spt4/5 domain-deletion mutants showing SDS PAGE
and chromatograms. A) Spt4/5, B) Spt5, C) Spt4/5 NGN, D) Spt5 KOW, E) Spt5 NGN.
Figure 4.15: SDS PAGE showing thrombin treatment and heat-inactivation of GST-tagged puri-
fied Spt4/5 domain deletion mutants. Purified GST-tagged proteins were treated with thrombin
overnight to separate the Spt4/5 mutant from GST. The thrombin-treated sample was subse-
quently heated at 65◦C for 30 minutes, resulting in the precipitation of the GST. The sample
was then centrifuged to separate the soluble and insoluble fractions, with the Spt4/5 domain
deletion mutants being in the soluble fraction.
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The domain-deletion variants of Spt4/5 were analysed by thermofluor, and the fluorescence in-
tensity was plotted against the temperature. SYPRO orange was used as the fluorescent dye.
This is due to the fact that it has a good signal:noise ratio. When it binds to denatured hen egg
lysozyme, it fluoresces with close to 500% the intensity compared to when it is in aqueous buffer
only (Niesen et al., 2007). The SYPRO orange was excited at 492 nm and the fluorescence emis-
sion was detected at 610 nm. The thermostable Spt4/5 does not denature when heated to 98◦C.
This is consistent with it being a hyperthermophilic protein (Figure 4.16A). Similarly Spt4/5
NGN (Figure 4.16C) and Spt5 KOW (Figure 4.16E) are also completely thermostable at 98◦C.
In contrast Spt5 (Figure 4.16B) and the NGN domain of Spt5 (Figure 4.16D) are heat-labile, and
melt at 85◦C, as indicated by the sigmoidal melting curve. The variants that melt all contain
the Spt5 NGN domain but do not contain Spt4. Therefore Spt4 stabilises the NGN domain of
Spt5, making it more resistant to thermal denaturation.
Although the melting curves are clear, the increase in fluorescence is lower than the theoret-
ical maximum. When Spt5 melts, the fluorescence increases from approximately 300 RFU to
approximately 600 RFU, an increase of 100%. When the Spt5 NGN melts, the fluorescence
increases from approximately 500 RFU to just over 1000 RFU, an increase of 100%. This may
be because in (Niesen et al., 2007), where the melting of hen egg lysozyme is analysed, 10 mM
3-(cyclohexylamino)-1propanesulfonic acid, 150 mM NaCl was used as the buffer, whereas N500
was used for the analysis of the Spt4/5 domain-deletion mutants. For both Spt5 and Spt5 NGN,
the fluorescence emission intensity decreases after reaching its maximum, which is indicative of
the aggregation of the denatured protein.
4.3.2 Expression and Purification of Spt4
Spt4 was expressed in Rosetta 2 cells from a pET151D vector with an N-terminal hexa-histidine
tag. Spt4 was purified on a NiNTA affinity column and the resulting protein was pure and highly
enriched (Figure 4.17).
4.3. Domain Dissection of Spt4/5 131
Figure 4.16: Thermofluor analysis of Spt4/5 domain-deletion mutants. A) Spt4/5 is thermostable
and does not denature, B) Spt5 denatures at 85◦C, C) Spt4/5 NGN is themostable and does
not denature, D) Spt5 NGN denatures at 85◦C, E) Spt5 KOW is thermostable and does not
denature. RFU is the relative fluorescence unit.
4.3.3 Spt4 Protects Spt5 from Proteolysis
The susceptibility of Spt5 and Spt4/5 to proteolytic digestion was analysed by a limited pro-
teolysis approach. In a limited proteolysis assay, protein of interest is incubated with varying
concentrations of protease for a defined time. The products of proteolysis are analysed by SDS
PAGE (Cleveland et al., 1977). Globular domains of proteins are typically fairly resistant to
proteolysis, with proteases preferring disordered or flexible regions as substrates (Fontana et al.,
2004). Some studies suggest that a region of at least 12 flexible amino acids is required for
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Figure 4.17: SDS PAGE showing the purification of His-tagged Spt4 from a NiNTA column.
proteolysis to occur (Hubbard, 1998). Consequently it is not necessarily expected that protease
cleavage is determined by the protease specificity alone, but rather the local protein confor-
mations and flexibility (Fontana et al., 2004). Due to the preference for flexible or disordered
regions, limited proteolysis may be used on proteins that are proving difficult to crystallise. This
will remove the disordered regions and thereby increase the likelihood of forming crystals.
In order to analyse the function of Spt4, limited proteolysis was performed on Spt4/5 and Spt5
using trypsin as the protease. Spt4/5 is resistant to proteolysis by trypsin even at the highest pro-
tease concentrations (Figure 4.18A). Spt5 alone, in contrast, is cleaved at 12.5, 25, and 50 µg/ml
trypsin into two fragments (Figure 4.18B). This indicates that Spt5 has greater structural in-
tegrity when bound to Spt4. Analysis of the P. furiosus Spt4/5 crystal structure provides insight
into how Spt4 may protect Spt5 from proteolysis. In addition to binding the NGN domain of
Spt5, Spt4 also occludes the flexible linker between the NGN and KOW domains (Figure 4.18C).
It is therefore likely that Spt4 protects the flexible linker of Spt5. Trypsin cleaves proteins after
arginine and lysine residues. The NGN domain of Spt5 contains four arginines and six lysines.
The KOW domain of Spt5 contains two arginines and seven lysines. The linker between the two
domains contains one lysine (K84) (Figure 4.19). It is clear that not every positive residue of
Spt4/5 is susceptible to cleavage, as this would result in many small protein fragments which
would be too small to visualise on a 16% acrylamide gel. Since DEER has shown that there
is flexibility between the two domains, and proteases have a tendency to cleave flexible linker
regions of proteins, it is likely that the lysine in the linker is the positive residue most susceptible
4.3. Domain Dissection of Spt4/5 133
to cleavage and the substrate of trypsin. This could be investigated through N-terminal Edman
sequencing, or by mass spectrometry of the digested Spt5 fragments. Alternatively K84 could
be mutated to a non-polar residue and the assay repeated to determine whether proteolysis still
occurs in the same manner.
Figure 4.18: Limited proteolysis of A) Spt4/5 and B) Spt5. Trypsin concentrations in µg/ml
indicated above lanes. Spt4/5 is resistant to trypsin cleavage, even at the highest concentrations
of protease. In contrast, Spt5 alone is cleaved into two fragments at the three highest trypsin
concentrations. C) Spt4 may protect the flexible linker of Spt5 from proteolysis.
4.3.4 Spt4 is Stabilised by a Cys4 Zinc Finger
Spt4 contains four conserved cysteines that coordinate a zinc ion (Hirtreiter et al., 2010b) (Fig-
ure 4.20). Limited proteolysis of Spt4 was conducted in the absence and presence of EDTA to
explore the role of Zn2+ coordination on its stability. Addition of EDTA at a final concentration
of 250 mM causes chelation of the Zn2+ ions. There are eight lysines and one arginine in Spt4
that are possible substrates for trypsin. Spt4 is completely resistant to degradation by trypsin
(Figure 4.21A). When EDTA is added, Spt4 becomes susceptible to proteolysis (Figure 4.21B).
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Figure 4.19: A) Space-filling M. jannaschii Spt5 homology model with positively charged lysine
and arginine residues coloured in red. B) Amino acid sequence of M. jannaschii Spt5 with
positive residues coloured in red. K84, which is positioned within the flexible linker, is probably
the target for trypsin.
Since proteases typically degrade flexible regions of proteins, it stands that when the Zn2+ is
removed, Spt4 becomes more flexible or loses structural integrity. Therefore the Zn2+ is required
to maintain the structural integrity of Spt4.
Figure 4.20: Coordination of zinc by Spt4. Four conserved cysteine residues coordinate a zinc
atom. M. jannaschii Spt4 shown from PDB file 3LPE. Purple: Spt4. Yellow: Cysteines of Spt4.
Grey: Zn.
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Figure 4.21: Limited proteolysis of Spt4 in the A) absence, and B) presence of EDTA. Addition
of EDTA results in the chelation of Zn2+, and Spt4 is degraded. When the Zn2+ remains coor-
dinated by the cysteines, Spt4 is resistant to trypsin degradation at the highest concentrations
of protease.
4.3.5 Discussion
In this chapter a biophysical characterisation of Spt4/5 has been performed. An SDSL approach
followed by DEER was carried out whereby the Spt5 NGN and KOW domains were each labelled.
This revealed that Spt5 is able to exist in at least two conformations in solution, as evidenced
by distinct distance distributions. Spt4 influences the relative proportion of the populations.
This raises the possibility that the two conformations have different functions and that Spt4
may regulate their interconversion, for example by switching Spt5 from a RNAP processivity-
enhancing factor to transcription-translation coupling factor. The Spt4-free Spt5 would possibly
rely upon interactions with additional proteins to stabilise the NGN domain. Alternatively one
of the conformations of Spt5 may be inactive and the other active in a similar manner to RfaH.
Distances between two points on a protein can also be determined by the incorporation of flu-
orescent labels into the protein, where the emission spectrum of one label overlaps with the
absorption spectrum of the second label. Excitement of the first label will result in resonance
transfer of energy to the second label, with the efficiency of transfer being inversely propor-
tional to the distance. This experiment is called FRET (fluorescence resonance energy transfer).
FRET and EPR typically give results in good agreement with one another (Grohmann et al.,
2010; Klose et al., 2012). One advantage of SDSL, however, is the small size of spin labels.
3-(2-Iodoacetamido)-PROXYL is not much bigger than an amino acid (Figure 4.3), whereas
fluorescent labels are often large, bulky, and aromatic. Therefore incorporation of a nitroxide
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spin label should result in minimal perturbation of protein structure or function.
One possibility for further studying the role of Spt4 would be to analyse the relative levels
of Spt4 and Spt5 gene expression in vivo to determine whether they are expressed with equal
stoichiometry, or whether there is an excess of Spt5. This could be determined by quantitative
Western blotting using antibodies against Spt4 and Spt5. It would also be interesting to compare
expression levels from mid log and stationary-phase cells to determine whether Spt4 and Spt5
expression levels are regulated differently. Additionally, knocking out Spt4 and analysing the
effects on global gene expression would allow determination of whether Spt5 is able to efficiently
stimulate gene expression in the absence of Spt4 and whether Spt4 regulates the expression of
distinct subsets of genes.
A thermofluor assay was performed on domain-deletion variants of Spt4/5. This indicated that
the NGN domain of Spt5 is stabilised when bound to Spt4. This function of Spt4 is consistent
with M. jannaschii being a thermophile that grows at elevated temperatures. However, there are
bacteria which also grow at extreme temperatures that do not have Spt4. In addition eukary-
otic Spt5 is also bound by Spt4, although most eukaryotes do not grow at high temperatures.
This suggests that Spt4 may have additional functions. It is positioned close to where the DNA
strands anneal within the elongation complex and it may therefore have a role in this process or
in contacting the upstream DNA (Werner, 2013).
Limited proteolysis was used to study the susceptibility of Spt5 to tryptic digestion. Spt4/5 is
resistant to digestion. However Spt5 alone is cleaved into two fragments. Analysis of the P.
furiosus Spt4/5 crystal structure leads to the conclusion that Spt4 likely protects the Spt5 flex-
ible linker. This agrees with the DEER data in suggesting that Spt4 reduces the conformational
flexibility between the Spt5 NGN and KOW domains.
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5.1 Introduction
5.1.1 Structure and Function of NusA
In E. coli, nusA is an essential gene and homologues have been identified in all sequenced bacte-
rial genomes. Bacterial NusA comprises an RNAP-binding N-terminal domain, an S1 domain,
and two KH domains. A crystal structure of M. tuberculosis NusA without its N-terminal do-
main and in complex with an 11-mer RNA has been solved (Beuth et al., 2005). Within this
structure the two KH domains bind RNA, but the S1 domain does not. The two KH domains
are separated by 30 A˚ and form a single, continuous RNA-binding surface (Figure 5.1). This is
illustrated by the fact that one of the nucleotides within the RNA is contacted by residues from
both the KH1 and the KH2 domain. The bound RNA is in an elongated conformation and its
position is guided by regions of positive electrostatic charge. The KH domains undergo multiple
types of interaction with the RNA, providing sequence specificity. These include hydrogen bonds
from both side chains and the backbone, electrostatic interactions, and hydrophobic interactions
between non-aromatic side chains and the aromatic RNA bases. Furthermore, M. tuberculosis
NusA also makes interactions with 2′-OH groups of the ribose rings, thereby enabling it to dis-
tinguish between single-stranded DNA and single-stranded RNA. The crystal structure of free
NusA has also been solved, revealing that NusA does not undergo a conformational change upon
RNA binding (Beuth et al., 2005).
Figure 5.1: M. tuberculosis NusA bound to RNA (PDB 2ASB).
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5.1.2 Functions of Bacterial NusA
In bacteria, NusA is able to bind to RNAP and promote termination (Schmidt and Chamberlin,
1987). However, when acting in the context of an antitermination complex, NusA has the oppo-
site function, namely enabling RNAP to enter a pause and termination-resistant state. In E. coli
the host proteins NusA, NusB, NusE (S10), and NusG (Mason and Greenblatt, 1991) assemble
towards the 5′ end of the transcript at conserved sequences called BoxA and BoxB, with NusA
binding a spacer region between them. Antitermination was first described in bacteriophage
λ-infected cells. Phage λ hijacks the host RNAP and Nus factors to enable expression of its own
genes. Antitermination also occurs on ribosomal operons, which are not protein-coding. This
prevents termination by rho, and enables robust expression of the rRNA.
NusA also functions in the processing of the 16S ribosomal RNA. The ribosome assembles co-
transcriptionally, and mutations within NusA prevent efficient ribosome biogenesis and result
in a buildup of 21S precursor (Bubunenko et al., 2013). NusA facilitates rRNA folding through
constraining it at its 5′ end. NusA binds to RNAP and to a BoxA-like region towards the 5′
end of the transcript. The 3′ end of the rRNA is constrained by the fact that it is within the
RNAP active site. Consequently the RNA forms a loop as expression of the rRNA progresses,
facilitating its folding.
5.1.3 Whole Genome Occupancy of M. jannaschii NusA
ChIP (Chromatin Immunoprecipitation) data obtained by Dr Katherine Smollett in our lab sup-
ports a role for archaeal NusA in transcriptional regulation. In ChIP-seq, cells are grown and
the protein that is bound to DNA is crosslinked by formaldehyde treatment. The cells are then
lysed and the DNA is sheared. The protein of interest is then pulled out by immunoprecipita-
tion and the crosslinks reversed by heat treatment. The DNA that was bound by the protein is
sequenced, and the obtained sequences can then be identified within the genome (Johnson et al.,
2007).
The data demonstrates that the Spt4/5 occupancy along protein-encoding and non-protein-
encoding genes mirrors that of RNAP (Figure 5.2) indicating that Spt4/5 is a general transcrip-
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tion factor. NusA is also present across the entirety of the genes. However, its profile does not
mirror RNAP and Spt4/5, and it associates with transcription units in a different manner. This
could be via NusA-RNAP or NusA-RNA interactions. Alternatively, NusA may be associated
indirectly via other proteins. However, the fact that NusA is present across transcription units
provides a sound rationale for studying archaeal NusA at a transcriptional level.
Figure 5.2: Gene occupancy of putative antitermination factors as determined by ChIP. A) The
protein-encoding methyl coenzyme M reductase operon. Methyl coenzyme M reductase catalyses
the final step in the methane-production pathway. B) The ribosomal operon A, which encodes
the RNA component of the ribosome, and is not translated. For both protein-encoding and non-
protein-encoding genes RNAP (grey) is present across the entire gene. Spt4/5 (green) closely
follows the path of RNAP indicating that it is associated with the elongation complex. NusA
(brown) is present along the entirety of protein-encoding and non-protein-encoding genes, but
does not follow the RNAP profile. Graphs show Log2(IP/input) averaged over replicates. RNAP:
n=3, Spt4/5: n=3, NusA: n=2.
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5.1.4 Chapter Aims
The aims of this chapter are to analyse the RNA binding of M. jannaschii NusA. To this end
a homology model of M. jannaschii NusA was generated. This was to enable prediction as to
whether it is likely to adopt a similar fold to previously solved bacterial and archaeal NusA struc-
tures. This chapter will analyse the RNA-binding activities of NusA by employing a site-directed
mutagenesis approach to determine regions of the protein that are important for RNA binding. A
comparison between non-biological A2 RNA and biologically relevant rRNA leader/downstream
regions will be made. The cloning of the leader and downstream regions of the rrnA gene
may also give hints as to whether archaeal NusA is involved in rRNA processing. This chapter
also aims to determine whether M. jannaschii NusA binds to RNA with any sequence bias,
or whether it binds with little discrimination by using a technique called Scaffold-Independent
Analysis. This could potentially yield insights into its function. For example, if it were to show
preference for a BoxA-like sequence this would suggest a possible antiterminator role.
5.2 Generation of M. jannaschii NusA Homology Model
Whilst bacterial and archaeal crystal structures of NusA have been solved, there is no structure
available for M. jannaschii NusA. The structure of Aeropyrum pernix NusA in isolation, and
in complex with RNA has been solved (PDB 2CXC) (Shibata et al., 2007). A. pernix is a hy-
perthermophilic crenarchaea that grows at 70–100◦C. To gain insight into the possible structure
of M. jannaschii NusA, the sequences of M. jannaschii NusA and A. pernix NusA were first
aligned. The alignment indicates that the two proteins are homologous and that they share 30%
sequence identity. From this it was concluded that A. pernix NusA was a good template for
generating a M. jannaschii NusA model (Figure 5.3A). The homology model was created using
SWISS-MODEL1 (Schwede et al., 2003). The homology model indicates that M. jannaschii
NusA also comprises two KH domains, each containing two α helices and three β strands. The
RNA-binding GXXG motifs are located on the loop between the two α helices in each domain.
The model overlays very well with the parent structure (Figure 5.3D).
1http://swissmodel.expasy.org/interactive
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Figure 5.3: Generation of M. jannaschii NusA homology model using SWISS-MODEL. A) Se-
quence alignment between M. jannaschii and A. pernix NusA. RNA-binding GXXG loops indi-
cated in green boxes. B) Crystal structure of A. pernix NusA (PDB 2CXC) used as the parent
structure. GXXG loops indicated in red. C) Homology model. D) Overlay of A. pernix parent
structure (red) and the M. jannaschii homology model (blue).
5.3 Analysis of NusA RNA-Binding Mutants
5.3.1 Expression and Purification of NusA Mutants
NusA mutants were expressed in Rosetta 2 cells. Protein was extracted from the cells and the
supernatant was heat-inactivated to denature most of the endogenous E. coli proteins. The
remaining soluble protein was purified on a heparin column (Figure 5.4).
5.3.2 EMSAs Using Fluorescently Labelled A2 RNA
In order to characterise the RNA-binding activity of NusA, electrophoretic mobility shift as-
says (EMSA) were performed. In an EMSA two putative interacting partners are incubated
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Figure 5.4: SDS PAGE of NusA mutant purifications by heparin affinity chromatography.
A) Wild type, B) KH1 GDDG, C) KH2 GDDG, D) KH1/2 GDDG, E) K64E, K65E, F) KH1/2
GDDG K64E, K65E.
together, with the first partner maintained at constant concentration and the second partner
titrated in. The incubations are then loaded on to a native polyacrylamide gel and separated
by electrophoresis. As no SDS is present the complexes maintain their integrity as they migrate
through the gel. Higher molecular weight complexes have lower mobility through the gel than
single species, and therefore complex formation is identified by a shift of a band in the gel.
Usually one of the partners is radio-labelled or fluorescently labelled to enable detection.
Varying concentrations of NusA mutants were incubated with a constant concentration of Cy3-
labelled A2 RNA. In all EMSAs using A2 RNA the RNA concentration was 50 nM, and the
protein concentrations were 1 µM, 2.5 µM, 5 µM, 7.5 µM, 10 µM, 15 µM, and 20 µM. When
labelled RNA is incubated with wild-type NusA, complex formation is observed at 5 µM demon-
strating that NusA is able to bind to RNA (Figure 5.5).
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Figure 5.5: NusA bandshifts with A2 RNA probe. The RNA concentration is 50 nM. NusA
concentration in µM indicated above individual lanes. Complex formation is observed weakly at
5 µM, and more strongly at 7.5 µM.
Mutational analysis was conducted on NusA to determine the relative contribution of the two
KH domains to RNA binding. The GXXG loops of the two KH domains were mutated to GDDG
using a splice-by-overlap methodology (see Chapter 2). This is a well-characterised mutation
for abolishing the RNA-binding of KH domains without compromising their structural integrity
(Hollingworth et al., 2012). Mutation of the KH1 GXXG motif to GDDG (K50, G51–to–D50,
D51) impairs the RNA-binding activity of NusA, with complex formation not being observed
until the concentration of NusA reaches 15 µM (Figure 5.6 left panel). This indicates that the
KH1 domain of NusA contributes to RNA-binding. Mutation of the KH2 GXXG motif to GDDG
(E117, K118–to–D117, D118), in contrast, has no effect on the RNA-binding activity of NusA
(Figure 5.6 middle panel). Complex formation is observed at 5 µM NusA, which is the same as
for the wild-type protein. This demonstrates that the KH2 domain of NusA has little or no role
in RNA binding. This is possibly because one of the residues in the KH2 GXXG motif (E117) is
already negatively charged. The relative contributions of the two domains is supported by anal-
ysis of a double KH mutant where both KH domain GXXG loops have been mutated to GDDG.
With the double KH domain mutant, complex formation is observed at 15 µM (Figure 5.6 right
panel). This is the same as for the single KH1 mutant.
The double KH mutant was expected to completely abolish RNA binding, based on previous
reports of KH domain proteins (Hollingworth et al., 2012). The fact that it still binds RNA
suggests that there are other regions of NusA that are involved in the binding of RNA. Further
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Figure 5.6: NusA bandshifts with A2 RNA probe. The RNA concentration is 50 nM. NusA
concentration in µM indicated above individual lanes. Mutation of the KH1 GXXG loop to
GDDG results in a strong phenotype. Conversely mutation of the KH2 GXXG loop to GDDG
has no effect on RNA binding. Combination of the KH1 and KH2 GXXG loop mutations has
the same phenotype as the single KH1 mutant, suggesting that the KH2 domain has no role in
RNA binding.
analysis of the NusA homology model identified the presence of two positively charged lysine
residues (K64, K65) in the cleft between the two KH domains (Figure 5.7).
Figure 5.7: Space filling M. jannaschii NusA homology model showing the GXXG loops (red)
and the two lysine residues K64, and K65 (blue).
It seemed likely that K64 and K65 bind to RNA via electrostatic interactions with the negatively
charged ribose-phosphate backbone of the RNA. To test this hypothesis, the two lysines were
mutated to glutamate in order to reverse their charge. The mutant was soluble and stable at
65◦C. The charge-reversal mutation resulted in a minor phenotype, with slightly impaired RNA
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binding (Figure 5.8 left panel), indicating that K64 and K65 are involved in the interaction
with RNA. Combination of the double KH domain mutation with the charge reversal mutation
completely abolished RNA binding, with no complex formation observed even at the highest
concentrations of NusA (Figure 5.8 right panel).
Figure 5.8: NusA bandshifts with A2 RNA probe. The RNA concentration is 50 nM. NusA
concentration in µM indicated above individual lanes. Mutation of the K64 and K65 to glutamate
mildly impairs RNA binding indicating a role for these two residues in the binding of RNA.
Combining the two KH GXXG loop mutations with the double K–to–E mutation completely
abolishes the RNA binding activity of NusA.
5.4 Cloning of the M. jannaschii 16S rRNA Leader and
Downstream Regions
For protein-encoding genes in bacteria, the binding of the KOW domain of NusG to the S10
protein of the ribosome prevents termination by the rho helicase, which competes for binding to
the KOW domain. rRNA operons encode the RNA that is incorporated into the ribosome and
therefore they are not translated. This means that they are more prone to termination by rho.
Antitermination complex formation reduces rho termination across the rRNA operon. Complex
formation occurs when NusA binds towards the 5′ end of rRNA as it is being transcribed. NusA
is just one component of antitermination complexes, which also include NusG, NusB, and the
ribosomal protein S10.
NusA also facilitates the co-transcriptional folding of rRNA. The 3′ end of the transcript is bound
within the active centre of RNAP. The 5′ end of the transcript is bound by RNAP-associated
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NusA. Therefore, as the RNA chain increases in length, it forms a growing loop which facilitates
its correct folding. The 16S rRNA leader and the region downstream of the 16S rRNA gene are
complementary in sequence and hybridise to form a region of dsRNA that is cleaved by RNaseIII
to liberate the 16S rRNA. In NusA mutants, rRNA processing functions abnormally. It is not
known whether archaeal NusA also binds to the rrn operon leader regions.
M. jannaschii contains two rRNA operons, called rrnA and rrnB. The 16S rRNA(A) leader and
downstream elements were cloned into a pGEM-T vector. The rrnA operon is on the negative
DNA strand in the M. jannaschii genome. The leader region of the 16S rRNA was cloned
starting at position 159,635 and terminating at 159,460 of the M. jannaschii genome. The PCR
reaction resulted in two products of about 275 bp and 180 bp. This is probably because the two
ribosomal leader sequences in M. jannaschii have highly similar sequences. The expected size
was 175 bp, so the lower mass product was correct. The downstream region of the 16S rRNA
gene was cloned, starting at position 157,990 and terminating at 157,910 of the M. jannaschii
genome. The PCR reaction resulted in one product of 80 bp, as expected (Figure 5.9). In addi-
tion, a leader-downstream fusion construct was also cloned using a splice-by-overlap extension
methodology (see Chapter 2). This resulted in a product of 255 bp. Taq DNA polymerase was
used for the PCR reactions as it leaves A overhangs, required for ligation into the pGEM-T
vector. Radiolabelled RNA was subsequently prepared by in vitro transcription and purified
using G25 spin column.
The predicted fold of the cloned rRNA regions was determined using RNAfold (Gruber et al.,
2008). RNAfold predicts the secondary structure of RNA and ssDNA based on minimum free en-
ergy constraints. Although secondary structure is predicted for the 175 nucleotide leader region,
the prediction is not high confidence, indicated by the green colour. This represents about a 50%
confidence (Figure 5.10A). The downstream region is only 80 nucleotides long and is predicted
to form two short regions of double-stranded RNA, each of about 5 basepairs. The prediction
is high confidence, indicated by the red colour (Figure 5.10C). The fusion of the leader and
downstream RNA is 255 nucleotides long. An extended region of about 38 basepairs is predicted
with very high confidence. The leader and downstream regions are complementary in sequence,
suggesting that they undergo Watson-Crick base-pairing during transcription of the 16S rRNA
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Figure 5.9: A) Cloning of ribosomal RNA leader and downstream regions. For the ribosomal
leader sequence, two PCR products were obtained. The lower molecular weight sample was
of the correct size. The bands were excised, gel extracted, and subsequently cloned into a
pGEM-T vector. B) A splice-by-overlap extension methodology was used to fuse the leader and
downstream elements. The PCR product was also gel extracted and ligated into a pGEM-T
vector.
gene in archaea (Figure 5.10B).
Figure 5.10: Predicted folds of A) 16S rRNA leader, B) leader-downstream fusion, C) down-
stream regions of the M. jannaschii rrnA 16S gene.
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5.4.1 EMSAs Using Riboprobes
EMSA assays were performed using the NusA mutants and the riboprobes (Figure 5.11). RNA
was at the same concentration in all reactions. 10 µl of riboprobe diluted 1:50 in RNase-free
water was added to the reaction in a final volume of 20 µl. Varying final concentrations of pro-
tein were used in each reaction (25 nM, 125 nM, 250 nM, 500 nM, 1 µM, 2 µM, and 10 µM). As
with the A2 RNA bandshifts, the KH1 GDDG mutant has lower affinity for the leader, fusion,
and downstream RNA, whereas the KH2 GDDG mutation does not decrease the affinity. For
the wild-type protein, strong complex formation is evident at 500 nM for the leader, fusion, and
downstream riboprobes. For the KH1 GDDG mutant strong complex formation is not observed
until 1 µM, although there is still a weak shift at 500 nM. The KH2 GDDG mutant shows higher
affinity for the leader and downstream RNA than for the fusion. A strong band shift is present
at 250 nM for the leader and downstream RNA, as opposed to 500 nM for the fusion. Whilst
the general observations of RNA-binding of the mutants is similar to the A2 RNA, the binding
is of higher affinity for the riboprobes. For the A2 RNA, complex formation is not evident until
the protein concentration reaches the region of 5 µM (Figure 5.5). Band shifts occur at an or-
der of magnitude lower for the riboprobes indicating that NusA binds the ribosomal leader and
downstream regions with higher affinity than the A2 RNA. NusA-bound RNA was quantified as
a percentage of total RNA from a control lane containing no NusA using ImageJ.
5.5 Scaffold-Independent Analysis
In order to gain insight into the possible function of archaeal NusA, a technique called scaffold-
independent analysis (SIA) (Beuth et al., 2007) was performed to determine what, if any, pref-
erence NusA has for RNA sequence. SIA is an HSQC-based assay that enables determination
of the sequence specificity of an RNA-binding KH domain. It can determine positive and nega-
tive discrimination of nucleotides. In order to perform SIA, the protein of interest is incubated
with pools of RNA pentamers. This is because KH domains bind a region of RNA between 4–5
nucleotides long (Lewis et al., 2000). The first nucleotide in the pentamer is bound at its 2′
OH and phosphate group in a non-sequence-specific manner (Lewis et al., 2000). Therefore in
SIA the first nucleotide of the pentamer is always a U and referred to as position 0. The other
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Figure 5.11: EMSA performed with the NusA mutants on the rRNA(A) 16S leader, and
rRNA(A) 16S fusion riboprobes. Concentration of protein in nM shown above wells. NusA-
RNA complexes were quantified using ImageJ (red).
four nucleotides, however, are bound in a sequence-specific manner. Three out of the remaining
four positions are random (either A, U, G or C, referred to as N). In the remaining position the
identity of the nucleotide is known and always constant in a given RNA pool. The preference of
the KH domain for each position of the RNA pentamer is analysed independently of the other
positions. Thus for each position, four HSQC spectra are recorded (one for each of the 4 RNA
nucleotides). Each spectrum is recorded with a pool of 64 RNA pentamers (There are three
random nucleotides within each pentamer, each of which can take one of four identities. This
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Position 1 Position 2 Position 3 Position 4
A pools UANNN UNANN UNNAN UNNNA
C pools UCNNN UNCNN UNNCN UNNNC
G pools UGNNN UNGNN UNNGN UNNNG
U pools UUNNN UNUNN UNNUN UNNNU
Table 5.1: RNA oligo pools used in SIA. For each of the four analysed positions, four separate
HSQC spectra are recorded in which the identity of the nucleotide at the analysed position
is known and constant (one of A, U, G, or C). The nucleotide identity at the remaining three
positions is random (N). Thus in each library there is a pool of 64 different RNA pentamers. The
nucleotide preference at each position is determined independently of the other three positions.
gives 43 possible variants.) (Table 5.1). One advantage of SIA analysis is that it allows the
determination of RNA-binding specificity under equilibrium conditions. RNAs with a higher
affinity for the protein will have a greater proportion bound, resulting in a larger change in the
chemical shifts of the HSQC spectra. The relative bias for a nucleotide at any given position is
ascertained by comparing the perturbation size of the change in the chemical shift relative to
the spectrum of free protein.
5.5.1 HSQC NMR Spectroscopy
Some atomic nuclei have spin. Spin has already been discussed with respect to electrons (see
Chapter 4). 1H, 15N, and 13C are commonly used in protein NMR. Since 15N and 13C are not
naturally abundant, they must be incorporated into proteins by expressing them in minimal me-
dia where the nitrogen and carbon sources are highly enriched in the desired isotope (see Chapter
2). Like electrons, 1H, 15N, and 13C have a spin number of 1/2. This means that when placed
in an external magnetic field they can take one of two possible orientations. In an analogous
manner to EPR, atomic nuclei that have spin can be excited from the lower to the higher energy
state by providing energy that is equal to the difference between the two spin states. Atomic
nuclei resonate in the MHz region, compared to electrons which resonate in the GHz region. It
is possible for magnetisation to be transferred between nuclei. In 15N-1H HSQC spectroscopy
magnetisation is transferred from the 1H that is bonded to the 15N, to the 15N, and then back to
the 1H. The 1H and 15N chemical shifts are therefore correlated. This results in a 2D spectrum
where all NH groups give rise to a peak. All amino acids are represented by a backbone NH peak
except for the imino acid proline which has no NH group. In addition the NH of tryptophan,
asparagine, and glutamine side chains also give rise to shifts. An HSQC spectrum can pro-
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vide information regarding whether a protein is well folded, in which case the spectrum will be
well dispersed. The position of the chemical shifts may be affected by interaction with another
biological molecule, making HSQC a useful technique for probing interactions between molecules.
Figure 5.12: Transfer of magnetisation in an HSQC experiment. Magnetisation is transferred
from the 1H that is bonded to the 15N, to the 15N, and then back to the 1H.
SIA only works on single KH domains. Since NusA contains two KH domains it was necessary
to selectively knock out their RNA-binding activity. Otherwise both KH domains would bind
the RNA pentamers, resulting in two signals which could not be separated. Therefore the KH1
GDDG mutant was used.
5.5.2 The NusA KH2 Domain Binds RNA with Little Preference for
Sequence
Initially the HSQC spectrum of the free protein was overlaid against a spectrum containing a
completely random pentamer to determine whether RNA addition resulted in crosspeak shifts.
Once this was established, the SIA analysis was carried out. All HSQC spectra were recorded
at a protein concentration of 70 µM. RNA pentamers were also added at 70 µM. The spectra
were recorded on a Brucker Avance spectrometer, operating at 700 MHz.
Each RNA-binding spectrum was overlaid with the spectrum of free protein (Figure 5.14) and
the peaks that changed upon RNA binding were identified. Eight chemical shifts were selected
5.5. Scaffold-Independent Analysis 153
Figure 5.13: HSQC spectra obtained in NusA KH1 GDDG SIA experiment showing A, C, G,
and U pools for positions 1, 2, 3, and 4. Spectra of free protein in red. Spectra of samples
containing a 1:1 ratio of protein:RNA are overlaid in blue.
that changed in each spectrum and each position of the pentamer was analysed independently.
For each of the eight selected shifts, four relative chemical shift changes were determined upon
RNA addition (one for each of the four nucleotides). This typically gave values in the range of
0–0.3 ppm. For each of the eight selected peaks in the spectra, the four relative shift changes
were normalised to the highest value by dividing them by the highest relative distance change.
This gave a number between 0–1 for each possible nucleotide at each analysed position of the
pentamer. The eight normalised shift changes were averaged to give the final SIA selectivity
scores. This was repeated for each of the four analysed positions of the pentamer, and the al-
lowed and disallowed nucleotides were determined.
SIA on the KH2 domain of NusA did not reveal strong binding specificity, although there does
appear to be negative selection for particular nucleotides in positions 1, 3 and 4. In position 1,
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Figure 5.14: Relative shift changes for the eight selected peaks upon RNA addition at A) position
1, B) position 2, C) position 3, and D) position 4. For each peak A is blue, C is orange, G is
yellow, and U is green. E) Averaged SIA selectivity scores for each analysed position of the
RNA pentamer. The relative affinities for each nucleotide are indicated. Positions 1 and 3 show
negative selectivity for C. Position 4 shows negative selectivity for U.
A, G and U are all accommodated but there is negative selection against C. In position 2 all
ribonucleotides are accommodated, although G seems to be particularly favoured. In position 3,
C is again selected against. In position 4 all nucleotides seem to be bound by NusA reasonably
well. G is particularly favoured and there is possibly negative selection against U.
5.5.3 HSQC Analysis of Additional NusA RNA-Binding Mutants
The SIA experiment on the KH1 GXXG–to–GDDG mutant did not demonstrate strong se-
quence specificity. Given that bandshift assays indicated that NusA may bind RNA via a novel
site, HSQC spectra of the NusA RNA-binding mutants were recorded to determine whether it
was worthwhile performing SIA on the KH2 GDDG mutant. These spectra were recorded on a
Brucker Avance, operating at 600 MHz.
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Figure 5.15: HSQC spectra of NusA RNA-binding mutants. Red: free protein. Blue: 1:1 ratio
protein-to-RNA. A) WT, B) KH1 GDDG, C) KH2 GDDG, D) KH1/2 GDDG, E) K64E K65E.
All RNA-containing spectra recorded with NNNGN pentamers, except KH1 GDDG which was
recorded with NNNNC pentamers. Protein and RNA at 1:1 ratio (70 µM). The same shifts
change upon the addition of RNA for all mutants.
All of the mutants result in spectra that are well dispersed (Figure 5.15), indicating that they
are properly folded and that there is no aggregation. They confirm that the mutants, including
the double KH1/2 GDDG mutant, are able to bind to RNA as evidenced by the change in some
of the chemical shifts upon the addition of RNA. The EMSAs suggest that the KH1 domain,
and not the KH2 domain contributes more strongly to RNA binding, however the HSQC spec-
tra clearly indicate that the same shifts are changing in both the KH1 and the KH2 mutants.
Furthermore the same shifts change upon the addition of RNA in all of the mutants, indicated
in black circles. This is an unexpected observation and strongly suggests that NusA binds RNA
via a novel binding site, using residues other than the GXXG motifs and the K64, K65 region.
This also indicates that performing SIA on the KH2 GDDG mutant may not be informative
because SIA only works for canonical KH domains.
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5.6 Analysing NusA by 3D NMR
5.6.1 Expression and Purification of Double-Isotopically Labelled
NusA
Three-dimensional NMR was performed on NusA to determine precisely which residues are
involved in the binding of RNA. Three-dimensional NMR requires protein that has been isotopi-
cally labelled with 15N and 13C. In addition the protein was expressed in D2O media. Deuterated
proteins have a decreased rate of relaxation of their spins from dipole-dipole interactions and
therefore give spectra of greater quality. Although about 80% of the hydrogens within the pro-
tein are 2H, the NH hydrogens are able to exchange with the solvent. Therefore 1H resonances
can still be observed on proteins expressed in D2O media. An overnight culture was grown in
minimal media and used to inoculate 3 L the following morning. Protein expression was induced
at an OD600 of 0.6, and the cells were harvested 5 hours thereafter. NusA was extracted, purified
on a heparin column and concentrated to approximately 400 µM. The sample was analysed by
NMR using an HNCACB pulsed experiment. Within this experiment resonance is transferred
from the 1Hβ to 13Cβ, and then from 13Cβ to 13Cα. Resonance is also simultaneously trans-
ferred from 1Hα to 13Cα. From 13Cα the resonance is transferred to 15N, and finally to the 1H of
the backbone amide (Figure 5.16A). Thus there are three dimensions to the resulting spectrum:
13C, 15N, and 1H. HN(CO)CACB experiments were also conducted. In the HN(CO)CACB ex-
periment, resonance is transferred from 1Hβ to 13Cβ, and then from 13Cβ to 13Cα. Resonance
is also simultaneously transferred from 1Hα to 13Cα. It is then transferred to 13CO, and then
to the 15N of the backbone amide and finally to the 15NH (Figure 5.16B). Again, there are three
dimensions to the spectrum. These two experiments are both routinely used together to assign
a protein backbone in an NMR spectrum. Together, they enable shifts from one residue to be
linked to shifts from the next residue, which enables sequential assignment of residues.
5.6.2 Assigning the NusA Residues that Bind RNA
The NMR spectrum is currently being assigned by Katherine Collins of Professor Andres Ramos’s
group and is approximately 60% complete. It is already clear that the residues currently as-
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Figure 5.16: Transfer of magnetisation in 3D NMR experiments used to assign the backbone of
M. jannaschii NusA. A) In the HNCACB experiment magnetisation is transferred from 1Hβ to
13Cβ. Then it is transferred from 13Cβ and 1Hα to 13Cα. Finally magnetisation is transferred
to 15N, and then to the 1H of the backbone amide. B) In the HN(CO)CACB experiment
magnetisation is transferred from 1Hβ to 13Cβ. Then it is transferred from 13Cβ and 1Hα to
13Cα. From here it is transferred to 13CO, and then to the 15N of the backbone amide and
finally to the 15NH.
Figure 5.17: A) 3D NMR spectrum of M. jannaschii NusA and current assignment of residues
that bind RNA. A) 3D Spectrum showing 15N and 1H dimensions. B) Homology model of M.
jannaschii NusA showing currently assigned residues (green). Residues predicted to bind RNA
in red.
signed as RNA-binding are not similar to those in bacteria (Figure 5.17). The residues assigned
as binding RNA are across the entire surface of the homology model, unlike in bacteria where
the RNA spans the two GXXG loops only. In contrast, the two GXXG loops in archaea, both
of which have been assigned, do not shift upon the addition of RNA. This suggests either that
M. jannaschii NusA binds to RNA via a radically different mechanism to bacterial NusA, or
that the assignment is not providing an accurate model of how NusA actually binds RNA in
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vivo. Support for the assignment comes from the 15N–1H HSQC spectra that were performed
on the RNA-binding mutants. These indicated that the same shifts change upon RNA addition
for all mutants. This in turn strongly suggests that residues other than the GXXG motifs are
binding the RNA. One factor which could be problematic is the use of RNA pentamers. Whilst
individual KH domains bind regions of RNA 4–5 nucleotides long, the region of RNA that NusA
binds in vivo is part of a long transcript, not an isolated pentamer. Using longer RNAs in an
NMR experiment may not be feasible, however. This may enable multiple copies of NusA to
bind to individual RNAs, which would in turn decrease the rate of tumbling and result in poor
dispersion of the NMR spectrum.
5.7 Discussion
Within this chapter the RNA-binding properties of M. jannaschii NusA have been analysed.
Bandshift assays were performed to determine regions of NusA that bind to RNA. Mutation of
the KH1 GXXG loop impairs RNA binding, but mutation of the KH2 GXXG loop has no effect.
Combining the two GXXG–to–GDDG mutations with the K64E, K65E mutation completely
abolishes RNA binding, indicating a role for the two lysine residues in the binding of RNA.
This reveals that NusA may be interacting with RNA via a novel binding site. Comparison
of bandshift assays using A2 RNA and the 16S leader/downstream regions suggests that NusA
does bind some sequences preferentially to others. Complex formation occurs at a 10-fold lower
NusA concentration for the biologically relevant riboprobes than for the A2 RNA.
The SIA analysis of the KH1 GXXG–to–GDDG mutant did not reveal a strong sequence bias
for NusA. The lack of apparent sequence specificity may indicate that NusA does not have a
sequence-specific function in archaea. However, the data also points to NusA associating with
RNA via a novel binding site which has not been observed in KH domain proteins before. This
explains why the SIA did not provide a clear sequence specificity; SIA analyses canonical KH
domains, but M. jannaschii NusA does not bind RNA in a canonical fashion.
Analysis of the remaining KH domain mutants by HSQC indicates that the same peaks change
in their chemical shifts upon the addition of RNA for the KH1 and KH2 mutants. This provides
5.7. Discussion 159
yet further evidence that NusA is binding RNA via a novel binding site, and utilising regions of
the protein other than the GXXG loops and the lysine residues K64 and K65. 3D NMR was per-
formed to allow assignment of all residues that are involved in the binding of NusA. Currently the
spectrum is approximately 60% assigned. From the peaks that have been assigned it is clear that
NusA is interacting with the RNA in an unexpected way. The two GXXG loops are apparently
not involved at all. Those residues whose chemical shifts change upon the addition of RNA are
scattered across the protein, and there is no obvious region or path where the RNA is binding.
This may be due to the fact that RNA pentamers were used in the experiment, as opposed to
more biologically relevant longer RNAs. Upon completion of the assignment it will be possible
to reach a clearer conclusion as to whether RNA really does bind across all over the NusA sur-
face, or whether a new approach needs to be taken to successfully create a model of RNA binding.
An alternative approach to determine the sequence specificity of NusA would be to use RNA
SELEX (Systematic Evolution of Ligands by Exponential Enrichment). SELEX enables the in
vitro selection of nucleic acid aptamers that are bound by a protein (Stoltenburg et al., 2007).
It requires the production of a large library of random DNA sequences with 5′ and 3′ adaptors
that are targets for primers. The DNA library must be converted to RNA and is then incubated
with the immobilised protein of interest. Aptamers that do not bind are washed away. The ap-
tamers that do bind are reverse-transcribed and amplified by PCR using primers against 5′ and
3′ adaptors. The enriched aptamers are re-transcribed into RNA and the cycle is repeated. The
binding conditions increase in stringency each round to select for the highest affinity binders.
The sequences of the aptamers can then be determined and the sequence preference of the pro-
tein identified. SELEX has the advantage that large RNAs can be analysed. This has the
additional advantage of allowing selection for and against RNA secondary structure, which is a
very important factor in protein-RNA interactions.
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6.1 The State of the Art
RNAP is an essential multi-subunit enzyme found in all domains of life that carries out the
process of transcription (Werner and Grohmann, 2011). RNAPs across the three domains of life
show a high degree of structural conservation with a characteristic ‘crab claw’ structure. The
archaeal transcription machinery represents a streamlined version of that found in eukaryotes.
Archaeal RNAP closely resembles eukaryotic RNAPII and contains a number of subunits that
are not found in bacteria, most notably the Rpo4/7 stalk.
RNAP is a highly processive enzyme that is able to transcribe 1000s of nucleotides at a time.
However, RNAP is also subject to frequent pausing. Pausing provides opportunity for regula-
tion by facilitating the binding of transcription factors to the elongation complex, but it also
slows transcription (Landick, 2009). Various general transcription elongation factors function to
reduce pausing and promote processive elongation. The Gre factors in bacteria and TF(II)S in
archaea/eukaryotes promote RNA cleavage in backtracked RNAP. The result of this cleavage is
that the 3′ end of the RNA is correctly positioned in the active site for incorporation of further
nucleotides. The Gre factors and TF(II)S act via the same mechanism but are not homologous
(Kettenberger et al., 2003; Opalka et al., 2003). NusG and its archaeal/eukaryotic homologue
Spt5, in contrast, are the only universally conserved RNAP-associated transcription elongation
factors (Werner and Grohmann, 2011). NusG contains an N-terminal NGN domain and a C-
terminal KOW domain. It increases the processivity of RNAP by binding to the coiled-coil
of the RNAP clamp domain, thereby enclosing the DNA entry channel. Spt5 in archaea and
eukaryotes functions via the same mechanism (Hirtreiter et al., 2010a). Whilst the processivity-
enhancing function of NusG proteins is conserved across the three domains of life, NusG proteins
have evolved additional functions that differ between bacteria, archaea, and eukaryotes. These
additional functions are mediated via the KOW domain(s).
In bacteria the multiple functions of NusG are well-documented. The KOW domain binds to
the termination factor rho (Li et al., 1993), facilitating the silencing of foreign DNA (Cardinale
et al., 2008). The NusG KOW domain is also able to bind to the ribosomal protein S10, sug-
gesting that it is able to directly couple transcription and translation by bridging RNAP and
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the ribosome (Burmann et al., 2010b). In eukaryotes, the functions of Spt4/5 have also been
well-documented. In metazoans, Spt4/5 is required to mediate the phenomenon of promoter-
proximal stalling, where RNAP pauses about 40 nucleotides downstream of the transcription
start site in an activated state (Rougvie et al., 1988). The Spt5 KOW domains also bind RNA
processing and nucleosome remodelling factors (Lindstrom et al., 2003).
The functions of Spt4/5 in archaea are less well characterised. Whilst it is known that the NGN
domain of Spt5 binds to RNAP, and that Spt4/5 increases the processivity of RNAP, very little
is known about its other functions. For example, it is not known whether Spt5 is capable of
binding to ribosomes. Earlier data suggests that Spt4 stabilises the NGN domain but this has
never been quantified (Hirtreiter et al., 2010a). T. maritima NusG, and RfaH both exhibit
conformational flexibility between their N-terminal and C-terminal domains (Belogurov et al.,
2007; Dro¨gemu¨ller et al., 2013). Archaeal Spt4/5 has not been examined to determine whether
there is flexibility between the NGN and KOW domains. However, the fact that it has not been
possible to crystallise full length M. jannaschii Spt4/5 suggests that there are flexible regions
within the protein.
NusA is a protein that also binds to RNAP thereby modulating transcription (Schmidt and
Chamberlin, 1987). Unlike NusG, it is not universally conserved and is present in bacteria and
archaea only. In bacteria, NusA promotes pausing when acting in isolation. However, NusA also
functions as a component of the antitermination complex, in which it has the opposite function
(DeVito and Das, 1994). The antitermination complex enables RNAP to enter a pause and
termination-resistant state. This protects against rho-dependent termination, and also enables
RNAP to read through intrinsic terminators. In E. coli, antitermination was discovered in phage
λ-infected cells where the phage protein N hijacks the host proteins NusA, NusB, NusE (S10)
and NusG to promote expression of its genome. NusA also functions to promote the correct and
efficient folding of rRNA (Bubunenko et al., 2013).
The functions of NusA in archaea are also less well characterised. Archaeal NusA is a streamlined
version of that found in bacteria. It contains two KH domains only. It is not known therefore
whether it retains its RNAP-binding activities. It has previously been shown that NusA binds
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to RNA, but no attempt has been made to determine its sequence specificity or to dissect the
relative contributions of the NusA domains to RNA binding (Shibata et al., 2007).
6.2 Contribution to Knowledge Within This Thesis
This thesis presents an in-depth biochemical and biophysical analysis of Spt4/5 from the archaeon
M. jannaschii. Archaeal cell extract was separated by Superose 6 size exclusion chromatogra-
phy. The elution profiles of the ribosome (S10) and RNAP (Rpo4/7) were characterised. It was
then shown that Spt4/5 elutes in three peaks. These are ribosome-bound, RNAP-bound, and
free protein. This provides evidence, for the first time, that archaeal Spt4/5 may have a role
in translation. The Spt4/5 complexes are nuclease-sensitive, with Spt4/5 dissociating from the
transcription and translation complexes upon DNase treatment. This is consistent with Spt4/5
being a transcription factor that binds to actively transcribing DNA-bound RNAP. The inter-
action between Spt4/5 and the ribosomes was then analysed using MST. This gave a Kd in the
low µM range and is the first time the interaction between Spt4/5 and whole ribosomes has
been quantified. The affinity of the interaction is consistent with transcription being a dynamic
process. The interaction needs to be strong enough to allow robust gene expression. However,
dissociation of Spt4/5 from both RNAP and the ribosome is required for transcription termina-
tion and for repetition of the transcription cycle.
DEER was performed on double nitroxide spin-labelled Spt4/5. Spt4/5 exhibits flexibility be-
tween the NGN and KOW domains of Spt5. The data suggests that Spt5 is able to exist in
more than one conformation and that the presence of Spt4 restricts its mobility. This is the
first time that distinct Spt5 conformations have been observed in archaea. Spt4 may promote
the expression of distinct gene subsets or convert Spt5 from a processivity-enhancing factor to
a transcription-translation coupling factor. This could be achieved through Spt4 positioning
the KOW domain, allowing for the recruitment of transcription factors. Thermofluor assays on
Spt4/5 domain-deletion mutants demonstrated that Spt4 stabilises the NGN domain of Spt5.
The NGN domain does not denature at 98◦C when it is bound by Spt4. The NGN domain dena-
tures at 85◦C when unbound. This is the first time that the stabilisation of the NGN domain by
Spt4 has been quantified. Limited proteolysis assays demonstrated that Spt5 is more susceptible
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Figure 6.1: Summary of factor interactions determined within this thesis. The KOW domain of
Spt5 binds to the S10 protein of the ribosome. NusA is stably associated with the ribosome and
binds RNA with little sequence specificity.
to digestion when Spt4 is removed. Spt5 is cleaved into two fragments that likely correspond to
the NGN and KOW domains. This suggests that there is flexibility in the inter-domain linker
and therefore supports the data obtained by DEER. Spt4 restricts the flexibility between the
two domains of Spt5 by making contacts with the flexible linker (Figure 6.2).
NusA from fractionated cell extract was also shown to elute in the same fractions as the ribo-
some, but not in the same fractions as RNAP. This is consistent with the fact that the bacterial
NusA N-terminal domain, which binds RNAP, is not present in archaea. Analysis of the size
fractionation of NusA from non-nuclease-treated cell extract indicated that NusA elutes in a
broad peak. This suggests that it is bound to multiple RNAs of various sizes, rather than to a
specific species of RNA. Analysis of purified ribosomes on a Superose 12 column confirmed that
NusA is stably associated with the ribosome.
The RNA-binding of M. jannaschii NusA was analysed. A homology model of M. jannaschii
NusA was generated, and this aligned well with the structure from A. pernix. Band shift assays
on KH domain GXXG–to–GDDG mutants indicated that the KH1 domain of NusA contributes
to RNA-binding much more than the KH2 domain. The bandshift assays also suggested that
NusA may bind RNA via a novel binding site, as NusA was still able to bind to RNA when both
GXXG loops had been mutated. Combining the two KH GXXG–to–GDDG mutations with the
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Figure 6.2: Summary of Spt5 conformations. A) Spt4 binds to the NGN domain and protects
the flexible linker. This also restricts the conformational flexibility of Spt5. B) In the absence
os Spt4, there is more conformational flexibility in the Spt5 interdomain linker. C) Comparison
of the P. furiosus Spt4/5 crystal structure and the M. jannaschii homology model. In the P.
furiosus crystal structure, Spt4 is observed to make contact with the flexible linker. Spt5 is
more compact in the crystal structure. In the homology model Spt4 does not protect the flexible
linker and Spt5 is more elongated.
charge reversal of two lysine residues (K64 and K65) to glutamate completely abolished binding.
HSQC analysis supports the notion that NusA binds RNA via a novel binding site, as the same
peaks change their chemical shifts upon the addition of RNA in all of the mutants. Repeating
the EMSAs using the rrnA leader and downstream regions, and a fusion of the two resulted in
complex formation at lower concentrations of NusA. For the Cy3-labelled A2 RNA, bandshifts
were observed at 5 µM NusA whereas for the rRNA riboprobe, bandshifts were observed at 250–
500 nM. This represents a 10-fold higher affinity suggesting that NusA does have some sequence
bias. However SIA analysis on the KH1 GXXG–to–GDDG mutant did not yield a clear sequence
bias. It is therefore not clear whether archaeal NusA preferably binds to the rrnA leader and
downstream regions in vivo. 13C, 15N, 2H labelled NusA was prepared and a 3D NMR spectrum
was recorded to enable assignment of residues that are involved in the binding of NusA. Ap-
proximately 60% of the protein has currently been assigned and will hopefully shed new insights
into the mechanism of RNA binding. However it is already clear that something interesting
is occurring. The GXXG motifs have been identified as non-RNA binding. GXXG motifs are
usually considered the key players in KH domain-RNA interactions. It will hopefully become
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clearer how M. jannaschii NusA binds RNA upon completion of the NMR spectrum assignment.
6.3 Future Perspectives
This thesis has provided significant insights into the function of the archaeal Spt4/5 and NusA
proteins. However, these insights raise further questions regarding how these factors carry out
their roles. Superose 6 separation of cell extract and MST indicate that Spt4/5 interacts with
ribosomes. The interaction could be further confirmed by co-pelleting experiments, which have
the advantage of not requiring ribosome labelling. The functional interplay between RNAP,
Spt4/5, and the ribosome could be analysed by developing an in vitro coupled transcription-
translation system, similar to that which has been reported in bacteria (Castro-Roa and Zenkin,
2012).
In vitro studies enable the molecular mechanisms of complex processes to be elucidated. How-
ever, the true biological significance of these studies can only be ascertained through in vivo
validation. There is no genetics system available for M. jannaschii. However, it is possible
to knock out proteins and to introduce mutants into the crenarchaea Sulfolobus acidocaldarius
(Wagner et al., 2009), which our lab has recently started studying. Introducing mutations into
Spt4/5 that abolish its interaction with the ribosome and analysing the effects on gene expression
would indicate whether the interaction between Spt4/5 and the ribosome regulates transcription.
Data within this thesis demonstrates that Spt4 stabilises the NGN domain of Spt5. It would
be interesting to determine whether this stabilisation is essential for cell viability by attempting
to knock out Spt4. Analysis of global transcription in the presence and absence of Spt4 would
identify whether Spt4 is responsible for regulation of specific subsets of genes.
The Superose 6 size separation of M. jannaschii cell extract provides strong evidence that NusA
does not bind to RNAP. Furthermore the ribosomal protein S10 is only found in ribosome-
associated fractions and not in its free form. This strongly suggests that NusA and S10 do not
not participate in an antitermination complex. Further insights into the role of NusA could
also be obtained by taking an in vivo approach and determining where within the transcrip-
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tome it binds. For example, does NusA bind to the rrn operon leader sequence and regulate
ribosome biogenesis? This could be determined by using a method such as CLIP which enables
determination of the in vivo occupancy of RNA-binding proteins (Ule et al., 2005). In CLIP,
proteins are covalently cross-linked to RNA using UV light and the cells are then disrupted.
The protein-RNA complexes are subsequently immunoprecipitated, and the RNA is partially
digested then radiolabelled. After SDS PAGE analysis the cross-linked protein is transferred to
a nitrocellulose membrane and excised. The protein is digested by proteinase K, and the RNA
is reverse-transcribed to cDNA, amplified by PCR, and sequenced. The sequences can then be
identified in the transcriptome.
Another line of study would be to introduce the NusA RNA-binding mutations into archaeal
cells and analyse the cell viability. It would be interesting to determine whether one of the KH
domains has a more important role in vivo, and whether this would validate the in vitro EMSAs
presented in thesis.
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